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Abstract  
ENGLISH 
Worldwide, colorectal cancer (CRC) is the third most incident cancer and the second in terms of 
mortality for both sexes combined. Besides an ageing population and the acquisition of 
westernized dietary habits of high-income countries, other modifiable risk factors such as obesity, 
physical inactivity and smoking increase the risk of CRC development, which brings to light that 
CRC is largely a preventable disease. Moreover, some dietary patterns such as the Mediterranean 
diet and the consumption of characteristic foods of this pattern, such as dairy products, have 
been consistently related to decreased risk of CRC development. However, prospective scientific 
evidence in this field focusing on elderly populations is scarce.  
The general objective of this thesis was to evaluate dietary and lifestyle determinants of CRC 
incidence. Thus, the potential associations between dairy product consumption with the risk of 
CRC within the frame of the PREvención con DIeta MEDiterránea (PREDIMED) cohort were 
investigated. On the other hand, in order to support our results regarding dairy product intake 
and CRC incidence, we carried out a systematic review and metanalysis of the available evidence 
coming from prospective cohort and case-control studies in adults, to examine the associations 
between the consumption of specific types of dairy products and CRC risk. Furthermore, the 
associations between the adherence to the 2018 WCRF/AICR (cancer-specific recommendations) 
and the low-risk lifestyle (LRL) (this index comprises smoking status, alcohol consumption, 
physical activity, diet and body mass index) scores, and the incidence of CRC in the PREDIMED 
population were also assessed. 
The results of this thesis show that high total dairy product consumption was inversely associated 
with CRC incidence in elderly Spanish individuals with cardiovascular risk, and especially, of 
importance was the intake of low-fat milk, which was the main driver behind the inverse 
association. However, the consumption of other dairy product subtypes (whole-fat and low-fat 
dairy products; total, low-fat and whole-fat yogurt; cheese; total, low-fat and whole-fat milk; 
concentrated full-fat dairy products, sugar-enriched dairy products and fermented dairy products) 
was not significantly associated with CRC risk. In addition, the systematic-review and meta-
analysis of observational studies included in the present thesis showed that higher consumption 
of total dairy products and total milk was consistently inversely related to CRC risk at all sites, 
cheese consumption was inversely associated with the risk of CRC and proximal colon cancer, and 
low-fat milk consumption was associated with decreased colon cancer risk in adults. No significant 
associations were found between CRC incidence and the consumption of low-fat dairy products, 
whole milk, fermented dairy products and cultured milk. Finally, adhering to emergent lifestyle 
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scores, such as the 2018 WCRF/AICR and the LRL scores, was substantially associated to a lower 
CRC risk in the PREDIMED study.  
In conclusion, consuming dairy products such as low-fat milk might contribute to decrease CRC 
risk in elderly individuals with high CVD risk. Moreover, our systematic review and meta-analyses 
conducted in adults showed inverse associations with CRC for the consumption of total milk and 
cheese. The associations between different subtypes of dairy products and CRC risk differed by 
colon cancer location and subsite. Besides, following cancer-specific recommendations and 
healthier dietary and lifestyle patterns might also contribute to decrease CRC risk in elderly 
individuals who are at high cardiovascular risk.  
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CATALAN 
Mundialment, el càncer colorectal (CCR) és el tercer càncer més incident i el segon en termes de 
mortalitat en ambdós sexes combinats. A més d'un envelliment de la població i de l’adquisició 
d’hàbits dietètics occidentalitzats dels països amb rendes altes, altres factors de risc modificables 
com l'obesitat, la inactivitat física i el tabaquisme augmenten el risc de desenvolupament de CCR. 
És per això que, el CCR és en gran part una malaltia que es pot prevenir. D'altra banda, alguns 
patrons dietètics com la dieta mediterrània i el consum d'aliments característics d'aquest patró, 
com els productes làctics, han estat relacionats amb la disminució del risc de desenvolupament 
de CCR. No obstant això, les evidències científiques prospectives en aquest camp que estudiïn 
poblacions d'edat avançada és escassa.  
L'objectiu general d'aquesta tesi és avaluar els determinants dietètics i d'estil de vida de la 
incidència de CCR. Per tant, es van investigar les possibles associacions entre el consum de 
productes làctics amb el risc de CCR en el marc de la cohort PREvención con DIeta MEDiterránea 
(PREDIMED). D'altra banda, amb l'objectiu de corroborar els nostres resultats en relació amb la 
ingesta de productes làctics i la incidència de CCR, vam dur a terme una revisió sistemàtica i 
metanàlisi de les evidències disponibles procedents d’estudis de cohort prospectius i de casos-
control en adults, amb l’objectiu d’estudiar les associacions entre el consum de diferents subtipus 
de productes làctics i el risc de CCR. D'altra banda, també es va avaluar la incidència de CCR en 
la població PREDIMED, associada a l'adherència a l’índex 2018 WCRF/AICR (recomanacions 
específiques de càncer) i a l’índex d'estil de vida de baix risc (LRL) (aquest índex comprèn l’hàbit 
tabàquic, la ingesta d'alcohol, l’activitat física, la dieta i l’índex de massa corporal). 
Els resultats d'aquesta tesi mostren que, un consum elevat de productes lactis totals es va 
associar inversament amb la incidència de CCR en persones espanyoles d’edat avançada amb risc 
cardiovascular, i especialment, la ingesta de llet baixa en greix, va mostrar ser el principal 
contribuent de l’associació inversa. No obstant això, la ingesta d'altres subtipus de productes 
làctics (productes làctics sencers i baixos en greix; iogurt total, baix en greix i sencer; formatge; 
llet total, baixa en greix i sencera; productes làctics concentrats en greix, productes làctics 
ensucrats i làctics fermentats) no es va associar significativament amb el risc de CCR. A més, la 
revisió sistemàtica i metanàlisi d'estudis observacionals inclosa en la present tesi, va mostrar que 
un major consum de productes làctics totals i de llet total es relacionava inversament de forma 
consistent amb el risc de CCR en totes les localitzacions. El consum de formatge es va associar 
inversament amb el risc de CCR i de càncer de còlon proximal, i el consum de llet desnatada es 
va associar amb un risc disminuït de càncer de còlon. No es van trobar associacions significatives 
entre el risc de CCR i el consum de productes làctics baixos en greix, llet sencera, productes 
làctics fermentats i llet fermentada. Finalment, l'adherència a índexs emergents d'estil de vida, 
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com els índexs 2018 WCRF/AICR i LRL, es va associar substancialment amb un menor risc de CCR 
en l'estudi PREDIMED.  
En conclusió, consumir productes làctics, com la llet baixa en greix, podria contribuir a disminuir 
el risc de CCR en persones d’edat avançada amb risc cardiovascular elevat. D'altra banda, la 
revisió sistemàtica i metanàlisi realitzada en adults mostra associacions inverses amb el risc de 
CCR pel consum de llet i de formatge totals. Les associacions entre els diferents subtipus de 
productes làctics i el risc de CCR va diferir segons la localització del càncer de còlon. A més, seguir 
recomanacions específiques per la prevenció del càncer i patrons de dieta i estil de vida més 
saludables també poden contribuir a disminuir el risc de CCR en persones grans amb elevat risc 
cardiovascular.  
 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY AND LIFESTYLE DETERMINANTS ASSOCIATED WITH THE RISK OF COLORECTAL CANCER 
Laura Barrubés Piñol 
SPANISH 
Mundialmente, el cáncer colorrectal (CCR) es el tercer cáncer más incidente y el segundo en 
términos de mortalidad en ambos sexos combinados. Además del envejecimiento de la población 
y de la adquisición de hábitos dietéticos occidentalizados de los países con ingresos altos, otros 
factores de riesgo modificables como la obesidad, la inactividad física y el tabaquismo aumentan 
el riesgo de desarrollo de CCR, lo que hace que este cáncer sea en gran medida una enfermedad 
prevenible. Además, algunos patrones dietéticos como la dieta mediterránea y el consumo de 
alimentos característicos de este patrón, como los productos lácteos, se han relacionado 
consistentemente con la disminución del riesgo de CCR. Sin embargo, las evidencias científicas 
prospectivas en este campo, centradas en poblaciones de edad avanzada es escasa.  
El objetivo general de esta tesis es evaluar los determinantes dietéticos y de estilo de vida de la 
incidencia de CCR. Por tanto, se investigaron las posibles asociaciones entre el consumo de 
productos lácteos con el riesgo de CCR en el marco de la cohorte PREvención con DIeta 
MEDiterránea (PREDIMED). Por otro lado, con el fin de corroborar nuestros resultados en relación 
con la ingesta de productos lácteos y la incidencia del CCR, llevamos a cabo una revisión 
sistemática y metanálisis de las evidencias disponibles procedentes de estudios de cohorte 
prospectivos y de casos y controles en adultos, para examinar las asociaciones entre el consumo 
de diferentes subtipos de productos lácteos y el riesgo de CCR. Además, también se evaluaron 
las asociaciones entre la adherencia al índice 2018 WCRF/AICR (recomendaciones específicas para 
el cáncer) y al índice de estilo de vida de bajo riesgo (LRL) (este índice comprende el hábito 
tabáquico, el consumo de alcohol, la actividad física, la dieta y el índice de masa corporal) y la 
incidencia de CCR en la población PREDIMED. 
Los resultados de esta tesis muestran que el consumo elevado de productos lácteos totales se 
asoció inversamente con la incidencia de CCR en personas españolas de edad avanzada con riesgo 
de enfermedad cardiovascular y, especialmente, la ingesta de leche baja en grasa fue el principal 
contribuyente a la asociación inversa. Sin embargo, la ingesta de otros subtipos de productos 
lácteos (productos lácteos enteros y bajos en grasa; yogur total, bajo en grasa y entero; queso; 
leche total, baja en grasa y entera; productos lácteos concentrados en grasa, productos lácteos 
azucarados y productos lácteos fermentados) no se asoció significativamente con el riesgo de 
CCR. Además, la revisión sistemática y metanálisis de los estudios observacionales incluidos en 
la presente tesis mostró que un mayor consumo de productos lácteos totales y de leche total 
estaba relacionado inversamente, de forma consistente, con el riesgo de CCR en todas las 
localizaciones. El consumo de queso se asoció inversamente con el riesgo de cáncer de colon y 
de colon proximal, y el consumo de leche baja en grasa se asoció con una disminución del riesgo 
de cáncer de colon en adultos. No se encontraron asociaciones significativas entre el CCR y el 
consumo de productos lácteos bajos en grasa, leche entera, productos lácteos fermentados o 
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leche fermentada. Por último, la adherencia a índices emergentes de estilo de vida, como los 
índices 2018 WCRF/AICR y LRL, se asoció sustancialmente a un menor riesgo de CCR en el estudio 
PREDIMED.  
En conclusión, el consumo de productos lácteos como la leche baja en grasa podría ayudar a 
reducir el riesgo de CCR en personas de edad avanzada con alto riesgo cardiovascular. Por otro 
lado, la revisión sistemática y metanálisis llevada a cabo en adultos, mostró asociaciones inversas 
con el riesgo de CCR para el consumo total de leche y queso. Las asociaciones entre los diferentes 
subtipos de productos lácteos y el riesgo de CCR difirieron según la localización del cáncer de 
colon. Además, el seguimiento de recomendaciones específicas para la prevención del cáncer y 
seguir patrones de estilo de vida más saludables también puede contribuir a disminuir el riesgo 
de CCR en personas mayores con riesgo cardiovascular.  
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I. INTRODUCTION 
 
1. COLORECTAL CANCER  
 
1.1. Definition  
 
The term cancer defines a wide range of malignant tumors that might influence almost all organs 
and tissues of the body. It is principally a consequence of genetic mutations within a cell, which 
result in the proliferation of abnormal cells 1. 
Colorectal cancer (CRC), often referred to as bowel cancer, is a type of lower gastrointestinal 
cancer that includes malignant tumors of the colon and rectum (colorectum) 23.  
1.2. Anatomical subsites  
Although CRC develops in a single organ, this type of cancer is a highly heterogeneous disease 
across anatomic location of the primary tumor 4. The colorectum is anatomically divided into three 
segments: proximal colon (bowel segment from the cecum to the proximal two thirds of the 
transverse colon), distal colon (distal third of the transverse colon to the upper anal canal) and 
rectum. Because these three segments of the large intestine have different embryological origin, 
disparity in the incidence, pathogenesis, oncological pathways and outcome exists between the 
tumors developed 5–8. In addition, variations in the gut microbiota of the colon and host 
characteristics may also influence on this heterogeneity across the tumor locations 9,10. 
On the other hand, CRC risk factors differ by subsite in the large bowel suggesting that tumors in 
different anatomical locations might have distinct etiologies 8,11–13. Recently, in the European 
Prospective Investigation into Cancer and Nutrition (EPIC) study (n=521,330 men and women; 
14.9 years of follow-up), current smoking was associated with increased risk of proximal colon 
and rectal cancer, but not with distal colon cancer 12.  
According to demographical factors, variable distribution of subsite specific CRC has been also 
described 8. Proximal colon cancer is more prevalent in women 12, older individuals 14,15, and white 
and black individuals 168. Distal colon cancer is more prevalent in men 17 and younger individuals 
15, and rectal cancer in early-onset CRC (<50 years of age) 18 and Asian individuals 19,20.  
1.3. Incidence and mortality 
Globally, cancer causes one in eight deaths 21 and many countries have recorded a greater 
number of deaths from cancer than from cardiovascular disease (CVD) annually 22. By 2030, the 
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global cancer burden is estimated to increase to 21.7 million new cases and 13 million deaths 
mainly owing to an ageing population 21. 
In 2018, the International Agency for Research on Cancer (IARC) estimated approximately 18.1 
million new cases and 9.6 million cancer deaths globally. CRC accounted for over 1.8 million new 
cases and 881,000 deaths. Worldwide, CRC is the third most incident cancer (10.2% of the total 
cases) and the second in terms of mortality (9.2%) for both sexes combined. By sex, CRC is the 
second most commonly diagnosed cancer in females (Figure 1) and the third among males 
(Figure 2) 23. 
 
 
Figure 1. Estimated age-standardized incidence and mortality rates (worldwide) in 2018, females, all ages (per 100,000 
inhabitants). Source: GLOBOCAN 2018. 
 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY AND LIFESTYLE DETERMINANTS ASSOCIATED WITH THE RISK OF COLORECTAL CANCER 
Laura Barrubés Piñol 
 
 
Figure 2. Estimated age-standardized incidence and mortality rates (worldwide) in 2018, males, all ages (per 100,000 
inhabitants). Source: GLOBOCAN 2018. 
 
Geographical trends 
CRC incidence rates strongly vary around the globe being approximately 3-fold higher in 
economically developed countries than in transitioning countries 23. For colon cancer, the highest 
incidence rates occur in some parts of Europe (Hungary, Slovenia, Slovakia, the Netherlands and 
Norway), Australia/New Zealand, North America, Eastern Asia (Japan, Republic of North Korea, 
and Singapore in women) and in Uruguay. Even though rectal cancer incidence rates have similar 
regional distribution as colon cancer, the highest incidences are found in the Republic of Korea 
among males, and in Macedonia among females. In the meantime, most regions of Africa and 
Southern Asia have the lowest incidence figures for both cancers 23.  
However, increasing incidence rates do not always necessarily translate into increasing mortality 
statistics. In 2017, Arnold and collaborators 24 identified three CRC incidence and mortality 
tendencies connected with development levels. These global temporal patterns were: a) 
increasing incidence and mortality (many low- and middle-income countries comprising several 
Eastern European countries and in populations in Latin America and Asia); b) increasing incidence 
and decreasing mortality (several European countries, Canada and Singapore); and c) decreasing 
incidence and mortality (highly developed countries such as Australia, Iceland, New Zealand and 
Japan).  
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Taking all these into account, because CRC incidence rates have been linked with economic 
transition and Western lifestyles, this disease could be considered as a marker of socioeconomic 
development 24. 
1.4. Physiopathology  
Cancer appears as a consequence of mutations in somatic cells affecting critical genes involved 
in the regulation of cell proliferation and survival 25. This is a multi-step process characterized by 
the acquisition of different biological capabilities (i.e. hallmarks of cancer). Furthermore, tumors 
contain stromal cells that contribute to the development and expression of certain hallmark 
capabilities 26.  
More than 90% of CRCs are adenocarcinoma, which is a malignant neoplasm developed from 
glandular epithelial cells from the inner lining of the colon and rectum. Other rare types of CRCs 
include squamous cell carcinoma, adenosquamous carcinoma, spindle cell carcinoma and 
undifferentiated carcinoma 8,27. 
 
Natural history of colorectal cancer 
The natural history of CRC comprises four main stages (Figure 3) which are initiation, promotion, 
progression and metastasis 28. Initiation is characterized by irreversible genetic damages that 
predispose affected cells to neoplastic transformation. Subsequently, the initiated cells proliferate 
inducing abnormal growth (neoplasm) during the promotion phase. In the progression stage, 
further genetic and epigenetic alterations are undergone conferring selective growth advantage 
to cells. In this stage, benign tumor cells transform into malignant cancer cells and obtain 
metastatic potential. Metastasis occurs because of dissemination of cancer cells from the primary 
organ to other organs and tissues through the bloodstream or the lymphatic system. The most 
common metastatic site is the liver, followed by the lung and bone.  
The duration of each phase has wide ranges taking a long time since adenomas transform into 
cancer over 10-20 years. Of note, for hereditary CRC, progression through some of the stages 
can be faster 29,30.  
Pathways of colorectal carcinogenesis 
CRC is usually characterized by the proliferation of normal glandular epithelial cells of the colon 
and rectum into benign adenomatous polyps. The cell origin for most CRCs is currently assumed 
to be a stem cell or stem-cell-like cell (placed in the base of the colonic crypts) which are the 
product of progressive accumulation of genetic and epigenetic alterations that inactivate tumor-
suppressor genes and activate oncogenes. Additionally cancer stem cells have been also proposed 
to be the seeds of metastases 31,32.  
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The polyp develops into an advance adenoma (clearly premalignant), afterwards into an invasive 
adenocarcinoma, and eventually metastatic cancer 3,33 (Figure 3). It is worth mentioning that, 
although all adenomas have the potential to become cancerous, less than 10% are estimated to 
progress to invasive cancer 34. 
The aforementioned classic tumor progression model based on the adenoma-carcinoma sequence 
explains the majority of CRCs, and was first described by Fearon and Vogelstein in 1990 35. 
However, subsequent works have shown that CRC can arise through alternative carcinogenic 
pathways (Figure 3): a) the adenoma-carcinoma sequence 35 (85-90% of sporadic CRCs); b) the 
serrated pathway 36,37 (10-15% of sporadic CRCs); and c) the inflammatory pathway (<2% of all 
CRCs) 38.  
Relative to genetic abnormalities produced in colorectal carcinogenesis, the adenoma-carcinoma 
sequence is mainly associated with the development of chromosomal instability (CIN)-positive 
subtype, which encompasses alteration in the chromosome number 8.  
In the serrated pathway, B-Raf proto-oncogene (BRAF) mutation occurs as a critical early event 
inducing uncontrolled cell proliferation that contributes to the formation of hyperplastic polyp. 
Furthermore, CpG island methylation phenotype (CIMP) leads to epigenetic silencing of a 
considerable number of tumor-suppressing genes, including MutL Homolog 1 (MLH1), fostering 
progressions to sessile serrated adenoma and eventually cancer 8,36,37. 
Unlike the other pathways, in the inflammatory pathway, dysplasia takes place in the background 
of chronic mucosal inflammation, frequently present in flat mucosa with multifocality 39. In 
comparison to the general population, patients with inflammatory bowel disease, mainly 
ulcerative colitis, have 2.4-fold higher CRC risk 8,40. In this pathway, p53 mutations are an initial 
event and adenomatous polyposis coli (APC) mutations occur late in the carcinogenic process and 
are much less frequent 38. 
 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY AND LIFESTYLE DETERMINANTS ASSOCIATED WITH THE RISK OF COLORECTAL CANCER 
Laura Barrubés Piñol 
 
Figure 3. Pathways of colorectal carcinogenesis. Adapted from: Keum, et al. Nat Rev Gastroenterol Hepatol. 
2019;16(12):713-732 8. 
 
 
2. RISK FACTORS FOR COLORECTAL CANCER 
 
The etiology of CRC is multifactorial. Not only have genetic factors substantial effects on CRC 
development, but also lifestyle and environmental risk factors play a fundamental role on 
colorectal carcinogenesis 41. This section comprises an extended review of both non-modifiable 
and modifiable risk factors which have been associated with the risk of developing CRC.  
2.1. Non-modifiable risk factors 
2.1.1. Sex  
Concerning sex differences, men present higher incidence and mortality age-adjusted rates of 
CRC (1.4 and 1.5-fold difference, respectively) than women, at all anatomical subsites. This could 
be, in part, due to a combination of multiple factors. In comparison to females, males might 
exhibit greater vulnerability to environmental factors than by genetic factors, as well as increased 
exposure to such risk factors (e.g. cigarette smoking) 8,42. Moreover, women might have better 
awareness and screening for CRC in comparison to men 16,43. Also, it has been suggested that 
women might benefit from the potential protective effect of endogenous and exogenous hormones 
8,44–46, albeit the existing research on this field remains inconclusive 43,46,47.  
2.1.2. Age 
Since CRC is an age-related disease, the risk of developing CRC increases with age. Worldwide, 
rates of CRC incidence and death increase quickly after 50 years old, with approximately 90% of 
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cases and deaths occurring after this age 8,48. Nonetheless, although CRC is primarily diagnosed 
in elderly people, its incidence in younger individuals (<50 years old) has been increasing over 
the past decade, especially rectal cancer and left-sided colon cancer. In addition, this population 
have shown to develop advance-stage disease at diagnosis than those above 50 years of age 49–
53. 
2.1.3. Race/ethnicity 
CRC burden varies considerably across race and ethnicity. Current statistics in the United States 
53 have described the highest incidence and mortality rates in black individuals, followed closely 
by American Indians and Alaska Natives, and the lowest in Asian Americans/Pacific Islanders. 
These dissimilarities could reflect differences in socioeconomic status 54, prevalence of lifestyle 
factors associated with CRC risk 55, CRC screening 56 and treatment, as well as genetic factors 
8,57,58. 
2.1.4. Genetic risk factors 
Most of the CRCs (c.a. 60-65%) appear sporadically through acquired somatic genetic and 
epigenetic aberrations, whereas the remaining 35-40% of cases are an inherited form of the 
disease 8. The hereditary components of CRC are: a) family history of CRC (25%) 59,60; b) 
hereditary cancer syndromes (5%) such as hereditary nonpolyposis CRC (HNPCC) also known as 
Lynch syndrome (2-4%) -though the two terms describe different, although overlapping diseases 
61- , or familial adenomatous polyposis (FAP) (<1%) 62,63; c) common known but CRC low-
penetrance genetic variations (<1%); and d) other inherited aberrations still remaining to be 
known.  
In connection with family history, the degree and number of relatives affected with CRC, or their 
age at diagnosis affect the risk of developing CRC in those individuals with positive family history 
of the disease 60,64,65.  
The most common form of hereditary CRC is Lynch syndrome which is characterized by a 
dominant pattern of heredity carrying germline genetic mutations in any of the DNA mismatch 
repair genes (MLH1, MSH2, MSH6 and PMS2) 66. Those individuals with the disease present about 
a 20% chance to develop CRC by age 50 years as well as higher risk of developing more than one 
type of cancer 67,68.  
The second most common hereditary CRC syndrome is FAP. In the same way as Lynch syndrome, 
FAP is an autosomal dominant disease, albeit caused by germline mutations in the APC gene. FAP 
is characterized by the appearance of hundreds to thousands of pre-cancerous colorectal polyps 
throughout the large bowel and has a very early onset.  It is noteworthy that, nearly 100% of 
patients with FAP develop CRC by after 40 years 68,69. 
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It should be pointed out that, CRC associated with heritably components is not completely 
hereditary because environmental factors also contribute to carcinogenesis 8,70. 
2.1.5. Other non-modifiable risk factors 
Scientific literature has described other high-risk factors increasing CRC risk 3,68. Among these 
conditions are inflammatory bowel disease 40,71–73, abdominal radiation 74–76, cystic fibrosis 77, 
cholecystectomy 78,79, androgen deprivation therapy in men 80 and Streptococcus bovis 
Bacteremia 81,82. 
2.2. Modifiable risk factors 
Compelling evidence have confirmed the central role of modifiable risk factors in the development 
of CRC 70,83. In the Diet, nutrition, physical activity and colorectal cancer report by the World 
Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) 84, which is one of 
the many parts that make up the Continuous Update Project (CUP) Third Expert Report 85; it was 
stated that there is strong evidence that being physically active decreases the risk of colon cancer, 
and that whole grains, foods containing dietary fiber, dairy products and calcium supplements are 
protective factors of this type of cancer. On the other hand, there is strong evidence that the 
consumption of red and processed meat, the intake of two or more alcoholic drinks per day, being 
overweight and obese and being tall increases the risk to develop CRC (Figure 4). Besides an 
ageing population and westernized dietary habits of high-income countries, other risk factors such 
as obesity, physical inactivity and smoking increase the risk of CRC development 86. In the section 
that follows, a more complete description of the modifiable risk factors associated with CRC is 
detailed. 
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DIET, NUTRITION, PHYSICAL ACTIVITY AND COLORECTAL CANCER 
 DECREASES RISK INCREASES RISK 
STRONG 
EVIDENCE 
Convincing Physical activity 
Processed meat 
Alcoholic drinks 
Body fatness 
Adult attained height 
Probable 
Wholegrains 
Food containing dietary 
fiber 
Dairy products 
Calcium supplements 
Red meat 
LIMITED 
EVIDENCE 
Limited-suggestive 
Foods containing vitamin C 
Fish 
Vitamin D 
Multivitamin supplements 
Low intakes of non-starchy 
vegetables 
Low intakes of fruits 
Foods containing heme iron 
Limited-no 
conclusion 
Cereals (grains) and their products; potatoes; animal fat; 
poultry; shellfish and other seafood; fatty acid 
composition; cholesterol; dietary n-3 fatty acid from fish; 
legumes; garlic; non-dairy sources of calcium; foods 
containing added sugars; sugar (sucrose); coffee; tea; 
caffeine; carbohydrate; total fat; starch; glycemic load; 
glycemic index; folate; vitamin A; vitamin B6; vitamin E; 
selenium; fat; methionine; beta-carotene; alpha-
carotene; lycopene; retinol; energy intake; meal 
frequency; dietary pattern 
STRONG 
EVIDENCE 
Substantial effect 
on risk unlikely - 
Figure 4. Summary of the evidence on diet, nutrition, physical activity and body fatness related to colorectal cancer risk 
according to the WCRF/AICR 2018. Adapted from: WCRF/AICR. CUP Expert Report 2018 85.  
Abbreviations: WCRF/AICR, World Cancer Research Fund/American Institute for Cancer Research; CUP, Continuous 
Update Project. 
 
2.2.1. Body fatness 
Incidence of obesity-related cancers 87–96 rises in parallel with the dramatic increase in the 
prevalence of overweight and obesity in many parts of the world 97. Epidemiological studies 
support that excess adiposity measured by body mass index (BMI), waist circumference (WC) 
and waist-to-hip ratio is an established risk factor for CRC, and that this association is stronger 
for colon cancer than rectal cancer 97,98.  
In a systematic review and meta-analysis of prospective observational studies 98, associations 
between BMI and CRC risk (risk ratio [95% CI] for 5 kg/m2 increase in BMI) were significantly 
stronger in men (1.24 [1.21-1.28]; 1.09 [1.06-1.12]) than in women (1.09 [1.05-1.14]; 1.02 
[0.99-1.04], for both colon and rectal cancer, respectively.  
Along the same lines, a prospective cohort study within the frame of the Nurses’ Health Study 
and Health Professionals Follow-up Study (23-24 years of follow-up) suggested that obesity is 
associated with less CRC risk in women than in men 99. This could be explained because in 
comparison to women, men present higher susceptibility towards visceral obesity, which is 
associated with increased CRC risk than gluteofemoral adipose tissue distribution 100. Moreover, 
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as previously described in this section, endogenous estrogens confer CRC risk protection. Thus, 
despite the excess adiposity of women in later life, its cancer-promoting effect through insulin 
and insulin-like growth factor 1 (IGF1) could be counterbalanced by the anticancer effect of 
estrogens 8. 
It is noteworthy that, even though BMI (which reflects overall body fatness) and WC (which 
represents visceral adiposity) are measures of adiposity consistently associated with CRC risk, 
WC might be a stronger risk factor for CRC than BMI 99,101,102. It has been suggested that visceral 
adipose tissue (VAT) may play an underlying role in linking excess adiposity to colorectal 
carcinogenesis. VAT secrets more proinflammatory adipokines 103 and is heavily infiltrated with 
immune cells such as macrophages 104, hence contributing to the development of low-grade 
chronic systemic inflammation and related insulin resistance (IR) 105,106. This inflammatory state 
in the tumor microenvironment may promote tumor growth and progression 8. 
In view of the above and considering that an imbalance between food intake and energy 
expenditure leads to an excessive accumulation of adipose tissue, the patterns of altered levels 
of adipokine among obese subjects may be considered as predictive of CRC risk. Therefore, 
measures to prevent obesity could be protective against both chronic diseases and cancer 107.  
2.2.2. Insulin resistance and diabetes 
High energy intake in Western diets together with physical inactivity has been related to increased 
prevalence of obesity. As commented in the previous section, obese people develop IR and 
subsequent hyperinsulinemia. This metabolic condition leads to reduced synthesis of insulin-like 
growth factor binding protein (IGFBP) 1 in the liver, and probably also decreases its synthesis 
locally in other tissues. In addition, increased fasting insulin levels have been also related with 
reduced levels of IGFBP2 in the blood. This results in augmented amount of free IGF1 which 
alongside insulin has been proposed to promote colorectal carcinogenesis. The insulin-IGF1 
signaling pathway, through activation of insulin and IGF-1 receptors, has been suggested to 
promote colorectal carcinogenesis by increasing cell proliferation and reducing apoptosis of the 
intestinal mucosa 8,107–109.  
Regarding type 2 diabetes (T2D), this metabolic condition is associated with IR, and in most cases 
with compensatory hyperinsulinemia. Increasing evidence suggest that those individuals with T2D 
have an increased risk of CRC than non-diabetic people 110,111. In a systematic review and meta-
analysis of cohort studies in China, it was reported that individuals with T2D may have 27% 
higher risk of CRC than non-diabetic individuals (summary relative risk (RR) [95% confidence 
interval (CI)] = 1.27 [1.21-1.34], P value= 0.002, I2= 48.4%) 110. Similarly, another meta-
analysis of cohort studies found a statistically significant positive correlation between T2D and 
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CRC risk (summary RRs [95% CI] = 1.21 [1.02-1.42]) albeit with significant heterogeneity 
between studies (I2= 96%) 111.  
Therefore, though the relationship between IR and CRC risk has been shown to be consistent, 
further longitudinal studies evaluating CRC risk associated with T2D are warranted. Since the 
literature on this topic is inconclusive, it is of great importance to continue to investigate the role 
of T2D in CRC preventive behaviors 112, as well as to elucidate CRC subsite and gender differences 
in this association. 
2.2.3. Physical activity 
According to the latest evidence published by the WCRF/AICR 84, physical activity (PA) of all types 
(occupational, household, transport and recreational) convincingly decreases the risk of colon 
cancer (Figure 4) although no conclusion was drawn for rectal cancer. 
Of note, CRC cancer and, especially colon cancer, is one of few cancers together with breast 
cancer for which lack of PA has been recognized as a risk factor. In 2018, an umbrella review (19 
reviews, 26 meta-analyses and 541 original studies) analyzing the associations between PA and 
several cancer sites reported that recreational PA was associated with a 21% reduction in the risk 
of colon cancer (RR [95% CI] = 0.79 [0.71-0.86]) with strong grade of evidence. 113. 
Even though the optimal intensity and dose of PA to prevent CRC has not been yet defined. Both 
the World Health Organization (WHO) and the American Cancer Society advise adults to engage 
in at least 150 min. of moderate-intensity aerobic PA (3-5.9 metabolic equivalents of task (MET)) 
or at least 75 min. of vigorous-intensity PA (≥6 METs), or an equivalent combination of the two 
throughout the week (of note, 2 min. of moderate intensity activity = 1 min. of vigorous intensity 
activity) 114–116. 
2.2.4. Dietary patterns 
Because foods and nutrients are not consumed in isolation, it has been suggested that dietary 
patterns might thus be more predictive of disease risk and mortality than foods or nutrients 
independently. Hence, nutritional epidemiology has shifted its focus from individual nutrients or 
specific foods to overall dietary patterns. On that basis, a dietary pattern could decrease or 
increase CRC risk by the combined effect of its components 8,117. Moreover, some dietary indexes 
such as the dietary inflammatory index (DII®) have gained much attention since they offer a tool 
for measuring the inflammatory potential and quality of individuals’ diets 118. 
Generally, the ‘healthy’ dietary patterns, such as the prudent or Mediterranean dietary pattern, 
mainly characterized by high consumption of fruits and vegetables, wholegrains, nuts and 
legumes, virgin olive oil, fish and other seafood, moderate intake of dairy products and red wine, 
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and low in meat, processed meat and sugar drinks, appears to be protective against colorectal 
adenoma and cancer incidence. On the other hand, the ‘unhealthy’ dietary patterns, such as the 
Western dietary pattern, which are based on high consumption of red and processed meat, sugar-
sweetened beverages (SSBs), refined grains, desserts and potatoes have been associated with 
higher risk of CRC 118–121. Notwithstanding, even though the most convincing evidences show a 
potential role of overall diet in certain cancers, evidence is not conclusive and may be driven or 
mediated by lifestyle factors 119. 
In their last report, the WCRF/AICR judged that evidence for the associations between dietary 
patterns and CRC is limited and no conclusion was drawn 84 (Figure 4). However, subsequent 
meta-analytical evidence support that a priori dietary patterns such as the Dietary Approaches to 
Stop Hypertension (DASH) diet 122 might be associated with decreased CRC risk (RR [95% CI] = 
0.80 [0.74-0.85]) whereas another dietary pattern characterized by a combination of pro-
inflammatory foods might increase the risk of CRC (RR [95% CI] = 1.43 [1.25-1.63]) 123. 
In light of this, the identification of potential associations of the overall whole diet with CRC 
development might provide valuable understandings for the definition of dietary guidelines as a 
way to prevent CRC 118. However, since there are few studies evaluating the associations between 
dietary patterns and CRC and they show inconclusive results, further prospective research on this 
field is needed. 
2.2.5. Foods 
Concerning individual foods, in the CUP Expert Report 2018 84 it was concluded that convincing 
evidence has been achieved that consumption of whole grains, foods containing dietary fiber and 
dairy products decreases CRC risk, whilst consumption of red and processed meat and alcoholic 
drinks intake is associated with an increased risk of developing CRC. Findings for other dietary 
components comprising cereals and their products, potatoes, shellfish and other seafood, poultry, 
legumes, foods containing added sugars, among other foodstuffs, are still controversial and no 
conclusion was drawn (Figure 4). 
Red and processed meat 
In 2018, the CUP Panel judged that consumption of red meat is probably a cause of CRC (Figure 
4) 84. Red meat consumption can influence CRC risk through different potential carcinogenic 
compounds. On the one hand, heme iron which is present at high levels in red meat has exhibited 
to promote colorectal carcinogenesis by inducing formation of endogenous carcinogenic N-nitroso 
compound 124–126. On the other hand, heterocyclic amines and polycyclic aromatic hydrocarbons 
formed when meats are cooked at high temperatures have been shown to increase CRC risk in 
experimental studies 127–129. 
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Concerning processed meat, there is stronger evidence to consider that its consumption is a 
convincing cause of CRC. Similar to red meat, processed meat is rich in heme iron and protein 
which can promote tumorigenesis via the same mechanism such as those described above 127. In 
addition, processed meat is characterized by higher fat content than red meat, which may 
stimulate CRC through production of secondary bile acids, although human studies supporting 
this hypothesis are weak. Also, processed exogenous N-nitroso compounds from processed meat, 
are thought to increase CRC risk 8,125,126,129.  
In 2018, a meta-analysis of prospective studies by Schwingshackl and co-workers 130 found that 
each 100 g/day increase in red meat consumption was associated with a 12% higher risk of CRC 
(RR [95% CI] = 1.12 [1.06-1.19]; n=21), whereas a 50 g/d increment in processed meat intake 
was related with 17% augmented CRC risk (RR [95% CI] = 1.17 [1.10-1.23]; n=16). In the same 
line, in a later systematic review and meta-analyses of 29 prospective cohort studies evaluating 
the relationship between CRC incidence and processed meat consumption, the association for 
CRC (Hazard Ratio (HR)50 g/d [95% CI] = 1.15 [1.06-1.24]) and for colon cancer risk (HR50 g/d 
[95% CI] = 1.25 [1.15-1.37]) was similar. However, processed meat intake was not significantly 
related with rectal cancer risk when comparing high versus low intake in either women or men 
(HR [95% CI] = 1.21 [0.98-1.49]) 131.  
Foods containing dietary fiber 
In the last CUP report, it was concluded that the consumption of foods containing dietary fiber 
probably protects against CRC 84 (Figure 4).  
There are some physical mechanisms and prebiotic effects that may explain the anticarcinogenic 
role of dietary fiber against colorectal carcinogenesis 132. Dietary fiber is fermented within the 
bowel, forming short-chain fatty acids such as butyrate, which has been shown to have anti-
proliferative effects in experimental studies. Other mechanisms by which greater dietary fiber 
intake may lower CRC risk comprise the reduction of the intestinal transit time and increased 
fecal bulk, which could reduce the duration of exposure for potential fecal mutagens to interact 
with the intestinal epithelium, and a reduction of secondary bile acid production 133,134. High-fiber 
diets may also reduce IR, which is a risk factor for CRC and other types of cancer 135.  
Recently, a meta-analysis including 11 prospective cohort studies 136 demonstrated that 
individuals with the smallest intake of dietary fiber have a 21% and 14% higher risk of distal 
colon cancer (RR [95% CI] = 0.79 [0.71-0.87]) and proximal colon cancer (RR [95% CI] = 0.86 
[0.78-0.95]), respectively, in comparison to those with the highest intake. In the same line, 
another meta-analysis of cohort and case-control studies by Gianfredi 137 found a 26% reduction 
in colon cancer risk (95% CI = 0.67-0.82) after comparing highest versus the lowest dietary fiber 
intake, although moderate statistical heterogeneity was detected. For rectal cancer, current meta-
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analytical evidence 132 suggests a 22% risk reduction of CRC linked to dietary fiber intake (RR 
[95% CI] = 0.77 [0.66-0.89]) after evaluating a total of 2,876,136 subjects. However, this result 
should be taken cautiously since there was moderate heterogeneity between the included studies 
(I2= 59.11%). 
Taken together, evidences and strong mechanistic plausibility suggest that dietary fiber intake 
might play a protective role against CRC. Nonetheless, epidemiological evidence has shown 
controversial results mainly due to heterogeneity between study designs, fiber sources, among 
others. Additionally, most studies report data on overall CRC, which represents a difficulty to 
evaluate the associations with dietary fiber intake for colon and rectum separately. Therefore, 
further prospective studies should be undertaken in this area in order to overcome these 
challenges. 
Alcoholic drinks 
Ethanol in alcoholic drinks is a convincing cause of CRC based on evidence for intakes above 30 
g/day, which is equivalent about two drinks a day (Figure 4). Also, there is robust evidence for 
mechanisms operating in humans 84. This association is stronger in men than in women probably 
due to hormone-related variations in alcohol metabolism and higher alcoholic drink intakes and 
under-reporting of alcohol consumption in men 68,138,139. Concerning levels of alcohol 
consumption, it has been suggested that there is a J-shaped association between alcohol 
consumption and CRC risk 140. In comparison to non-/occasional drinking, light/moderate drinking 
(up to 2 drinks/day) was related with a 8% decreased CRC, heavy drinking (2-3 drinks/day) was 
not significantly associated with the risk of developing CRC, and very heavy drinking (>3 
drinks/day) was associated with 25% significant increased CRC risk 140. 
Ethanol reaches colonocytes probably through the systemic circulation and probably diffuses into 
lumen, which is metabolized by microbial alcohol dehydrogenase into acetaldehyde. This last 
metabolite can cause injury to the intestinal mucosa and regenerative cellular proliferation. On 
the other hand, intracellular acetaldehyde may foster colorectal carcinogenesis by causing DNA 
damage and destroying intracellular folate 8,141–143.  
2.2.6. Other modifiable risk factors 
In addition to diet, nutrition and PA, outlined above, other recognized risk factors comprising 
smoking and some medications can affect the risk of developing CRC 144. Smoking 40 
cigarettes/day (2 packs) increased CRC risk about 40% and virtually doubled the risk of CRC 
mortality 145. Smoking may affect differentially by anatomic subsites predisposing more towards 
proximal colon and rectal cancer 12,68. Furthermore, it has been shown that long-term use (≥5 
years) of at least 75 mg. daily of aspirin can lower incidence and mortality due to CRC 146. 
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Nonetheless, since non-steroidal anti-inflammatory drugs (NSAIDs) are associated with greater 
risk of gastrointestinal bleeding and heart attack, its consumption for preventing CRC is not 
recommended in the general population 12. Also, hormone therapy in postmenopausal women has 
been shown to decrease the risk of CRC 147.  
 
3. A FOCUS ON DAIRY PRODUCT CONSUMPTION AND HEALTHY 
LIFESTYLE PATTERNS AS DETERMINANTS OF CRC INCIDENCE IN 
ELDERLY INDIVIDUALS AT HIGH CARDIOVASCULAR RISK 
 
Based on the evidence reported above, the present doctoral thesis focuses specifically on the 
association between healthy lifestyle patterns in general, and dairy product consumption in 
particular, and their relationship with CRC risk. Hence, a more detailed literature review on these 
topics are given in the following section. 
3.1. Dairy products 
3.1.1. Definition of dairy products 
In the Spanish Food Code 148, the definition of dairy products and their different subtypes 
comprises those foods derived from milk, not altered or adulterated, without colostrum and 
hygienically extracted from milking healthy and well-fed domestic mammal females. Moreover, 
dairy product subtypes (cream, butter, cheeses and melted cheeses, fermented dairy, dairy 
serums, casein and curd) are those products obtained from milk through appropriate technological 
treatments.  
In the present doctoral thesis, the Spanish Food Code definition of dairy products was followed in 
Chapters 1 and 2. However, because Chapter 3 is based on a meta-analysis comprising other 
papers investigating the associations between dairy product consumption and CRC risk, the dairy 
product category considered in each paper was used. 
3.1.2. Nutritional composition of dairy products 
Dairy products contain a unique nutrient package that contribute significantly to meet the 
nutritional requirements for protein, calcium, magnesium, phosphorus, potassium, zinc, 
selenium, vitamin A, riboflavin, vitamin B12 and pantothenic acid. Additionally, since dairy 
products have a high-water content, this food group has relatively low energy density. 
Furthermore, milk and other dairy products are one of the best sources of dietary calcium since 
they offer a high calcium bioavailability as well as a high calcium content. It is proposed that this 
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nutritional composition is difficult to meet in diets that eliminate dairy product consumption for 
any reason (for instance, vegan diets). It is also noteworthy that many beneficial effects of dairy 
products on health outcomes are likely to be linked with the interaction between these nutrients 
rather than to the action of each nutrient separately 149–152. 
3.1.3. Dietary recommendations and dairy products 
In most dietary guidelines from different countries, the consumption of dairy products is 
encouraged, especially of milk, yogurt and cheese. However, these guidelines do not give specific 
recommendations on the type and amount of dairy product consumption 153–155. 
In Spain, different Scientific Societies and Foundations have published several dietary guidelines 
mainly based on the traditional Mediterranean diet (MedDiet). The Fundación Dieta Mediterránea 
recommends the consumption of 2 servings per day of low-fat fermented dairy products, specially 
yogurt and cheese from sheep and goat, as they are considered typical foods in the Mediterranean 
countries 156. For their part, the Iberoamerican Nutrition Foundation (FINUT) 157 and the Agencia 
Española de Consumo, Seguridad Alimentaria y Nutrición (AECOSAN) recommend a daily 
consumption of dairy products such as milk, yogurt and cheese. The AECOSAN recommendation 
is based on the food pyramid from the Spanish Strategy Nutrición, Actividad Física y Prevención 
de la Obesidad (NAOS), the objective of which is to prevent obesity 158. Lastly, the Sociedad 
Española de Nutrición Comunitaria (SENC) recommends the consumption of 2 to 3 servings of 
low-fat dairy products (cheese, yogurt and brick milk) daily 159.  
With regard to dairy fat content, most current dietary guidelines advocate the consumption of 
fat-free or low-fat dairy products in the context of a healthy diet to prevent chronic diseases 
153,155,160,161. However, the scientific rationale behind this recommendation is still under debate 
152,162. Prospective cohort evidence has shown no association between the consumption of full-fat 
dairy products and either the risk of CRC 163,164 or a significant reduction in the risk 165. Thus, 
further research on the association between the consumption of milk foods and the risk of CRC 
should be of considerable interest in terms of public health. 
3.1.4. Dairy products consumption and colorectal cancer risk 
As mentioned before, adherence to a healthy dietary pattern has shown to be essential for the 
primary prevention of CRC. According to this, a study which is part of the Global Burden of 
Diseases, Injuries, and Risk Factors Study 166 analyzing data from 195 countries concluded that 
certain dietary risk factors account for a larger burden of CRC than smoking or alcohol intake 
globally.  
In 2018, the WCRF CUP 144 reviewed the very latest accumulated evidence from around the world 
from cohort studies and randomized controlled trials on diet, nutrition, adiposity, and PA and their 
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relationship with CRC. Despite the consumption of specific foods such as processed meat 
increases the risk of CRC with convincing evidence, further research is needed in order to increase 
evidence for other food groups such as dairy products. 
The traditional Mediterranean dietary pattern, which has been previously mentioned, is 
characterized by a moderate intake of dairy products (principally cheese and yogurt). MedDiet 
adherence has been related to a reduction in the risk of CRC 167. According to the WCRF/AICR, 
the evidence suggesting a protective role of dairy products (total dairy, milk, cheese and dietary 
calcium intake) consumption against CRC was judged as probable (strong evidence) 144 (Figure 
4).  
Case-control studies investigating the link between dairy product consumption and CRC risk has 
shown inconsistent results 168,169,178,170–177. However, prospective cohort studies have consistently 
reported lower risk of CRC associated with higher consumptions of dairy products, especially milk 
165,179–186. In the same line, the most current systematic reviews and meta-analyses of prospective 
studies comprising updated high-quality works with many cases have reported that total dairy 
product or milk consumption is inversely associated with CRC risk 130,187.  
In 2017, Vieira and collaborators carried out a systematic-review and meta-analysis of 
prospective studies 187 in order to update the evidence of the WCRF/AICR CUP. In the dose-
response meta-analysis of this work, a significant inverse relationship between the consumption 
of total dairy products and milk and the risk of CRC incidence was found. For each 400 g/day 
increase in the intake of dairy products, CRC risk decreased by 13% (RR [95% CI] = 0.87 [0.83-
0.90]; I2=18%; n=10) whilst no association was observed with rectal cancer. For milk 
consumption, an increase of 200 g/day was associated with a decreased risk of CRC (RR [95% 
CI] = 0.94 [0.92-0.96]; I2=0%; n=9), colon cancer (RR [95% CI] = 0.93 [0.90-0.96]; I2=30%; 
n=9) and rectal cancer (RR [95% CI] = 0.94 [0.91-0.97]; I2=0%; n=7). The inverse associations 
found in the case of milk intake with CRC and colon cancer were significant in men, but not in 
women, whereas for rectal cancer, the inverse association was significant only in women. The 
consumption of 50 g/day of cheese was not significantly associated with the risk of developing 
CRC (RR [95% CI] = 0.94 [0.87-1.02]; I2=10%; n=7) or colon cancer (RR [95% CI] = 0.91 
[0.80-1.03]; I2=19%; n=6), and the association for rectal cancer was marginally significant (RR 
[95% CI] = 0.95 [0.90-1.00]; I2=0%; n=4). 
Schwingshackl and co-workers 130 led a systematic search for prospective studies evaluating the 
association between 12 food groups, including dairy products, and CRC risk. These authors 
observed an inverse association (RR [95% CI] = 0.83 [0.76-0.89]; I2=61%; n=18) after 
comparing the highest versus the lowest intake category of dairy (overall intake range: 0-1,710 
g/day). For each additional daily 200 g intake of dairy products, a 7% decrease in CRC risk was 
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observed (RR [95% CI] = 0.93 [0.91-0.94]; I2=0%; n=15). In secondary analyses, both low and 
high-fat dairy product intakes were inversely associated with CRC risk.  
3.2. Healthy lifestyle patterns  
As discussed above, both diet quality and other environmental factors have been shown to have 
an important role in the development of chronic diseases. According to this, several a priori 
defined food groups and general index-based dietary patterns have been related with lower CRC 
risk, supporting the hypothesis that high overall diet quality might decrease the risk of CRC 188–
190. 
Considering that not only diet quality influences the risk of developing CRC, but also other 
environmental factors different from diet as well, healthy lifestyle indices have emerged to gain 
new insight into the development of CRC. Lifestyle scores generated a priori according to current 
scientific knowledge allow us to examine the potential combined effect of the individual score 
components on the incidence of different diseases. Previous work on CRC nutritional epidemiology 
has been mainly focused on the WCRF/AICR score 191. However, very little is known about other 
lifestyle indices and their association with this cancer.  
3.2.1. World Cancer Research Fund/American Institute for Cancer Research 
(WCRF/AICR) score  
In 2018, the WCRF/AICR launched the Diet, Nutrition, Physical Activity, and Cancer: A Global 
Perspective, the WCRF/AICR Third Expert Report 85. This report comprises 10 cancer prevention 
recommendations, which represent a package of healthy lifestyle behaviors comprising following 
a healthy diet, maintaining a healthy body weight, and engaging in regular PA.  
Following the latest cancer-specific recommendations from the WCRF/AICR, the 2018 WCRF/AICR 
score was developed with the purpose of establishing a simple, standardized scoring system for 
researches to quantify adherence to the recommendations and to assess its impact on cancer risk 
as well as with other health-related outcomes 192. 
WCRF/AICR score and CRC risk 
Some prospective cohort 191,193–198 and case-control 199–201 studies have investigated the 
associations between CRC risk and adherence to cancer-specific nutritional recommendations 
based on the WCRF/AICR score with inconsistent results. In addition, there was no unified method 
to assess the adherence to the former recommendations. Thus, each study developed their own 
scoring system which makes comparisons between studies difficult 192. On the other hand, limited 
longitudinal studies 198,201 have been conducted to assess associations based on the updated 2018 
WCRF/AICR recommendations.  
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In a systematic literature review and meta-analysis published in 2020 202, including 38 articles 
(17 prospective, 8 case-control and 13 cross-sectional), the association between adherence to 
the 2007 WCRF/AICR score and health outcomes has been investigated. It was found that each 
1-point increment in the score was significantly associated with a 14% decrease in CRC risk (RR 
[95% CI] = 0.86 [0.82-0.89]; n=10). Importantly, the authors concluded that primary prevention 
of CRC should emphasize modification of modifiable lifestyle factors, and that future studies 
examining the updated 2018 WCRF/AICR guidelines will further clarify such associations 202.  
In 2020, Shams-White and co-workers published a commentary in the Cancer Epidemiology, 
Biomarkers & Prevention journal strongly encouraging researchers to use the standardized score 
to improve comparability across populations and countries. Also, the authors suggested that 
articles based on this score should provide detailed descriptions of the methodology in order to 
promote transparency and reproducibility 192. 
3.2.2. Low-risk lifestyle score 
The low-risk lifestyle (LRL) score is another lifestyle score including five modifiable lifestyle factors 
(smoking status, alcohol consumption, PA, diet and BMI). In the context of the Nurses’ Health 
Study and the Health Professionals Follow-up Study, a consistent significant inverse association 
between the LRL score and all-cause mortality, including cancer and CVD mortality, and with CVD 
incidence was reported 203.  
This prospective analysis by Li included 11,527 participants with T2D diagnosed during follow-up 
who were free of CVD and cancer at the time of diabetes diagnosis (follow-up period of 13.3 
years). The multivariate-adjusted HRs for those participants having ≥3 low-risk lifestyle factors 
compared with none were (HR [95% CI] = 0.48 [0.40-0.59]) for total CVD incidence, (HR [95% 
CI] = 0.53 [0.42-0.66]) for incidence of coronary heart disease, (HR [95% CI] = 0.33 [0.21-
0.51]) for stroke incidence, and (HR [95% CI] = 0.32 [0.22-0.47]) for CVD mortality (all p-
trend<0.001) 203. 
Recently, this index has been also related with an increased healthy life expectancy free of T2D, 
CVD and cancer 204. However, information regarding this score with cancer incidence is lacking 
203,205.  
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4. COLORECTAL CANCER CLINICAL FEATURES AND DIAGNOSIS  
 
4.1. Presenting symptoms 
CRC is principally an asymptomatic disease until it reaches and advance stage. That is why, 
screening is so important. Patients with this cancer can present a wide range of signs and 
symptoms such as occult or obvious rectal bleeding, changes in bowel habits, anemia or 
abdominal pain which vary according the anatomic location of the tumor 12,86,206. 
Cancers rising in the cecum and ascending colon might become quite large without resulting in 
any obstructive symptoms or noticeable alterations in bowel habits because stool is rather liquid 
as it passes through the ileocecal valve into the right colon. Lesions on the right colon usually 
cause ulcerations leading to insidious blood loss without a change in the appearance of the stools. 
Consequently, common symptoms in these patients are fatigue, palpitations or even angina 
pectoris. Moreover, they can present hypochromic, microcytic anemia due to iron deficiency. 
Tumors arising in the transverse and descending colon tend to impede the passage of stool which 
is more formed. Thus, the symptoms when tumors arise in this area are abdominal cramping, 
occasional obstruction and even perforation. When tumors arise in the rectosigmoid are frequently 
associated with hematochezia, tenesmus and narrowing of the caliber of stool whilst anemia is an 
infrequent finding 12,86,206. 
4.2. Diagnosis 
▸ Endoscopy: Colonoscopy is the method of choice to diagnose CRC. In order to ensure 
detection, lesions (tumors or polyps) require careful and complete inspection of the mucosa 
as well as an optimal preparation of the bowel 86,207,208.  
▸ Imaging: Imaging techniques are used as a complementary tool for diagnosis although these 
methods are mostly employed for locoregional and distant staging. For instance, computed 
tomography (CT) colonography is used after incomplete or inadequate colonoscopy. For rectal 
cancer, locoregional staging is normally done by magnetic resonance imaging (MRI). Other 
technics such as Positron Emission Tomography (PET)-CT imaging are also being used 
although its exact role for staging and assessment of disease burden in advanced stages is 
still discussed 86,209–211. 
▸ Laboratory: On the other hand, all guidelines recommend not only obtaining a complete 
blood count but also checking carcinoembryonic antigen concentrations at the time of 
diagnosis. Elevated carcinoembryonic antigen levels at baseline is related with worse 
prognosis. This laboratory tool also might indicate residual disease when concentrations of 
this antigen do not normalize in the postoperative phase 86,212.  
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▸ Pathology: In order to determine pathological staging and subsequent management, 
histology is still the basis. In addition to the classic TNM (T: depth of tumor penetration, N: 
presence of lymph node involvement, and M: presence or absence of distant metastases) 
staging, histological subtyping, grading and histological assessment of lymphatic, perineural, 
and venous invasion, the value of a large number of tumor-based markers is increasingly 
being recognized 86,211,213–215. 
 
5. TREATMENT  
 
▸ Endoscopic treatment: Some early CRCs are amenable to local treatment only. Therefore, 
immediately following the diagnosis, malignant polyps might be resected endoscopically. Of 
note, endoscopic resection is a feasible option for many large polyps and T1 cancers 86.  
▸ Surgical treatment: Surgery is the cornerstone of curative intent treatment when a 
malignant lesion is detected in the large bowel. Moreover, quality of CRC resection is crucial 
and can be assessed with objective parameters. Before surgical treatment, an evaluation for 
the presence of metastatic disease should be undertaken. In the case of rectal cancer, surgery 
is more complicated due to the accessibility and intricate anatomy of the pelvis 386. 
▸ Radiotherapy for rectal cancers: Preoperative radiation therapy to the pelvis is 
recommended for patients with rectal cancer because it lessens the risk of local recurrence 
216. The absolute risk decrease that is achieved with this treatment option depends on the 
tumor stage and quality of the surgery 386. 
▸ Local treatments for metastatic disease: Due to technical innovations, there is an 
increasing number of local therapies, such as resection of liver metastases 217, to treat stage 
IV CRCs which aim to control and possible cure at long-term disease. Even though randomized 
trials have not demonstrated the worth of eradicating restricted metastatic tumors, this option 
is generally accepted. It should be noted that, local treatment of lung metastases is more 
controversial and peritoneal metastases have long been considered as an untreatable 
condition 86. 
▸ Systemic treatment: Systemic therapy for patients with CRC has become more effective 
being 5-fluorouracil (5-FU) the backbone of treatment for CRC. 5-FU is normally administered 
intravenously but can be also given orally in the form of capecitabine with apparently similar 
efficacy. In patients with advanced CRC, concomitant administration of other drugs such as 
folinic acid has been shown to improve 5-FU efficacy. In addition, monoclonal antibodies are 
also effective in these patients. For rectal cancer, preoperative or postoperative combined 
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therapy (5-FU or capecitabine plus radiotherapy) decreases the risk of recurrence and 
increments the probability of cure in patients with stage II and III tumors 3. 
 
6. PROGNOSIS  
 
The prognosis (prediction of disease outcome) for individuals having CRC is related to the extent 
to which cancer has spread at the time of diagnosis which is described as its stage. The two most 
common cancer-staging systems are the TNM system and the Surveillance, Epidemiology, and 
the End Results (SEER) summary staging system. The TNM system is used in clinical settings 
whereas the SEER summary staging system is employed for descriptive and statistical analyses 
of tumor registry data (Table 1)32. 
 
Table 1. Summary of the stages of CRC according the TNM system and the SEER summary 
staging system 32 
 Staging Characteristics 
C
an
ce
r 
st
ag
in
g
 s
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m
 
T
N
M
 
In situ Cancers that have not yet begun to invade the wall of the colon or rectum 
(preinvasive lesions). 
Local Cancers that have grown into the wall of the colon or rectum but have not 
extended through the wall to invade nearby tissues. 
Regional Cancers that have spread through the wall of the colon or rectum and have 
invaded nearby tissue, or that have spread to nearby lymph nodes. 
Distant Cancers that have spread to other parts of the body such as the liver or lung. 
S
E
E
R
 
Stage I 
(T1-
2N0M0) 
- Superficial lesions that do not involve regional lymph nodes and do not penetrate 
through the submucosa (T1) or the muscularis (T2). 
- 5-year survival >95% for T1 and >90% for T2. 
Stage II 
(T3-
4N0M0) 
- Tumors that penetrate through the muscularis (T3) but have not spread to lymph 
nodes. 
- 5-year survival: 70-85% 
Stage III 
(TXN1-
2M0) 
- Regional lymph node involvement (N1: 1-3 lymph node metastases, N2: ≥4 
lymph node metastases). 
- 5-year survival is 50-70% for N1 and 25-60% for N2. 
Stage IV 
(TXNXM1) 
- Metastatic spread to distant sites such as liver, lung or bone. 
- 5-year survival <5% 
Abbreviations: SEER, Surveillance, Epidemiology, and the End Results. 
 
Most recurrences of CRC occur during the first 4 years after surgical resection of large-bowel 
cancer. Thus, 5-year survival is a reliable indicator of cure. The likelihood of 5-year survival in 
patients with CRC is stage-related. The number of involved lymph nodes might more precisely 
judge prognosis. Other predictors of poorer outcomes immediately after total surgical CRC 
resection comprise: a) tumor penetration through the bowel wall; b) poorly differentiated 
histology; c) perforation and/or tumor adherence to adjacent organs; d) venous invasion; e) 
preoperative elevation of carcinoembryonic antigen titer (>5 ng/ml); f) specific chromosomal 
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deletion (in example, mutation in the BRAF gene); and g) right-sided location of the primary 
tumor. However, despite the growing number of scientific literature evaluating a multitude of 
prognostic factors, pathologic stage of diagnosis remains the best predictor of long-term 
prognosis 32. 
 
7. PREVENTION 
 
7.1.  Primary prevention 
In accordance with the abovementioned evidence, accumulating literature suggests that smoking 
cessation, following a healthy diet, maintaining a healthy weight and engaging in regular PA can 
prevent CRC. Additionally, the intake of some medications such as aspirin and other NSAIDs has 
been related to less risk of developing CRC 146,218. However, because of potential harms (e.g., 
gastrointestinal bleeding) its intake is not recommended to the general population for preventing 
CRC. Probably, there is a role for aspirin and NSAIDs intake as primary prevention in those 
individuals presenting defined hereditary predisposition such as Lynch syndrome and polyposis 
69,86. In addition, hormone replacement therapy in women is also associated with reduced risk for 
CRC 219. 
On the other hand, regular use of multivitamin 220,221, calcium 222 and vitamin D 223 supplements 
has been associated with reduced risk of CRC. However, despite biological plausible mechanisms 
working in humans, the WCRF/AICR judged that evidence for a decrease in CRC risk was limited 
for multivitamin and vitamin D supplement intake, whilst evidence for calcium supplements intake 
was concluded to be probable 84. 
7.2.  Secondary prevention 
Screening can reduce CRC risk and mortality because allows removal of precancerous lesions or 
early detection and treatment of CRC 224. Such screening programs are particularly important for 
individuals with a family history of the disease in first-degree relatives. There are some screening 
strategies for CRC available: digital rectal examination, stool testing (occult blood, fecal DNA), 
imaging (contrast barium enema, virtual colonography), and endoscopy (flexible sigmoidoscopy 
and colonoscopy) 3. Of note, there is high degree of heterogeneity in CRC screening among 
countries and professional organizations 8. In Spain, after introduction of screening programs, 
CRC mortality rates became plateaued, although CRC incidence rates continued to increase 248.  
7.3. Tertiary prevention 
After treatment for CRC, several factors have been related to improved outcomes and decreased 
risk of CRC-related death. These factors are largely the same as the factors for primary prevention 
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such as following a healthy lifestyle and regular use of aspirin and other NSAIDs. Because most 
studies on this field are observational, further randomized trials are needed in order to establish 
recommendations 24. 
Taking all the above into account, possibly, scoring systems based on individual risk calculation 
models including genetic and environmental factors along with family history of CRC might be 
useful to develop individualized CRC prevention strategies 86,225. 
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II. Rationale 
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II. RATIONALE  
 
As stated in the previous section, CRC is a central health problem since it is the second most 
common cause of cancer death in both sexes worldwide. On the one hand, CRC is linked with 
reduced life quality and expectancy. On the other hand, as a chronic disease, CRC have significant 
economic healthcare costs. It should be emphasized that, the global burden of CRC is expected 
to continue increasing, not only due to the growth of the aging population, but also because of 
the adoption of westernized dietary and lifestyle patterns. Thus, it is of great importance to 
address this issue in order to increase scientific evidence on CRC prevention that serves as the 
basis for directing effective public health strategies. 
There is a large body of consistent evidence highlighting the importance of the impact of some 
foods, such as red and processed meats and alcohol intake, on the risk of CRC incidence. However, 
evidences on CRC incidence associated with the consumption of other foods such as dairy 
products, which are widely consumed in the Mediterranean countries, are less strong. 
Importantly, most of the literature on this topic does not consider different dairy subtypes bearing 
in mind their content in fat and sugar, but rather different dairy subtypes with different nutritional 
characteristics are considered within the same category. Furthermore, most of dietary guidelines 
recommend avoiding the consumption of whole-fat dairy products and promote low-fat dairy 
product consumption without enough evidences. Therefore, this field needs to be deeply 
investigated to develop dietary recommendations based on consistent scientific evidences.  
On the other hand, it has been shown that individual nutrients, foods, drinks or specific 
components of foods seem increasingly less likely to be important individual factors in causing or 
protecting against CRC. Instead, research is increasingly focusing in dietary or lifestyle patterns 
from a holistic point of view. Although there is an increasing number of studies investigating the 
associations between following specific dietary patterns and the risk of CRC, evidence on CRC risk 
associated with adherence to healthy lifestyle patterns is scarce. In recent years, there has been 
growing interest in evaluating the risk of cancer associated with the adherence to the WCRF/AICR 
score, which is mostly composed of dietary components. Nonetheless, research considering the 
latest recommendations by the WCRF/AICR is lacking.  
Additionally, a critical area on nutritional cancer epidemiology is the impact of diet and other 
modifiable lifestyle components throughout the life course on cancer risk. Most of the evidences 
presented in the Introduction section are focused on healthy adult populations. However, there is 
still a need for epidemiological evidence to prevent CRC in aging individuals, which are at 
increased risk of CRC.  
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Therefore, considering the previously gaps of knowledge, the findings of the present doctoral 
thesis shed new light on the potential role of modifiable dietary and lifestyle determinants of 
incidence of CRC in a population at high CVD risk within the frame of the PREDIMED trial. 
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III. Hypotheses and 
objectives 
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III. HYPOTHESES AND OBJECTIVES 
 
▸ Hypothesis 1: Consumption of different subtypes of dairy products, considering their sugar 
and fat content might be differently associated with the risk of CRC in the PREDIMED study. 
 
• Objective 1.1 
To evaluate potential associations between total dairy products consumption and specific dairy 
product subtypes with the risk of CRC incidence within the frame of the PREDIMED cohort of older 
Spanish individuals at high CVD risk. 
▸ Hypothesis 2: High adhesion to a priori lifestyle scores (the WCRF/AICR and the LRL scores) 
might decrease the risk of developing CRC in the PREDIMED study. 
 
• Objective 2.1 
To evaluate the associations between the adherence to the 2018 WCRF/AICR and LRL scores and 
the incidence of CRC in elderly Spanish individuals at high CVD risk. 
• Objective 2.2 
To investigate the associated CRC risk for every individual component of each lifestyle score in 
elderly Spanish individuals at high CVD risk. 
▸ Hypothesis 3: The consumption of dairy products and the risk of developing CRC might be 
associated in different ways depending on the type of dairy product and CRC subsite and 
location. 
 
• Objective 3.1 
To meta-analyze the available evidence coming from prospective cohorts and case-control studies 
in adults to examine the association between the consumption of specific types of dairy products 
and CRC incidence. 
• Objective 3.2 
To investigate whether the associations between the consumption of dairy products and CRC risk 
depend on the CRC subsite (colon or rectal) and colon cancer location (proximal or distal colon). 
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IV. Material and methods 
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IV. MATERIAL AND METHODS 
This doctoral thesis is composed of 3 articles published in international journals with high scientific 
impact. The first two chapters of the thesis are prospective observational studies conducted in 
the context of the PREDIMED clinical trial. The last chapter of the thesis is based on a systematic 
review and meta-analysis of prospective and case-control studies. 
 
1. PREDIMED (PREvención con DIeta MEDiterránea) study 
The PREDIMED study is a multicenter, parallel-group, controlled trial conducted in Spain designed 
to evaluate the effect of a traditional MedDiet on the primary prevention of CVD (conducted 
between 2003 and 2011). The project was approved by the “Comité Ético de Investigación Clínica 
Hospital Clínic” from Barcelona (Project identification register: 2002-1244; date of approval: 16 
July 2002). Later, the Institutional Review Boards of each recruitment center approved the 
protocol (available at NEJM.org) and all participants provided informed consent before starting 
the study. The trial is registered (http://www.controlled-trials.com/ ISRCTN35739639). The main 
results of the study were published in The New England Journal of Medicine in 2018 226. 
The primary outcome of the PREDIMED trial was to evaluate the effects of two MedDiets on a 
composite endpoint of cardiovascular death, myocardial infarction and stroke in comparison with 
a low-fat control diet. Secondary outcomes were death from any cause, incidence of heart failure, 
diabetes mellitus, dementia or other neurodegenerative disorders and major cancers (colorectal, 
breast, lung, stomach and prostate). With the aim to better understand how dietary changes may 
modify the risk of clinical events, intermediate outcomes comprising changes in blood pressure, 
weight gain, fasting blood glucose, blood lipids and markers of inflammation were also assessed 
227.  
Enrollment of participants began on June 25, 2003, and the last participant was recruited on June 
30, 2009. Eleven centers from 9 cities in Spain participated in the recruitment process: Sevilla, 
Málaga, Reus-Tarragona, Barcelona, Islas Baleares, Pamplona, País Vasco, Valencia and Gran 
Canarias. After a median follow-up of 4.8 years, the trial was stopped because of a prespecified 
interim analysis. The database closeout took place on September 2011 and included primary end-
points events occurring through December 1, 2010. In order to explore other hypotheses 
subsequent follow-up continued as an observational multi-purpose cohort, and to carry out nested 
case-control analyses for studies of biomarkers and gene-nutrient interactions 227. 
 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY AND LIFESTYLE DETERMINANTS ASSOCIATED WITH THE RISK OF COLORECTAL CANCER 
Laura Barrubés Piñol 
▸ Inclusion criteria 
Participants were eligible to participate in the PREDIMED study if they were community-dwelling 
adults aged 55 to 80 years in men, and 60 to 80 years in women, free at CVD at enrollment 
(ischemic heart disease including angina pectoris or heart attack; stroke and peripheral 
arteriopathy), but who were at high CVD risk because they had either T2D or at least three of the 
following major risk factors:  
• Current smoking (>1 cigarette/day during the last month). 
• Hypertension (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg 
or antihypertensive medication). 
• High low-density lipoprotein (LDL) cholesterol levels (≥160 mg/dl or lipid-lowering 
therapy). 
• Low high-density lipoprotein (HDL) cholesterol levels (≤40 mg/dl in men or ≤50 mg/dl in 
women). 
• Overweight or obesity (BMI ≥25 kg/m2).  
• Family history of premature coronary heart disease. 
 
▸ Exclusion criteria 
Participants were excluded if they met one of the ensuing criteria: 
• Previous history of CVD: coronary heart disease (angina, myocardial infarction, coronary 
revascularization procedures or existence of abnormal Q waves in the electrocardiogram, 
stroke (ischemic or hemorrhagic, including transient ischemic attacks) and peripheral 
artery disease. 
• Presence of medical conditions that could impair the ability of the person to participate in 
the study or to attend visits. 
• Life expectancy less than one year. 
• Immunodeficiency or human immunodeficiency virus (HIV)-positive status. 
• Illegal drug use or chronic alcoholism or total daily consumption of 50 g of alcohol. 
• BMI ≥40 kg/m2. 
• Difficulties or major inconvenience to change dietary habits. 
• Impossibility to follow a MedDiet due to religious reasons or presence of disorders that 
affect chewing or swallowing. 
• Low predicted likelihood to change dietary habits according to Prochaska and Diclemente 
transtheoretical model. 
• Food allergy with hypersensitivity to any of the components in olive oil or nuts. 
• Participation in any drug trial or use of any investigational drug within the last year. 
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• Institutionalized patients for chronic care, those who lacked autonomy, were unable to 
walk, lacked a stable address or were unable to attend visits in the Primary Care Health 
Centers every three months. 
• Illiteracy. 
• Patients with an acute infection or inflammation were allowed to participate in the study 
after three months from the resolution of their condition. 
1.1.  Randomization and intervention 
A total of 7,447 participants were randomly allocated to three intervention groups in a 1:1:1 
ratio: MedDiet enriched with extra virgin olive oil (EVOO) (MedDiet+EVOO), MedDiet enriched 
with mixed nuts (MedDiet+nuts), or low-fat control group. The two groups assigned to the 
MedDiets received intensive education to follow the MedDiet supplemented with either EVOO (1 
l/wk.) or nuts (15 g walnuts, 7.5 g hazelnuts and 7.5 g almonds daily) at no cost. Those 
participants in the control group were given advice to follow a low-fat diet. PREDIMED dietitians 
were the responsible for all the dietary interventions and they received specific training sessions 
before and during the trial to ensure good implementation of the intervention. The main aim was 
to promote adherence to the Mediterranean dietary pattern in both MedDiet groups. During the 
trial, no calorie restriction was advised, nor was PA promoted.  
All the participants in the PREDIMED study attended to a face-to-face visit in their primary care 
centers at baseline, 6 months and yearly during the follow-up. In these visits, different 
questionnaires were administered, and anthropometric and biochemical measurements were 
collected.  
1.2.  Study population for the analyses in the PREDIMED trial 
In Chapters 1 and 2 of the present dissertation inclusion and exclusion criteria were the same as 
in the PREDIMED trial. Moreover, from the 7,447 participants, those individuals with energy intake 
values outside de pre-specified limits (<500 or >3500 kcal/day for women or <800 or >4000 
kcal/day for men) (n=153), and those with no baseline food frequency questionnaire (FFQ) 
(n=78) were excluded. Thus, the final sample for the analyses included 7,216 individuals. 
1.3. Ascertainment of colorectal cancer cases 
For the present doctoral thesis, new CRC events were defined as the first invasive CRC according 
to the International Classification of Diseases for Oncology topographical codes C18.0–C20.9. The 
results of the histological examination were considered confirmatory in most events (n=67). 
Events were identified from the following sources: a review of all the medical records by a panel 
of physicians and researchers blinded to the intervention, at both primary healthcare and hospital 
level, and the national death index. The Endpoint Adjudication Committee, whose members were 
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also blinded to the intervention, determined the cause of death, confirmed major events, and 
updated the endpoints of the PREDIMED study on a yearly basis. 
1.4. Ascertainment of dairy product consumption 
 
On a yearly basis, a validated semi-quantitative 137-food items 228 was administered by trained 
dietitians in order to assess dietary intake during the previous year. Participants were asked to 
report their frequency of consumption of food items comprising dairy products, on an incremental 
scale with 9 levels (never or almost never; 1–3 servings/month; 1, 2–4, and 5–6 servings/weeks; 
and 1, 2–3, 4–6, and >6 servings/day). Nutrient and energy consumption were estimated from 
the FFQ responses using Spanish Food composition tables 229,230. 
In the FFQ validation study, the intraclass correlation coefficient between consumption of total 
dairy products from the FFQ and repeated 24-hour food records was 0.84 228. The responses to 
individual dairy items of the FFQ were converted to average daily consumption (g/day) and 
categorized as total dairy products (including all types of milk, yogurt and cheese, custard, 
whipped cream, butter and ice-cream), low-fat dairy products (semi-skimmed/skimmed milk and 
skimmed yogurt) and whole-fat dairy products (whole-fat milk, whole-fat yogurt and cheese). 
Dairy food consumption was also categorized by subtypes into the intake of milk (total, low-fat 
and whole-fat milk), yogurt (total, low-fat and whole-fat yogurt), cheese (Petit Suisse, ricotta, 
cottage, spreadable and semi-cured/cured cheeses), concentrated full-fat dairy (butter, whipped 
cream and all types of cheeses), sugar-enriched dairy products (condensed milk, milkshakes, ice 
cream and custard) and fermented dairy foods (all types of yogurt and cheese).  
1.5.  Assessment of lifestyle and clinical variables  
Trained personnel took anthropometric measurements (weight, height, and WC). All 
anthropometric variables were measured annually. 
▸ Weight and height were measured using calibrated scales and a wall-mounted 
stadiometer, respectively, with participants wearing light clothing and no shoes.  
▸ WC was measured midway between the lowest rib and the iliac crest using an 
anthropometric tape.  
▸ BMI was calculated by dividing the weight (kg) by the square of the height (m2).  
▸ Blood pressure was measured with a validated oscillometer (Omron HEM705CP, 
Hoofddorp, The Netherlands) in triplicate with a 5-min interval between each 
measurement.  
▸ PA: the validated Spanish version of the Minnesota leisure-time PA (LTPA) questionnaire 
231,232 was used to assess the amount and intensity of LTPA. The questionnaire consisted 
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of 67 activities divided into 9 sections. The participants were asked to complete the form, 
reporting the number of days and min./day they had performed the activities during the 
previous week and year. PA was quantified in METs per minute per day (METs min/day). 
This unit was calculated by multiplying the METs assigned to each activity and their mean 
duration in min. per day. LTPA was classified as light (intensity<4 METs), moderate 
(intensity= 4–5.5 METs), and vigorous (intensity≥6 METs). This questionnaire was 
completed during a baseline visit and annually thereafter.  
▸ Smoking status or education level, medical history, and medication use were asked using 
a general questionnaire about lifestyle variables that was completed and recorded at 
baseline and yearly thereafter. 
 
1.6. World Cancer Research Fund/American Institute for Cancer Research 
(WCRF/AICR) score operationalization 
To evaluate the associations between the accomplishment of the last cancer prevention 
recommendations 85 and the risk of developing CRC in the PREDIMED study, a 7-point score based 
on the last WCRF/AICR was constructed. The individual score components are shown in Figure 
5. More detailed information on the score construction is given in Chapter 2 (see the Results 
section). 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 5. Individual components of the 2018 WCRF/AICR score. 
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The cut-off points for each score component were based on the 2018 WCRF/AICR 
recommendations when available or previously published literature otherwise. For each of the 
recommendations, we assigned 1 point when the recommendation was met, 0.5 points when it 
was partially met, and 0 points when it was not met. For those components with sub-
recommendations, the considered component score was the average of the sub-recommendation 
scores. The mean score for each component was between 0.36 (red and processed meat 
consumption) and 0.70 (SSB intake) points. The final index was the sum of all the components 
and ranged from 0 to 7. Higher scores indicated better adherence to cancer prevention 
recommendations. 
 
1.7. Low-risk lifestyle score operationalization 
The LRL score was constructed in terms of adherence to five LRL-related factors proposed by Li 
and colleagues 203. Detailed information on the score operationalization can be obtained in 
Chapter 2 (see the Results section). The individual score components are shown in Figure 6.  For 
each risk factor, 1 point was given if the participant met the criterion for low risk, or 0 points 
otherwise. The mean score for each component was between 0.07 (healthy body weight) and 
0.62 (never smoking) points. The final score was the sum of all components (score range from 0 
to 5), with higher scores indicating a healthier lifestyle. 
 
 
 
 
 
 
 
 
 
 
Figure 6. Individual components of the Low-Risk Lifestyle score. 
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1.8.  Statistical analyses of the observational PREDIMED cohort studies: 
The analyses based on the PREDIMED study were conducted using data as if it was an 
observational prospective cohort study from a clinical trial. 
The baseline characteristics of the participants were expressed as means and standard deviation 
(SD) or medians and interquartile ranges [IQR] for continuous variables, and percentage (%) and 
number (n) for categorical variables. Chi-square (for categorical data), one-factor ANOVA test 
and t-Student tests (both for continuous data) were used to assess differences in the baseline 
characteristics of the participants.  
For each participant, we calculated the follow-up time as the interval between the date of 
randomization and the date of CRC diagnosis, death from any cause or the date of the last contact 
visit, whichever came first. 
To evaluate the risk of developing CRC associated with different exposures, multivariable Cox 
proportional regression models were used. The results were the HRs and their 95% CIs for the 
comparison between the highest versus the lowest quantiles for each exposure (consumption of 
dairy products in Chapter 1, and adherence to lifestyle recommendations in Chapter 2) in 
categorical analyses, and for each 1-point increment in the exposure variables in the continuous 
analyses. The linear trend was calculated by assigning the median value of each category and 
then using it as a continuous variable. 
All models were adjusted for potential confounders including intervention group, sex, age, LTPA, 
BMI, smoking status, family history of cancer, education level, history of diabetes, use of aspirin 
as well as other variables that could statistically significantly modify the associations.  
Analyses were performed using the STATA (14.0, StataCorp LP, Lakeway Drive, TX. USA) and R 
(v. 3.5.1) software (GNU General Public License, Boston, MA, USA). All P-values were two-sided, 
and a P-value <0.05 was considered statistically significant. 
 
2. DESIGN OF THE SYSTEMATIC-REVIEW AND META-ANALYSIS 
The systematic review and meta-analysis (Chapter 3) was conducted in accordance with the 
Cochrane Handbook for Systematic Reviews of Interventions 233. The results were presented 
following the “Meta-Analysis of Observational Studies in Epidemiology” 234 and the “Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement” guidelines 
235. The protocol for the systematic review and meta-analysis is available in PROSPERO 
(www.crd.york.ac.uk; identifier: CRD42017057490). 
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2.1. Study selection for the systematic-review and meta-analysis 
In Chapter 3 of the present thesis, identification and selection of relevant publications for the 
systematic review and meta-analysis was conducted. It was systematically searched for published 
case-control and prospective cohort studies investigating the associations between the 
consumption of total dairy products and their subtypes and the risk of developing CRC. 
▸ All studies that met the following criteria (inclusion criteria) were considered for inclusion 
in the meta-analysis: 
 
• Those conducted in humans (>18 years old). 
• Those written in English, Spanish or French. 
• Those in which the outcome of interest was CRC, colon or rectal cancer. 
• Those that provided estimates of the odds ratio (OR) or RR (such as the HR or risk ratio) 
with the corresponding 95% CIs or gave enough data for these values to be calculated.  
• Those in which the estimates were adjusted for age. 
• Those that evaluated the consumption of dairy products using validated food 
questionnaires.  
• Those that assessed the consumption of any subtype or total dairy product (cow, goat, or 
sheep milk; skim, low-fat, or full-fat milk; total, low-fat, or full-fat yogurt; cheese; and 
full-fat dairy, sweetened dairy, or other dairy products) as the exposure variable. 
 
▸ For the dose-response analysis we required the following criteria to be met:  
 
• A quantitative measure of intake had to be provided.  
• When there were several publications from the same study, we selected the publication 
with the largest number of cases. 
• If all the information required was not provided in the paper, we used the publication that 
provided enough information for a dose-response analysis to be conducted.  
 
▸ The following types of publications were excluded (exclusion criteria): 
 
• Non-original papers (reviews, commentaries, editorials, or letters). 
• Ecologic assessments and correlation studies. 
• Cross-sectional studies. 
• Meta-analysis studies. 
• Non-peer-reviewed articles. 
• Off-topic studies. 
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• Studies on CRC mortality.  
• Studies lacking specific CRC data.  
• Animal and mechanistic studies. 
• Studies conducted in children, adolescents, or pregnant women. 
• Supplements to the main manuscript. 
• Duplicate publications. 
• Low methodologic quality studies: Newcastle-Ottawa Scale (NOS) for cohort or case-
control studies scored less than 6 points. 
Of the 780 reports remaining after duplicates removed, 29 studies were included in the meta-
analysis: 15 prospective cohort studies and 14 case-control studies evaluating the associations 
between consumption of dairy product and CRC risk. 
2.2.  Statistical analysis of the systematic review and meta-analysis: 
To calculate the summary risk estimates and 95% CIs for the highest compared with the lowest 
categories of consumption of dairy products and dairy product subtypes, we conducted both 
random (≥5 study comparisons) and fixed (<5 study comparisons) effects analyses. We natural 
log–transformed and pooled the RRs/HRs (cohort studies) and ORs (case-control studies) using 
the generic inverse variance method. When the highest level of consumption was considered as 
the reference category, we recalculated the estimate (RR and 95% CI) of the highest category.  
When the results of the studies were stratified by subgroups, such as sex, they were treated as 
separate studies. We carried out prespecified stratified analyses for the study design (prospective 
cohort and case-control studies) and outcome (CRC, colon cancer, proximal or distal colon cancer, 
and rectal cancer). 
We performed linear and nonlinear dose-response analyses with data from the cohort studies. We 
carried out generalized least-squares trend estimation modeling and spline curve modeling 
(MKspline STATA command). This method requires at least 3 quantitative exposure levels or 
quantiles.  
Analyses were performed with Review Manager version 5.3 (The Nordic Cochrane Center) and 
STATA (14.0, StataCorp LP, Lakeway Drive, TX. USA) software. A 2-tailed P-value<0.05 was 
considered statistically significant. The heterogeneity among studies was assessed with the use 
of Cochran’s Q statistic and quantified with the I2 statistic (P<0.10 was considered significant, 
and I2≥50% was interpreted as substantial heterogeneity).  
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V. Results 
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Dairy Product Consumption and Risk of Colorectal Cancer
in an Older Mediterranean Population at High
Cardiovascular Risk
Laura Barrubes1,2, Nancy Babio 1,2, Guillermo Mena-Sanchez1,2, Estefania Toledo2,3, Judith B. Ramırez-Sabio4,5,
Ramon Estruch2,6,7, Emilio Ros2,7,8, Montserrat Fito2,9, Fernando Aros2,10, Miquel Fiol2,11, Jose Manuel Santos-Lozano2,12,
Lluıs Serra-Majem2,13, Xavier Pinto2,14, Miguel Angel Martınez-Gonzalez2,3, Jose Vicente Sorlı2,4, Josep Basora1,2,
and Jordi Salas-Salvado1,2 on behalf of the PREvencion con DIeta MEDiterranea Study Investigators
1 Universitat Rovira i Virgili, Department of Biochemistry and Biotechnology, Human Nutrition Unit, Reus, Spain
2 CIBER de Fisiopatologıa de la Obesidad y la Nutricion (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
3 Department of Preventive Medicine and Public Health, University of Navarra-Navarra Institute for Health Research, Pamplona, Spain
4 Department of Preventive Medicine, University of Valencia, Valencia, Spain
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Prospective studies have reported an inverse association between the consumption of total dairy products and milk and the
risk of colorectal cancer (CRC). Nonetheless, there is little and inconsistent evidence regarding subtypes of dairy product and
CRC risk. We assessed the associations between the consumption of total dairy products, their different subtypes and CRC
risk in older Mediterranean individuals at high cardiovascular risk. We analyzed data from 7,216 men and women (55–80
years) without CRC at baseline from the PREvencion con DIeta MEDiterranea study. Individuals were recruited between 2003
and 2009 and followed up until December 2012. At baseline and yearly thereafter, consumption of total and specific dairy
products was assessed using a validated 137-item food-frequency questionnaire. Cox proportional hazards ratios (HRs) of CRC
incidence were estimated for tertiles of mean consumption of dairy products during the follow-up. During a median [interquar-
tile range] follow-up of 6.0 [4.4–7.3] years, we documented 101 incident CRC cases. In the multivariable-adjusted models,
HRs and 95% confidence intervals (CIs) of CRC for the comparison of extreme tertiles of total dairy product and low-fat milk
consumption were 0.55 (95% CI: 0.31–0.99; p-trend 5 0.037) and 0.54 (95% CI: 0.32–0.92; p-trend 5 0.022), respectively. No
significant associations with other dairy products (whole-fat and low-fat dairy products; total, low-fat and whole-fat yogurt;
cheese; total, low-fat and whole-fat milk; concentrated full-fat dairy products, sugar-enriched dairy products and fermented
dairy products) were found. A high consumption of total dairy products and low-fat milk was significantly associated with a
reduced CRC risk.
Key words: colorectal cancer, mediterranean diet, dairy products, milk, PREDIMED study
Abbreviations: BMI: body mass index; CLA: conjugated linoleic acid; CRC: colorectal cancer; CVD: cardiovascular disease; EPIC: Euro-
pean Prospective Investigation into Cancer and Nutrition; EVOO: extra virgin olive oil; FFQ: food frequency questionnaire; IQR: inter-
quartile range; MedDiet: Mediterranean diet; MET: metabolic equivalent; PKC: protein kinase C
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Cancer accounts for one in eight deaths worldwide and
affects approximately one in four women and one in three
men during their life. In the last 30 years, cancer rates have
doubled and it is predicted that it will almost triple by
2030.1,2
Colorectal cancer (CRC) is one of the most prevalent
human cancers.3 In 2012, 1.36 million new CRC cases were
diagnosed, about 55% of which were in developed countries,4
probably due to the strong relationship between CRC and a
Westernized lifestyle.5
Unhealthy environmental factors such as smoking, physi-
cal inactivity, overweight or obesity, as well as adherence to
an unhealthful diet characterized by a high consumption of
red meat, processed meat and alcohol, and a low intake of
dietary fiber, have been related to an increased risk of
CRC.6–8
Adherence to a healthy diet has been reported to be
essential for the primary prevention of CRC as dietary factors
are estimated to contribute to nearly 50% of cases.9,10 The
traditional Mediterranean dietary pattern, which is character-
ized by an abundance of plant foods, olive oil and fish, a low
consumption of red meat and processed meat and a moder-
ate consumption of dairy products (principally cheese and
yogurt) has been associated with a lower incidence of CRC.11
Although evidence on the association between CRC and
such food groups as processed meat and alcoholic drinks is
robust enough to support the argument that there is a con-
vincing relationship, the evidence on the association between
the consumption of dairy foods and CRC development is less
strong.12,13 In addition, these evidences are mainly based on
total dairy, milk, cheese and dietary calcium intake, without
bearing in mind their fat and sugar content.8,12 Also, most of
the studies evaluating these associations have been performed
in apparently healthy populations.
Case–control studies have shown inconsistent results con-
cerning the relationship between dairy product consumption
and CRC.14–18 Furthermore, several prospective cohort stud-
ies have found that the consumption of dairy products, espe-
cially milk, was associated with a lower CRC risk.19–23 In
addition, the most recent systematic reviews and meta-
analyses of prospective studies24,25 including updated high-
quality studies with a large number of cases also found an
inverse association between consumption of total dairy prod-
ucts or total milk and CRC risk.
Nonetheless, because most of the studies are based on
total dairy products and total milk intake, there is a lack of
evidence on the association between specific subtypes of dairy
products with regard to their fat and sugar content, and the
incidence of CRC. On this basis, we hypothesized that the
consumption of different subtypes of dairy products, consid-
ering their sugar and fat content, might be differently associ-
ated to the risk of CRC. Therefore, we assessed how the
consumption of total dairy products and specific dairy prod-
uct subtypes is associated with the risk of CRC incidence
within the frame of the PREDIMED cohort of older individu-
als at high cardiovascular risk.
Materials and Methods
The present analysis was performed as an observational pro-
spective cohort study by using data from the PREDIMED
(PREvencion con DIeta MEDiterranea) study. The PRE-
DIMED study (PREDIMED website: http://www.predimed.es)
is a parallel-group, multicenter and controlled trial designed
to assess the effect of a traditional Mediterranean Diet (Med-
Diet) on the primary prevention of cardiovascular disease
(CVD) (registered at http://www.controlled-trials.com as
ISRCTN35739639).26 The design of the PREDIMED trial and
the results with respect to the primary endpoint have been
reported elsewhere.27 The study was conducted in accordance
with the Declaration of Helsinki. All participants provided
informed consent and the protocol was approved by the
institutional review boards of each recruitment center.
Although for the main outcome of CVD, the trial was com-
pleted after a median follow-up of 4.8 years in June 2011, the
endpoint for the present analysis was based on an extended
follow-up until December 2012.
Participants
Between 2003 and 2009, a total of 7,447 individuals were
recruited to the PREDIMED trial. Participants were men
(aged 55–80 years) and women (aged 60–80 years) with no
previously documented CVD at baseline but who were at
high risk because they had either type 2 diabetes mellitus or
at least three of the following cardiovascular risk factors: cur-
rent smoking, hypertension, hypercholesterolemia, low high-
density lipoprotein cholesterol, overweight/obesity or family
history of premature coronary heart disease. Exclusion crite-
ria were the presence of any severe chronic illness, alcohol or
What’s new?
Relative to other aspects of the Mediterranean diet, such as the intake of alcohol and processed meats, little is known about
the relationship between the consumption of dairy products or their fat content and colorectal cancer (CRC) risk. Here, poten-
tial relationships were assessed among older Mediterranean individuals at high risk of cardiovascular disease. The data sug-
gest that CRC incidence is inversely related to high total dairy product consumption. Of particular importance was the intake
of low-fat milk, which was the primary driver behind the inverse association. Other dairy products were not significantly asso-
ciated with CRC risk.
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drug abuse, a BMI 40 kg/m2 and allergy or intolerance to
olive oil or nuts.
Individuals were allocated to one of the three intervention
groups: MedDiet supplemented with nuts, MedDiet supple-
mented with extra virgin olive oil (EVOO), or advice to
reduce all sources of fat (control group).
For this analysis, we further excluded those participants
who had implausible daily energy intake values (<500 or
>3,500 kcal/day for women or <800 or >4,000 kcal/day for
men) and those who did not complete the baseline Food Fre-
quency Questionnaire (FFQ).
Ascertainment of incident and fatal colorectal cancer
CRC was a prespecified secondary outcome in the original
study protocol. Cases were defined as the first invasive CRC
(International Classification of Diseases for Oncology topo-
graphical codes C18.0–C20.9). Availability of the results from
a cytological or histological examination was considered to be
confirmation. Nonetheless, incident CRC cases were also
accepted when information about pathological anatomy was
not available. Cases were identified from a variety of sources:
review of all the medical records of each participant by a
panel of physicians and researchers (who were blinded to the
intervention), at both primary healthcare and hospital level,
and the National Death Index. The Endpoint Adjudication
Committee, whose members were blinded to the intervention,
determined the cause of death, confirmed major events and
updated the endpoints of the PREDIMED study on a yearly
basis.
Assessment of covariates
In a face-to-face interview with participants at baseline and
yearly during the follow-up, trained dietitians completed: (i)
a questionnaire about lifestyle variables, medical history and
medication use; (ii) a 14-item validated questionnaire
designed to assess adherence to the traditional MedDiet in all
the intervention groups and a separate 9-item screening ques-
tionnaire used to evaluate adherence to the control diet; (iii)
a validated semi-quantitative FFQ which included 137 food
items and frequencies of consumption of food items reported
on an incremental scale with 9 levels (never or almost never;
1–3 servings/month; 1, 2–4 and 5–6 servings/weeks; and 1,
2–3, 4–6 and >6 servings/day); (iv) the validated Spanish
version of the Minnesota Leisure-Time Physical Activity
questionnaire.28 The FFQ was previously validated in a Span-
ish population at high CVD risk.29 We used Spanish food
composition tables to estimate energy and nutrient intake.28
Energy restriction and physical activity were not encouraged
in any group during the intervention.
Additionally, trained personnel took anthropometric
measurements (weight, height and waist-circumference). To
measure weight and height, calibrated scales and a wall
mounted stadiometer were used, respectively, with partici-
pants wearing light clothing and with no shoes. Waist cir-
cumference was measured midway between the lowest rib
and the iliac crest using an anthropometric tape. Blood pres-
sure was measured with a validated oscillometer (Omron
HEM705CP, Hoofddorp, the Netherlands) in triplicate with a
5-min interval between each measurement.
Assessment of dairy consumption
In the FFQ validation study, the intraclass correlation coeffi-
cient between consumption of total dairy products from the
FFQ and repeated 24-hr food records was 0.84.29 The
responses to individual dairy items of the FFQ were con-
verted to average daily consumption (g/day) and categorized
as total dairy products (including all types of milk, yogurt
and cheese, custard, whipped cream, butter and ice-cream),
low-fat dairy products (semi-skimmed/skimmed milk and
skimmed yogurt) and whole-fat dairy products (whole-fat
milk, whole-fat yogurt and cheese). Dairy food consumption
was also categorized by subtypes into the intake of milk
(total, low-fat and whole-fat milk), yogurt (total, low-fat and
whole-fat yogurt), cheese (Petit suisse, ricotta, cottage,
spreadable and semi-cured/cured cheeses), concentrated full-
fat dairy (butter, whipped cream and all types of cheeses),
sugar-enriched dairy products (condensed milk, milkshakes,
ice cream and custard) and fermented dairy foods (all types
of yogurt and cheese). Consumption of dairy products at
baseline and in yearly follow-up assessments was adjusted for
total energy intake using the residual method.
Statistical analysis
For each participant, we calculated the follow-up time as the
interval between the date of randomization and the date of
CRC diagnosis, death from any cause or the date of the last
contact visit, whichever came first. To better represent the
long-term intake of dairy products and to minimize within-
person variation, the average energy-adjusted dairy product
consumption, based on data from all the FFQs during the
follow-up period was considered for the analysis. Participants
were categorized into tertiles of average total dairy products
and subtypes of dairy product consumption during the fol-
low-up.
The baseline characteristics of the participants are
expressed as means6 SD or medians and interquartile ranges
[IQR] for continuous variables, and percentages (%) and
number (n) for categorical variables. v2 and one-factor
ANOVA tests were used to assess differences in the baseline
characteristics of the study population.
Multivariable Cox proportional regression models were
used to evaluate the association between total dairy products
and subtypes of dairy product consumption during the
follow-up and the subsequent risk of developing CCR. Addi-
tional multivariable Cox proportional regression models were
carried out to estimate the associations between dietary cal-
cium intake from different food sources and CRC risk (Sup-
porting Information, Table 2). Hazard ratios (HRs) and their
95% CIs were calculated using the lowest tertile of intake as
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the reference category. The assumption of proportional haz-
ards was tested by analyzing the scaled Schoenfeld residuals.
Three different Cox regression models were fit. The crude
model was a univariate model. Model 1 was adjusted for the
following potential confounders: intervention group (control,
nut or olive oil supplemented MedDiets), sex (men/women),
age (years), leisure time physical activity as metabolic equiva-
lents (METs per min/d), BMI (kg/m2), smoking status (for-
mer, current or never), family history of cancer (yes/no),
education level (primary, secondary or high school/university,
graduate), history of diabetes (yes/no) and use of aspirin
(yes/no) at baseline. Model 2 was additionally adjusted for
the energy-adjusted tertiles of average consumption during
follow-up of vegetables, fruits, legumes, cereals, fish, meat,
olive oil and nuts (all in grams per day) and alcohol (grams
per day and quadratic term).
Statistical interaction between tertiles of total dairy prod-
ucts and dairy product subtypes and potential confounders
such as sex, diabetes status and BMI was evaluated by includ-
ing interaction terms in the models.
To test the robustness of our findings, we performed dif-
ferent sensitivity analyses: (i) we repeated the models after
excluding the incident CRC cases diagnosed within the first 2
years of follow-up to evaluate possible reverse causation, and
(ii) we replaced missing values of dietary variables (total
dairy products, low-fat milk, vegetables, fruits, legumes, cere-
als, meat, fish, nuts, olive oil, alcohol and energy intake) dur-
ing the follow-up by the carry-forward method.30 To assess a
possible association between the intake of calcium supple-
ments and the risk of CRC, (iii) we repeated the models after
adjusting for the intake of mineral supplements (yes/no) con-
taining calcium (Supporting Information, Tables 3 and 4),
and (iv) we also repeated the analyses after excluding those
individuals taking calcium supplements (Supporting Informa-
tion, Tables 5 and 6) at baseline.
We performed a secondary analysis to evaluate the poten-
tial calcium mediating role on the association between the
consumption of dairy products and CRC risk. Therefore, in
those exposure variables showing a significant association
with CRC incidence, we additionally estimated the associa-
tions after adding the total dietary calcium intake as a covari-
ate in the fully-adjusted model. Linear trend tests were
conducted by assigning the median value of each tertile of
dairy product consumption and then using it as a continuous
variable. All p values are two-tailed and p< 0.05 was consid-
ered statistically significant. Analyses were performed using
the STATA (14.0, StataCorp LP, TX) software.
Results
During a median [IQR] follow-up of 6.0 [4.4–7.3] years we
documented 101 incident cases of CRC. After excluding indi-
viduals with energy intake values outside the pre-specified
limits (n5 153) and those with no baseline FFQ (n5 78), we
finally included in our analysis 97 incident CRC cases from
the 7,216 study participants. The most common incident
cancer location among participants who developed CRC was
colon (79.4%) followed by rectum (20.6%).
Baseline characteristics of participants according to tertiles
of average total dairy product consumption are shown in
Table 1. The mean age of the participants was 67.0 years old,
57% of whom were women. When compared with individu-
als in the reference tertile of average total dairy product con-
sumption, those individuals in the top tertile were more
likely to be older, be women, have a higher BMI and suffer
from diabetes. Furthermore, these individuals had a lower
level of education and leisure time physical activity and were
less likely to smoke.
The median cumulative average total dairy product con-
sumption during the follow-up in the whole study population
was 350 g/day. The largest contributors to total dairy product
consumption were low-fat dairy products (72.6%). In particu-
lar, low-fat milk and low-fat yogurt accounted for 57.4% and
11.4% of total dairy product consumption, respectively. Sugar-
enriched dairy products were the dairy products that were least
consumed (1.4% of total dairy consumption). During follow-
up, the median cumulative average consumption was 65 g/day
for total yogurt, 25 g/day for cheese, 220 g/day for total milk,
26 g/day for concentrated-full fat dairy products, 5 g/d for
sugar-enriched dairy products and 97 g/day for fermented dairy
products (Supporting Information, Table 1).
Compared to individuals in the lowest tertile of dairy
product consumption, those in the top tertile consumed
higher amounts of fruits and legumes and lower amounts of
meat, fish, cereals, nuts, olive oil and alcohol (p< 0.05).
HRs of incident CRC across energy-adjusted tertiles of
average total and specific dairy product consumption are
shown in Tables 2 and 3. Additionally, HRs for CRC inci-
dence associated with the intake of dietary calcium from dif-
ferent food sources across energy-adjusted tertiles are shown
in Supporting Information, Table 2. In the fully-adjusted
model (model 2), participants in the upper tertile of total
dairy product consumption exhibited 45% lower risk of
developing CRC than those in the reference tertile [HR: 0.55;
95% CI: 0.31–0.99; p-trend5 0.037]. Neither whole-fat nor
low-fat dairy product consumption showed significant associ-
ations with CRC incidence. Nonetheless, low-fat dairy foods
exhibited a nonsignificant inverse association with the devel-
opment of CRC [HR: 0.62; 95% CI: 0.36–1.07; p-
trend5 0.072] after adjusting for confounders (Table 2).
After separately analyzing specific subgroups of dairy prod-
ucts, those individuals in the top tertile of low-fat milk con-
sumption exhibited a lower risk of CRC incidence in
comparison to those participants in the reference tertile [HR:
0.54; 95% CI: 0.32–0.92; p-trend5 0.022]. We did not find
significant differences in the risk of developing CRC with the
other subtypes of dairy products (Table 3).
We detected a significant inverse association between the
higher intake of calcium from low-fat milk and the risk of
CRC [HR: 0.53; 95% CI: 0.31–0.91; p-trend5 0.105] after
comparing with the lowest intake (model 2). The top tertile
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Table 1. Baseline characteristics of individuals at high cardiovascular risk across energy-adjusted tertiles of cumulative average total dairy
product consumption during follow-up1
Total dairy products consumption (g/day)2
T1 (266.43),
n 5 2,406
T2 (266.52–445.10),
n 5 2,405
T3 (445.26), INTRO
n 5 2,405 p value3
Total dairy products, g/day 166.9 6 78.1 338.6 6 45.7 634.8 6 140.3 <0.001
Age, years 66.3 6 6.4 67.3 6 6.2 67.6 6 6.0 <0.001
Women, % (n) 42.8 (1,030) 63.0 (1,514) 66.6 (1,601) <0.001
Education level, % (n) <0.001
Primary, secondary or high
school
90.7 (2,182) 93.8 (2,254) 94.1 (2,264)
University/graduate 9.3 (224) 6.3 (151) 5.9 (141)
Age at diagnosis of cancer, years 73.5 6 5.3 69.6 6 7.2 71.5 6 5.4 0.022
Family history of cancer, % (n) 48.9 (1,177) 48.6 (1,169) 50.0 (1,202) 0.608
Cancer location 0.229
Colon, % (n) 72.5 (29) 80.0 (28) 90.9 (20)
Rectum, % (n) 27.5 (11) 20.0 (7) 9.1 (2)
Diabetes, % (n) 44.0 (1,058) 48.9 (1,176) 53.8 (1,293) <0.001
Hypertension, % (n) 83.7 (2,013) 83.4 (2,006) 81.1 (1,951) 0.037
Waist circumference, cm
Women 98.1 6 10.7 98.8 6 10.6 98.3 6 10.6 0.274
Men 103.7 6 9.1 102.9 6 9.3 102.9 6 9.4 0.075
BMI, kg/m2 29.8 6 3.7 30.0 6 3.9 30.1 6 4.0 0.012
Leisure time physical activity, METs
min/day
244.3 6 246.9 218.5 6 221.6 230.3 6 246.6 0.001
Former smokers, % (n) 31.9 (768) 23.0 (552) 18.9 (454) <0.001
Current smokers, % (n) 19.0 (457) 10.4 (251) 12.3 (298) <0.001
Current medication use, % (n)
Use of aspirin 20.8 (500) 22.2 (534) 24.1 (579) 0.099
Use of hormone replacement
therapy (only women)
2.33 (24) 2.64 (40) 3.19 (51) 0.035
Intervention groups, % (n) 0.183
MedDiet 1 EVOO 33.4 (803) 33.9 (814) 35.6 (857)
MedDiet 1 nuts 34.3 (824) 31.9 (768) 31.9 (768)
Control low-fat diet 32.4 (779) 34.2 (823) 32.4 (780)
Energy intake (kcal/day) 2,321.7 6 561.5 2,059.1 6 502.9 2,327.6 6 522.3 <0.001
MedDiet adherence (score 1–14) 8.7 6 1.9 8.6 6 1.9 8.7 6 1.9 0.025
Food consumption, g/day4
Vegetables 330.1 6 148.8 336.4 6 133.4 335.7 6 150.6 0.258
Fruits 359.2 6 203.0 375.4 6 183.3 370.6 6 200.0 0.013
Legumes 20.4 6 14.5 19.8 6 10.6 21.6 6 14.3 <0.001
Meat 137.2 6 56.0 132.8 6 49.0 123.2 6 51.8 <0.001
Fish 102.2 6 49.2 100.7 6 47.9 94.8 6 49.2 <0.001
Cereals 242.2 6 88.3 225.9 6 74.3 207.4 6 80.83 <0.001
Nuts 10.7 6 13.9 10.5 6 12.2 9.2 6 13.2 <0.001
Olive oil 40.1 6 16.7 39.6 6 15.9 37.4 6 17.4 <0.001
Alcohol 12.4 6 16.9 7.9 6 10.8 4.7 6 9.7 <0.001
Abbreviations: T, tertile; BMI, body mass index; MET, metabolic equivalent task; MedDiet, Mediterranean diet; EVOO, extra virgin olive oil.
1Data are expressed as means (standard deviation) or medians [IQR, interquartile range] for continuous variables and percentage and number (n)
for categorical variables.
2Tertile cutoffs are based on energy-adjusted cumulative average of total dairy product consumption during the follow-up.
3p values for differences between tertiles were calculated by v2 or ANOVA tests for categorical and continuous variables, respectively.
4All dietary variables were adjusted for energy using the residual method.
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of dietary calcium intake from all food sources, dairy sources
and total milk showed a nonsignificant inverse association
with CRC incidence compared to the reference tertile (model
2) (Supporting Information, Table 2).
In a secondary analysis, we evaluated the associations
between total dairy products and low-fat milk consumption,
and the incidence of CRC after additional adjustment for
total dietary calcium intake in the fully-adjusted model. After
comparing participants in the top tertile with those in the
reference tertile, the associations were attenuated and became
nonsignificant for the consumption of both low-fat milk [HR:
0.61; 95% CI: 0.31–1.17; p-trend5 0.110] and total dairy
products [HR: 0.59; 95% CI: 0.23–1.49; p-trend5 0.275].
After CRC cases diagnosed within the first 2 years of
follow-up had been excluded, the inverse associations
between total dairy products [HR: 0.50; 95% CI: 0.25–1.00; p-
trend5 0.042] and low-fat dairy milk intake [HR: 0.53; 95%
CI: 0.29–0.97; p-trend5 0.041], and the risk of CRC inci-
dence were still significant.
In the sensitivity analysis of yearly updated dietary expo-
sures, the HR for the comparison between individuals in the
upper tertile with the participants in the first tertile was [HR:
0.59; 95% CI: 0.35–1.02; p-trend5 0.064] for total dairy
products and [HR: 0.63; 95% CI: 0.38–1.06; p-trend5 0.090]
for low-fat milk intake in the fully adjusted model. We found
no statistical interaction between total dairy and dairy prod-
uct subtypes, and sex, age or diabetes.
After considering the intake of calcium supplements as a
covariate in the Cox regression models, as well as when we
excluded those participants taking calcium supplements in the
baseline moment (Supporting Information, Tables 3–6), the
inverse associations between total dairy products and low-fat
milk consumption with the incidence of CRC remained.
Discussion
In this large prospective cohort study, we found suggestive evi-
dence that high consumption of total dairy products and low-fat
milk is associated with lower CRC incidence. The main
Table 2. Hazard ratios (95% confidence intervals) of colorectal cancer incidence across energy-adjusted tertiles of cumulative average con-
sumption of total dairy, whole-fat dairy and low-fat dairy products in elderly individuals at high cardiovascular risk
Tertiles of dairy consumption (g/day)1
T1 T2 T3 p-trend
Total dairy product consumption, median [P25–P75]; g/day2 206 [139–247] 350 [315–387] 564 [499–640]
Cases/person-year (n) 41/14,063 36/14,086 20/14,091
Rate per 1,000 person-years 2.92 2.56 1.42
Crude model 1.00 ref 0.88 (0.56–1.37) 0.49 (0.29–0.83) 0.007
Multivariate model 1 1.00 ref 1.00 (0.62–1.59) 0.58 (0.33–1.02) 0.044
Multivariate model 2 1.00 ref 0.96 (0.59–1.56) 0.55 (0.31–0.99) 0.037
Whole-fat dairy products, median [P25–P75]; g/day3 0 [0–1] 21 [14–28] 114 [65–217]
Cases/ person-year (n) 32/14,140 29/14,061 36/14,038
Rate per 1,000 person-years 2.26 2.06 2.56
Crude model 1.00 ref 0.91 (0.55–1.50) 1.13 (0.70–1.83) 0.589
Multivariate model 1 1.00 ref 0.92 (0.55–1.56) 1.03 (0.64–1.68) 0.940
Multivariate model 2 1.00 ref 0.89 (0.53–1.49) 1.01 (0.62–1.64) 0.982
Low-fat dairy products, median [P25–P75]; g/day4 67 [5–136] 254 [214–300] 495 [409–563]
Cases/person-year (n) 40/14,053 36/14,075 21/14,112
Rate per 1,000 person-years 2.85 2.56 1.49
Crude model 1.00 ref 0.90 (0.57–1.41) 0.52 (0.31–0.89) 0.016
Multivariate model 1 1.00 ref 0.98 (0.62–1.54) 0.62 (0.36–1.08) 0.078
Multivariate model 2 1.00 ref 0.97 (0.62–1.52) 0.62 (0.36–1.07) 0.072
Abbreviations: P, percentile; T, tertile.
Cox regression model 1 adjusted for intervention group, sex, age (years), leisure time physical activity (METs in min-day), BMI (kg/m2), current
smoker (yes/no), former smoker (yes/no), never smoker (yes, no), family history of cancer (yes/no), education level (primary or secondary/high
school university or graduate), history of diabetes (yes/no) and use of aspirin treatment (yes/no) at baseline.
Cox regression model 2 additionally adjusted for tertiles of cumulative average consumption during the follow-up of vegetables, fruits, legumes,
cereals, fish, meat, olive oil and nuts (all in g/day) and alcohol (g/day and quadratic term).
All models were stratified by recruitment center.
1Tertile cutoffs are based on energy-adjusted cumulative average total dairy products, whole-fat or low-fat dairy product consumption during the fol-
low-up.
2Includes all dairy products: all types of milk, yogurt and cheese, custard, whipped cream, butter and ice-cream.
3Includes whole-fat milk and whole-fat yogurt.
4Includes semi-skimmed/skimmed milk and low-fat yogurt.
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Table 3. Hazard ratios (95% CI) of colorectal cancer incidence across energy-adjusted tertiles of cumulative average consumption of specific
dairy products (yogurt, cheese, milk, concentrated full-fat dairy products, sugar-enriched dairy products and fermented dairy products) in
elderly individuals at high cardiovascular risk
Tertiles of specific dairy product consumption (g/day)1
T1 T2 T3 P-trend
Total yogurt, median [P25–P75]; g/day2 8 [1–22] 65 [54–85] 128 [122–186]
Cases/ person-year (n) 36/14,119 34/14,068 27/14,053
Rate per 1,000 person-years 2.55 2.42 1.92
Crude model 1.00 ref 0.95 (0.59-1.52) 0.75 (0.46-1.24) 0.249
Multivariate model 1 1.00 ref 1.13 (0.69-1.84) 0.92 (0.56-1.51) 0.705
Multivariate model 2 1.00 ref 1.15 (0.70-1.90) 0.94 (0.56-1.59) 0.800
Low-fat yogurt, median [P25, P75]; g/day3 1 [0–4] 40 [24–54] 122 [96–151]
Cases/ person-year (n) 37/14,070 30/14,116 30/14,054
Rate per 1,000 person-years 2.63 2.13 2.13
Crude model 1.00 ref 0.81 (0.50-1.31) 0.81 (0.50-1.31) 0.377
Multivariate model 1 1.00 ref 0.94 (0.57-1.54) 1.02 (0.63-1.65) 0.992
Multivariate model 2 1.00 ref 0.97 (0.59-1.61) 1.06 (0.65-1.73) 0.909
Whole-fat yogurt, median [P25–P75]; g/day4 0 [0] 6 [4–9] 45 [25–77]
Cases/ person-year (n) 33/14,153 35/14,046 29/14,041
Rate per 1,000 person-years 2.33 2.49 2.07
Crude model 1.00 ref 1.07 (0.66-1.72) 0.89 (0.54-1.46) 0.514
Multivariate model 1 1.00 ref 1.13 (0.69-1.86) 0.88 (0.53-1.47) 0.419
Multivariate model 2 1.00 ref 1.07 (0.65-1.79) 0.86 (0.51-1.46) 0.419
Cheese, median [P25–P75]; g/day5 11 [6–15] 25 [22–29] 44 [37–54]
Cases/ person-year (n) 32/14,163 29/14,037 36/14,040
Rate per 1,000 person-years 2.26 2.07 2.56
Crude model 1.00 ref 0.91 (0.55-1.51) 1.13 (0.70-1.82) 0.603
Multivariate model 1 1.00 ref 0.97 (0.57-1.64) 1.23 (0.75-2.02) 0.368
Multivariate model 2 1.00 ref 0.96 (0.56-1.64) 1.23 (0.74-2.06) 0.378
Total milk, median [P25–P75]; g/day6 117 [36–163] 220 [204–242] 449 [364–501]
Cases/ person-year (n) 40/14,057 33/14,088 24/14,095
Rate per 1,000 person-years 2.85 2.34 1.70
Crude model 1.00 ref 0.82 (0.52-1.30) 0.60 (0.36-0.99) 0.063
Multivariate model 1 1.00 ref 0.88 (0.56-1.40) 0.66 (0.39-1.12) 0.149
Multivariate model 2 1.00 ref 0.83 (0.52-1.33) 0.63 (0.36-1.10) 0.135
Low-fat milk, median [P25–P75]; g/day7 15 [0–90] 201 [188–211] 407 [329–497]
Cases/ person-year (n) 46/14,035 29/14,087 22/14,117
Rate per 1,000 person-years 3.28 2.06 1.56
Crude model 1.00 ref 0.63 (0.39-1.00) 0.48 (0.29-0.79) 0.004
Multivariate model 1 1.00 ref 0.70 (0.44-1.11) 0.55 (0.33-0.93) 0.025
Multivariate model 2 1.00 ref 0.68 (0.43-1.09) 0.54 (0.32-0.92) 0.022
Whole-fat milk, median [P25–P75]; g/day8 0 [0] 6 [3–10] 60 [21–181]
Cases/ person-year (n) 31/14,154 31/14,056 35/14,029
Rate per 1,000 person-years 2.19 2.21 2.49
Crude model 1.00 ref 1.00 (0.61-1.65) 1.14 (0.70-1.84) 0.561
Multivariate model 1 1.00 ref 1.10 (0.66-1.83) 1.10 (0.66-1.83) 0.773
Multivariate model 2 1.00 ref 1.07 (0.65-1.85) 1.06 (0.64-1.75) 0.892
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contributor to total dairy product consumption was milk, so the
inverse association between dairy food consumption and CRC
risk might be largely driven by milk intake, particularly low-fat
milk. We did not find any significant association between the
consumption of other specific types of dairy product and the
risk of CRC. These results suggest a potential benefit of dairy
foods for the prevention of CRC in older individuals. Some sys-
tematic reviews and meta-analysis of cohort studies have
assessed the associations of the consumption of total dairy prod-
ucts, milk and solid cheese24,25,31,32 and CRC risk. Our results
are in line with the last published systematic review and meta-
analysis of prospective studies which updated the evidence of
the WCRF-AICR Continuous Update Project in relation to the
association of food groups and beverages with CRC risk.24 In
this meta-analysis, a significant inverse association between the
consumption of total dairy products or milk, and CRC inci-
dence was reported. With regard to total dairy product con-
sumption and CRC risk, the aforementioned meta-analysis
reported similar associations in men and women. Of note, the
relationship between milk consumption and CRC risk was sig-
nificant only in men. No association was found between cheese
and CRC. Neither were any differences found in the associations
with cancer location or sex, probably because of the limited
number of incident cases. However, although an inverse associ-
ation between dairy product consumption and CRC risk is sug-
gested based on prospective cohort studies conducted in healthy
populations, there is insufficient evidence assessing this associa-
tion in older Mediterranean individuals at high cardiovascular
Table 3. Hazard ratios (95% CI) of colorectal cancer incidence across energy-adjusted tertiles of cumulative average consumption of specific
dairy products (yogurt, cheese, milk, concentrated full-fat dairy products, sugar-enriched dairy products and fermented dairy products) in
elderly individuals at high cardiovascular risk (Continued)
Tertiles of specific dairy product consumption (g/day)1
T1 T2 T3 P-trend
Concentrated full-fat dairy products [P25–P75]; g/day9 11 [6–16] 26 [23–30] 45 [38–55]
Cases/ person-year (n) 33/14,165 30/14,039 34/14,035
Rate per 1,000 person-years 2.33 2.14 2.42
Crude model 1.00 ref 0.91 (0.56-1.50) 1.04 (0.64-1.67) 0.786
Multivariate model 1 1.00 ref 0.96 (0.57-1.62) 1.12 (0.68-1.83) 0.607
Multivariate model 2 1.00 ref 0.95 (0.56-1.60) 1.11 (0.66-1.86) 0.638
Sugar enriched dairy products [P25–P75]; g/day10 0 [0–1] 5 [3–6] 14 [10–25]
Cases/ person-year (n) 30/14,177 38/14,087 29/13,976
Rate per 1,000 person-years 2.12 2.70 2.07
Crude model 1.00 ref 1.27 (0.79-2.06) 0.98 (0.59-1.64) 0.895
Multivariate model 1 1.00 ref 1.50 (0.91-2.47) 1.02 (0.59-1.79) 0.927
Multivariate model 2 1.00 ref 1.45 (0.87-2.41) 0.98 (0.55-1.75) 0.810
Fermented dairy products [P25–P75]; g/day10 36 [20–52] 97 [81–115] 166 [147–221]
Cases/ person-year (n) 39/14,111 30/14,097 28/14,031
Rate per 1,000 person-years 2.76 2.13 2.00
Crude model 1.00 ref 0.77 (0.48-1.24) 0.72 (0.44-1.17) 0.175
Multivariate model 1 1.00 ref 0.89 (0.54-1.46) 0.89 (0.54-1.46) 0.608
Multivariate model 2 1.00 ref 0.89 (0.54-1.48) 0.90 (0.53-1.53) 0.661
Abbreviations: P, percentile; T, tertile.
Cox regression model 1 adjusted for intervention group, sex, age (years), leisure time physical activity (METs in min-day), BMI (kg/m2), current
smoker (yes/no), former smoker (yes/no), never smoker (yes, no), family history of cancer (yes/no), education level (primary or secondary/high
school university or graduate), history of diabetes (yes/no) and use of aspirin (yes/no) at baseline.
Cox regression model 2 additionally adjusted for tertiles of cumulative average consumption during the follow-up of vegetables, fruits, legumes,
cereals, fish, meat, olive oil and nuts (all in g/day) and alcohol (g/day and quadratic term).
All models were stratified by recruitment center.
1Tertile cutoffs are based on energy-adjusted cumulative average total specific dairy product consumption during the follow-up.
2Includes all types of yogurt: low-fat and whole-fat yogurt.
3Includes low-fat yogurt.
4Includes whole-fat yogurt.
5Includes all types of cheese: petit Suisse, ricotta, cottage, spreadable and semi-cured/cured cheeses.
6Includes all types of milk: semi-skimmed/skimmed milk and whole-fat milk.
7Includes semi-skimmed and skimmed-milk.
8Includes whole-fat milk.
9Includes butter, whipped cream and all types of cheese.
10Includes condensed milk, milkshakes, ice cream and custard.
11Includes all fermented dairy products: all types of yogurt and cheeses.
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risk. Therefore, this study expands these associations to other
populations.
Few prospective studies have assessed the associations
between types of dairy product by fat content and the risk of
CRC.19,33 In the European Prospective Investigation into Can-
cer and Nutrition (EPIC),19 a study conducted in 477,122 men
and women followed for a mean of 11 years, the higher con-
sumption of different subtypes of milk was inversely associated
with CRC incidence. In our study, a significant reduction of
CRC risk was not observed in the case of whole-fat milk con-
sumption, possibly due to the low consumption of this subtype
of milk in our population (a median 1.7% of the total milk
intake), or because the fat content in whole-fat milk might miti-
gate the potential benefits of the other bioactive components.34
In the last decades, most dietary worldwide guidelines have
advocated the consumption of low-fat dairy products instead of
full-fat counterparts, being this the main reason for the low con-
sumption of whole-fat milk in our study.
In our cohort, associations between types of dairy product
other than milk, such as cheese or yogurt, and the incidence of
CRC were not detected which is in agreement with meta-
analytical evidence.31,32 Few prospective studies have found an
inverse association between cheese consumption and CRC. In
the EPIC study,19 cheese and yogurt consumption was inversely
associated with CRC in the categorical models, although in the
linear model the association was nonsignificant. Although we
observed a nonsignificant inverse association between total
yogurt intake and CRC risk, Pala et al.35 reported a significant
decrease in the risk of CRC associated with high yogurt con-
sumption. Differences in the populations studied, the dietary
assessment tools and the types of yogurt may explain this dis-
crepancy. Furthermore, both the bio-accessibility and bioavail-
ability of the nutrients contained in dairy products may be
different depending on the nature of their food matrix.36 For
example, the higher lactose content in milk compared with fer-
mented dairy products such as cheese or yogurt might decrease
the bioavailability of calcium.37 For this reason, but also because
of the lower consumption of fermented dairy products in com-
parison to milk, we suggest that perhaps we were not able to
detect significant associations between the consumption of
these subtypes of dairy products and CRC risk.
The main biological and widely studied mechanism
explaining the potential benefits of dairy products on CRC is
their calcium content. According to the last WCRF/AICR
report,12 dietary calcium is considered to be a nutrient that is
probably associated with CRC. After adjustment for dietary
calcium intake, we found that the associations between total
dairy product and low-fat milk consumption with CRC risk
were attenuated. Although we did not observe a consistent
inverse association after analyzing the HRs for CRC inci-
dence associated with dietary calcium intake, we could con-
sider calcium as a potential mediator of this association.
Calcium has been shown to exert its potential antitumor
action through two mechanisms. On the one hand, dietary
calcium can bind secondary bile acids and free fatty acids.
These are potential inducers of damage and proliferation
effects on colonic mucosa. On the other hand, calcium can
inhibit cell proliferation and promote differentiation and cell
apoptosis in normal and transformed colonic cells by activat-
ing calcium-sensing receptors in intestinal epithelial cells, and
consequently initiating a cascade of intracellular events which
activate protein kinase C (PKC) and stimulate the release of
intracellular stored calcium. PKC activation and its down-
stream cascade events may redirect the colon precancer cell
at early stages of the neoplastic process into the differentia-
tion pathway.38,39 Other micronutrients and bioactive constit-
uents of dairy products, such as conjugated linoleic acid
(CLA) and butyric acid might also exert a protective effect
against CRC. CLA, naturally present in dairy products, might
protect against CRC by inhibiting cell proliferation, modify-
ing the fluidity of cell membranes, decreasing the production
of inflammatory mediators like prostaglandins and stimulat-
ing the immune response.40–43 The butyric acid contained in
milk and milk products might play a role in colorectal neo-
plasia by inducing apoptosis, cell cycle arrest and differentia-
tion. However, these beneficial effects are more likely to be
due to the fermentation of dietary fiber in the colon by the
microbiota because butyric acid in foods is rapidly absorbed
in the small intestine and metabolized in the liver.39,44
Among the strengths of our study are its large-scale pro-
spective design, the ascertainment and confirmation of cancer
cases by an independent Event Adjudication Committee, the
use of a validated FFQ for measuring food consumption and
the ability to control for several potential confounders. Fur-
thermore, to minimize errors in diet measurement caused by
within-person variation and dietary changes, we have taken
advantage of the repeated measurements of intake and calcu-
lated the cumulative average for dietary variables.
Limitations should also be considered. First, it may be diffi-
cult to generalize our results to other populations because we
studied an older Mediterranean population at high cardiovascu-
lar risk. However, the inverse association between dairy con-
sumption and CRC has been recognized in young individuals
from different populations. Therefore, our results expand the
findings to the previously reported literature on this association.
Because dairy product consumption has been associated to a
decreased risk of obesity and diabetes, both conditions highly
prevalent in older populations, we cannot discard that these
inverse associations may be mediated by these metabolic condi-
tions.45,46 Second, although we used a validated FFQ to assess
dietary variables, potential measurement errors are unavoidable.
Third, because this is a prospective observational study based on
a randomized clinical trial, we cannot rule out a restriction on
the consumption of dairy products due to the dietary interven-
tion, especially in the control group, which may have an impact
on the outcomes. Likewise, the number of incident CRC cases
was quite limited. Consequently, we were not able to assess dif-
ferences in risk neither by tumor subsite nor sex.
In summary, a high consumption of total dairy products
and low-fat milk was strongly associated with a reduced risk
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of CRC in older Mediterranean individuals at high cardiovas-
cular risk. Because of the evidence on the benefits that low-
fat milk can have on the risk of CRC, and the lack of evi-
dence on an increased CRC risk derived from whole-fat dairy
consumption, there are no reasons to advice against whole-
fat dairy products. Thus, the recommendation to drink milk
might be reasonable. Further prospective studies and clinical
trials on secondary prevention are warranted to clarify the
associations between dairy foods and CRC risk.
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Supplemental Table 1. Energy adjusted dairy product consumption during follow-up in the study population 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: SD, standard deviation; P, percentile. 
1Includes all dairy products: all types of milk, yogurt and cheeses, custard, whipped cream, butter and ice-cream. 
2Includes whole-fat milk and whole-fat yogurt. 
3Includes semi-skimmed/skimmed milk and low-fat yogurt. 
4Includes all types of yogurt: low-fat and whole-fat yogurt. 
5Includes low-fat yogurt. 
6 Includes whole-fat yogurt. 
7 Includes all types of cheese: petit Suisse, ricotta, cottage, spreadable and semi-cured/cured cheeses. 
8 Includes all types of milk: semi-skimmed/skimmed milk and whole-fat milk. 
9 Includes semi-skimmed and skimmed milk. 
10 Includes whole-fat milk. 
11 Includes butter, whipped cream and all types of cheese. 
12 Includes condensed milk, milkshakes, ice cream and custard. 
13 Includes all fermented dairy products: all types of yogurt and cheeses. 
 
 
 Mean±SD; g/day Median [P25, P75]; g/day 
Total dairy products1 375.3±186.4 350 [247-499] 
Whole-fat dairy products2 59.0±112.2 21 [1-65] 
Low-fat dairy products3 279.2±197.5 254 [136-409] 
Total yogurt4 81.4±75.3 65 [22-122] 
Low-fat yogurt5 60.2±71.5 40 [3-96] 
Whole-fat yogurt6 21.2±42.6 6 [0-25] 
Cheese7 28.2±20.1 25 [15-37] 
Total milk8 256.8±161.4 220 [163-364] 
Low-fat milk9 219.0±171.8 201 [90-329] 
Whole-fat milk10 37.8±96.8 6 [0-21] 
Concentrated full-fat dairy products11 29.0±20.5 26 [16-38] 
Sugar-enriched dairy products12 8.9±20.4 5 [1-10] 
Fermented dairy products13 109.6±79.5 97 [52-147] 
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Supplemental Table 2. Hazard ratios (95% CI) of colorectal cancer incidence across energy-adjusted tertiles of average calcium consumption in elderly 
individuals at high cardiovascular risk. 
Calcium from low-fat milk, median [P25-P75]; g/day4 3[-10-17] 260[247-268] 647[292-661]  
    Cases/ person-year (n) 46/14035 29/14086 22/14119  
    Rate per 1000 person-years 3.28 2.06 1.56  
    Crude model 1.00 ref 0.63 (0.39-1.00) 0.48 (0.29-0.79) 0.004 
    Multivariate model 1 1.00 ref 0.69 (0.44-1.10) 0.55 (0.33-0.93) 0.025 
     Multivariate model 2 1.00 ref 0.68 (0.42-1.08) 0.53 (0.31-0.91) 0.105 
 
Calcium from total milk, median [P25-P75]; g/day5 
 
111[18-206] 
 
274[257-290] 
 
638[592-669] 
 
    Cases/ person-year (n) 40/14061 33/14075 24/14103  
    Rate per 1000 person-years 2.84 2.34 1.70  
    Crude model 1.00 ref 0.82 (0.52-1.31) 0.60 (0.36-0.99) 0.062 
    Multivariate model 1 1.00 ref 0.88 (0.56-1.40) 0.67 (0.39-1.13) 0.157 
     Multivariate model 2 1.00 ref 0.83 (0.52-1.33) 0.62 (0.35-1.10) 0.105 
Abbreviations: P, percentile; T, tertile. 
Cox regression model 1 adjusted by intervention group, sex, age (years), leisure time physical activity (MET-day), BMI (kg/m2), current smoker (yes/no), former smoker (yes/no), never smoker (yes, no), family history 
of cancer (yes/no), education level, history of diabetes (yes/no) and use of aspirin treatment at baseline. 
Cox regression model 2 additionally adjusted by average consumption during the follow-up of vegetables (g/d), fruit (g/d), legumes (g/d), cereals (g/d), fish (g/d), meat (g/d), alcohol  (g/d), olive oil (g/d) and nuts (g/d).  
All models were stratified by recruitment center. 
1Tertile cut-offs are based on energy-adjusted average calcium consumption during the follow-up. 
2 Includes dietary calcium from all food sources. 
3 Includes calcium from all dairy sources: all types of milk, yogurt and cheeses, custard, whipped cream, butter and ice-cream. 
4 Includes calcium from low-fat milk: semi-skimmed and skimmed milk. 
5 Includes calcium from all types of milk: semi-skimmed/skimmed milk and whole-fat milk. 
 Tertiles of calcium consumption (mg/day)1 
 T1 T2 T3 P- trend 
Calcium from all food sources, median [P25-P75]; g/day2 738[632-810] 992[931-1061] 1337[1232-1487]  
    Cases/ person-year (n) 45/14116 27/14103 25/14020  
    Rate per 1000 person-years 3.19 1.91 1.78  
    Crude model 1.00 ref 0.60 (0.37-0.97) 0.56 (0.34-0.91) 0.021 
    Multivariate model 1 1.00 ref 0.63 (0.39-1.04) 0.65 (0.39-1.09) 0.121 
     Multivariate model 2 
 
1.00 ref 0.60 (0.36-1.00) 0.60 (0.34-1.05) 0.091 
Calcium from dairy sources, median [P25-P75]; g/day3 330[234-398] 573[512-642] 916[823-1067]  
    Cases/ person-year (n) 41/14066 32/14110 24/14064  
    Rate per 1000 person-years 2.91 2.27 1.71  
    Crude model 1.00 ref 0.78 (0.49-1.23) 0.59 (0.35-0.97) 0.042 
    Multivariate model 1 1.00 ref 0.81 (0.50-1.32) 0.66 (0.39-1.12) 0.141 
     Multivariate model 2 
 
1.00 ref 0.78 (0.47-1.29) 0.61 (0.34-1.08) 0.105 
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Supplemental table 3. Hazard ratios (95% confidence intervals) of colorectal cancer incidence across energy-adjusted tertiles of cumulative average consumption 
of total dairy, whole-fat dairy and low-fat dairy products in elderly individuals at high cardiovascular risk after additional adjustment for intake of calcium 
supplements 
 Tertiles of dairy consumption (g/day)1  
 T1 T2 T3 P- trend 
Total dairy product consumption, median [P25-P75]; g/day2 206 [139-247] 350 [315-387] 564 [499-640]  
    Cases/ person-year (n) 41/14063 36/14086 20/14091  
    Rate per 1000 person-years 2.92 2.56 1.42  
    Crude model 1.00 ref 0.88 (0.56-1.37) 0.49 (0.29-0.83) 0.007 
    Multivariate model 1 1.00 ref 1.00 (0.62-1.59) 0.58 (0.33-1.01) 0.043 
     Multivariate model 2 1.00 ref 0.96 (0.59-1.56) 0.55 (0.31-0.99) 0.037 
Whole-fat dairy products, median [P25-P75]; g/day3 0 [0-1] 21 [14-28] 114 [65-217]  
    Cases/ person-year (n) 32/14140 29/14061 36/14038  
    Rate per 1000 person-years 2.26 2.06 2.56  
    Crude model 1.00 ref 0.91 (0.55-1.50) 1.13 (0.70-1.83) 0.589 
    Multivariate model 1 1.00 ref 0.92 (0.55-1.56) 1.03 (0.64-1.66) 0.940 
     Multivariate model 2 1.00 ref 0.89 (0.53-1.49) 1.01 (0.62-1.64) 0.982 
Low-fat dairy products, median [P25-P75]; g/day4  67 [5-136] 254 [214-300] 495 [409-563]  
    Cases/ person-year (n) 40/14053 36/14075 21/14112  
    Rate per 1000 person-years 2.85 2.56 1.49  
    Crude model 1.00 ref 0.90 (0.57-1.41) 0.52 (0.31-0.89) 0.016 
    Multivariate model 1 1.00 ref 0.98 (0.62-1.54) 0.62 (0.36-1.08) 0.077 
     Multivariate model 2 1.00 ref 0.97 (0.62-1.52) 0.62 (0.36-1.07) 0.071 
Abbreviations: P, percentile; T, tertile. 
Cox regression model 1 adjusted for intervention group, sex, age (years), leisure time physical activity (METs in min-day), BMI (kg/m2), current smoker (yes/no), former smoker (yes/no), never smoker (yes, no), family 
history of cancer (yes/no), education level (primary or secondary/high school university or graduate), history of diabetes (yes/no), use of aspirin treatment (yes/no) and use of calcium supplements (yes/no) at baseline. 
Cox regression model 2 additionally adjusted for tertiles of cumulative average consumption during the follow-up of vegetables, fruits, legumes, cereals, fish, meat, olive oil and nuts (all in g/day) and alcohol (g/day and 
quadratic term). 
All models were stratified by recruitment center. 
1Tertile cut-offs are based on energy-adjusted cumulative average total dairy products, whole-fat or low-fat dairy product consumption during the follow-up. 
2 Includes all dairy products: all types of milk, yogurt and cheese, custard, whipped cream, butter and ice-cream. 
3 Includes whole-fat milk and whole-fat yogurt. 
4 Includes semi-skimmed/skimmed milk and low-fat yogurt. 
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Supplemental table 4. Hazard ratios (95% CI) of colorectal cancer incidence across energy-adjusted tertiles of cumulative average consumption of specific dairy 
products (yogurt, cheese, milk, concentrated full-fat dairy products, sugar-enriched dairy products and fermented dairy products) in elderly individuals at high 
cardiovascular risk after additional adjustment for intake of calcium supplements 
 Tertiles of specific dairy product consumption (g/day)1  
 T1 T2 T3 P- trend 
Total yogurt, median [P25-P75]; g/day2 8 [1-22] 65 [54-85] 128 [122-186]  
    Cases/ person-year (n) 36/14119 34/14068 27/14053  
    Rate per 1000 person-years 2.55 2.42 1.92  
    Crude model 1.00 ref 0.95 (0.59-1.52) 0.75 (0.46-1.24) 0.249 
    Multivariate model 1 1.00 ref 1.13 (0.69-1.84) 0.92 (0.56-1.51) 0.705 
    Multivariate model 2 1.00 ref 1.15 (0.70-1.90) 0.94 (0.56-1.59) 0.799 
Low-fat yogurt, median [P25, P75]; g/day3 1 [0-4] 40 [24-54] 122 [96-151]  
    Cases/ person-year (n) 37/14070 30/14116 30/14054  
    Rate per 1000 person-years 2.63 2.13 2.13  
    Crude model 1.00 ref 0.81 (0.50-1.31) 0.81 (0.50-1.31) 0.377 
    Multivariate model 1 1.00 ref 0.94 (0.57-1.54) 1.02 (0.63-1.65) 0.991 
    Multivariate model 2 1.00 ref 0.97 (0.59-1.61) 1.06 (0.65-1.73) 0.910 
Whole-fat yogurt, median [P25-P75]; g/day4 0 [0] 6 [4-9] 45 [25-77]  
    Cases/ person-year (n) 33/14153 35/14046 29/14041  
    Rate per 1000 person-years 2.33 2.49 2.07  
    Crude model 1.00 ref 1.07 (0.66-1.72) 0.89 (0.54-1.46) 0.514 
    Multivariate model 1 1.00 ref 1.12 (0.69-1.86) 0.88 (0.53-1.47) 0.418 
    Multivariate model 2 1.00 ref 1.07 (0.65-1.79) 0.86 (0.51-1.46) 0.418 
Cheese, median [P25-P75]; g/day5 11 [6-15] 25 [22-29] 44 [37-54]  
    Cases/ person-year (n) 32/14163 29/14037 36/14040  
    Rate per 1000 person-years 2.26 2.07 2.56  
    Crude model 1.00 ref 0.91 (0.55-1.51) 1.13 (0.70-1.82) 0.603 
    Multivariate model 1 1.00 ref 0.97 (0.57-1.64) 1.23 (0.75-2.02) 0.368 
    Multivariate model 2 1.00 ref 0.96 (0.56-1.64) 1.23 (0.74-2.06) 0.379 
Total milk, median [P25-P75]; g/day6 117 [36-163] 220 [204-242] 449 [364-501]  
    Cases/ person-year (n) 40/14057 33/14088 24/14095  
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    Rate per 1000 person-years 2.85 2.34 1.70  
    Crude model 1.00 ref 0.82 (0.52-1.30) 0.60 (0.36-0.99) 0.063 
    Multivariate model 1 1.00 ref 0.88 (0.56-1.40) 0.66 (0.39-1.12) 0.148 
    Multivariate model 2 1.00 ref 0.83 (0.52-1.33) 0.63 (0.36-1.10) 0.134 
Low-fat milk, median [P25-P75]; g/day7 15 [0-90] 201 [188-211] 407 [329-497]  
    Cases/ person-year (n) 46/14035 29/14087 22/14117  
    Rate per 1000 person-years 3.28 2.06 1.56  
    Crude model 1.00 ref 0.63 (0.39-1.00) 0.48 (0.29-0.79) 0.004 
    Multivariate model 1 1.00 ref 0.70 (0.44-1.11) 0.55 (0.33-0.93) 0.025 
    Multivariate model 2 1.00 ref 0.68 (0.43-1.09) 0.54 (0.32-0.92) 0.022 
Whole-fat milk, median [P25-P75]; g/day8 0 [0] 6 [3-10] 60 [21-181]  
    Cases/ person-year (n) 31/14154 31/14056 35/14029  
    Rate per 1000 person-years 2.19 2.21 2.49  
    Crude model 1.00 ref 1.00 (0.61-1.65) 1.14 (0.70-1.84) 0.561 
    Multivariate model 1 1.00 ref 1.10 (0.66-1.84) 1.10 (0.66-1.83) 0.773 
    Multivariate model 2 1.00 ref 1.07 (0.65-1.78) 1.06 (0.64-1.75) 0.891 
Concentrated full-fat dairy products [P25-P75]; g/day9 11 [6-16] 26 [23-30] 45 [38-55]  
    Cases/ person-year (n) 33/14165 30/14039 34/14035  
    Rate per 1000 person-years 2.33 2.14 2.42  
    Crude model 1.00 ref 0.91 (0.56-1.50) 1.04 (0.64-1.67) 0.786 
    Multivariate model 1 1.00 ref 0.96 (0.57-1.62) 1.12 (0.68-1.83) 0.607 
    Multivariate model 2 1.00 ref 0.95 (0.56-1.60) 1.11 (0.66-1.86) 0.639 
Sugar enriched dairy products [P25-P75]; g/day10 0 [0-1] 5 [3-6] 14 [10-25]  
    Cases/ person-year (n) 30/14177 38/14087 29/13976  
    Rate per 1000 person-years 2.12 2.70 2.07  
    Crude model 1.00 ref 1.27 (0.79-2.06) 0.98 (0.59-1.64) 0.895 
    Multivariate model 1 1.00 ref 1.50 (0.91-2.47) 1.02 (0.59-1.79) 0.927 
    Multivariate model 2 1.00 ref 1.45 (0.87-2.41) 0.98 (0.55-1.75) 0.810 
Fermented dairy products [P25-P75]; g/day11 36 [20-52] 97 [81-115] 166 [147-221]  
    Cases/ person-year (n) 
 
39/14111 30/14097 28/14031  
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY AND LIFESTYLE DETERMINANTS ASSOCIATED WITH THE RISK OF COLORECTAL CANCER 
Laura Barrubés Piñol 
 
     
    Rate per 1000 person-years 2.76 2.13 2.00  
    Crude model 1.00 ref 0.77 (0.48-1.24) 0.72 (0.44-1.17) 0.175 
    Multivariate model 1 1.00 ref 0.88 (0.54-1.46) 0.89 (0.54-1.46) 0.608 
    Multivariate model 2 1.00 ref 0.89 (0.54-1.48) 0.90 (0.53-1.53) 0.661 
Abbreviations: P, percentile; T, tertile. 
Cox regression model 1 adjusted for intervention group, sex, age (years), leisure time physical activity (METs in min-day), BMI (kg/m2), current smoker (yes/no), former smoker (yes/no), never smoker (yes, no), family 
history of cancer (yes/no), education level (primary or secondary/high school university or graduate), history of diabetes (yes/no), use of aspirin (yes/no) and use of calcium supplement (yes/no) at baseline. 
Cox regression model 2 additionally adjusted for tertiles of cumulative average consumption during the follow-up of vegetables, fruits, legumes, cereals, fish, meat, olive oil and nuts (all in g/day) and alcohol (g/day and 
quadratic term). 
All models were stratified by recruitment center. 
1Tertile cut-offs are based on energy-adjusted cumulative average total specific dairy product consumption during the follow-up. 
2 Includes all types of yogurt: low-fat and whole-fat yogurt. 
3 Includes low-fat yogurt. 
4 Includes whole-fat yogurt. 
5 Includes all types of cheese: petit Suisse, ricotta, cottage, spreadable and semi-cured/cured cheeses. 
6 Includes all types of milk: semi-skimmed/skimmed milk and whole-fat milk. 
7 Includes semi-skimmed and skimmed-milk. 
8 Includes whole-fat milk. 
9 Includes butter, whipped cream and all types of cheese. 
10 Includes condensed milk, milkshakes, ice cream and custard. 
11 Includes all fermented dairy products: all types of yogurt and cheeses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY AND LIFESTYLE DETERMINANTS ASSOCIATED WITH THE RISK OF COLORECTAL CANCER 
Laura Barrubés Piñol 
 
Supplemental table 5. Hazard ratios (95% confidence intervals) of colorectal cancer incidence across energy-adjusted tertiles of cumulative average consumption of 
total dairy, whole-fat dairy and low-fat dairy products in elderly individuals at high cardiovascular risk after excluding those individuals taking calcium supplements 
at baseline (n= 6719) 
 Tertiles of dairy consumption (g/day)1  
 T1 T2 T3 P- trend 
Total dairy product consumption, median [P25-P75]; g/day2 206 [139-247] 350 [315-387] 562 [499-639]  
    Cases/ person-year (n) 40/13349 35/13209 17/12951  
    Rate per 1000 person-years 3.00 2.65 1.31  
    Crude model 1.00 ref 0.88 (0.56-1.39) 0.44 (0.25-0.77) 0.004 
    Multivariate model 1 1.00 ref 1.04 (0.65-1.68) 0.53 (0.29-0.97) 0.031 
     Multivariate model 2 1.00 ref 1.01 (0.61-1.66) 0.50 (0.27-0.94) 0.025 
Whole-fat dairy products, median [P25-P75]; g/day3 0 [0-1] 21 [13-28] 115 [66-215]  
    Cases/ person-year (n) 31/13285 25/13095 36/13129  
    Rate per 1000 person-years 2.33 1.91 2.74  
    Crude model 1.00 ref 0.82 (0.48-1.39) 1.18 (0.73-1.90) 0.406 
    Multivariate model 1 1.00 ref 0.85 (0.49-1.47) 1.07 (0.66-1.74) 0.744 
     Multivariate model 2 1.00 ref 0.83 (0.48-1.44) 1.07 (0.65-1.75) 0.740 
Low-fat dairy products, median [P25-P75]; g/day4  67 [5-136] 254 [214-299] 495 [409-562]  
    Cases/ person-year (n) 39/13250 35/13281 18/12977  
    Rate per 1000 person-years 2.94 2.64 1.39  
    Crude model 1.00 ref 0.89 (0.57-1.41) 0.47 (0.27-0.82) 0.009 
    Multivariate model 1 1.00 ref 0.99 (0.62-1.58) 0.58 (0.32-1.04) 0.061 
     Multivariate model 2 1.00 ref 0.99 (0.62-1.57) 0.57 (0.32-1.02) 0.054 
Abbreviations: P, percentile; T, tertile. 
Cox regression model 1 adjusted for intervention group, sex, age (years), leisure time physical activity (METs in min-day), BMI (kg/m2), current smoker (yes/no), former smoker (yes/no), never smoker (yes, no), family 
history of cancer (yes/no), education level (primary or secondary/high school university or graduate), history of diabetes (yes/no) and use of aspirin treatment (yes/no) at baseline. 
Cox regression model 2 additionally adjusted for tertiles of cumulative average consumption during the follow-up of vegetables, fruits, legumes, cereals, fish, meat, olive oil and nuts (all in g/day) and alcohol (g/day and 
quadratic term). 
All models were stratified by recruitment center. 
1Tertile cut-offs are based on energy-adjusted cumulative average total dairy products, whole-fat or low-fat dairy product consumption during the follow-up. 
2 Includes all dairy products: all types of milk, yogurt and cheese, custard, whipped cream, butter and ice-cream. 
3 Includes whole-fat milk and whole-fat yogurt. 
4 Includes semi-skimmed/skimmed milk and low-fat yogurt. 
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Supplemental table 6. Hazard ratios (95% CI) of colorectal cancer incidence across energy-adjusted tertiles of cumulative average consumption of specific dairy 
products (yogurt, cheese, milk, concentrated full-fat dairy products, sugar-enriched dairy products and fermented dairy products) in elderly individuals at high 
cardiovascular risk after excluding those individuals taking calcium supplements at baseline (n= 6719) 
 Tertiles of specific dairy product consumption (g/day)1  
 T1 T2 T3 P- trend 
Total yogurt, median [P25-P75]; g/day2 8 [1-22] 64 [54-85] 128 [122-184]  
    Cases/ person-year (n) 34/13457 33/13081 25/12970  
    Rate per 1000 person-years 2.53 2.52 1.93  
    Crude model 1.00 ref 1.00 (0.62-1.61) 0.76 (0.45-1.28) 0.292 
    Multivariate model 1 1.00 ref 1.18 (0.72-1.95) 0.91 (0.54-1.53) 0.703 
    Multivariate model 2 1.00 ref 1.21 (0.73-2.02) 0.93 (0.53-1.62) 0.784 
Low-fat yogurt, median [P25, P75]; g/day3 1 [0-4] 40 [24-54] 122 [96-150]  
    Cases/ person-year (n) 36/13322 29/13235 27/12951  
    Rate per 1000 person-years 2.70 2.19 2.08  
    Crude model 1.00 ref 0.81 (0.50-1.32) 0.77 (0.47-1.27) 0.285 
    Multivariate model 1 1.00 ref 0.94 (0.57-1.56) 0.95 (0.57-1.58) 0.749 
    Multivariate model 2 1.00 ref 0.98 (0.59-1.63) 0.98 (0.58-1.65) 0.821 
Whole-fat yogurt, median [P25-P75]; g/day4 0  6 [4-9] 45 [25-78]  
    Cases/ person-year (n) 32/13324 31/13151 29/13034  
    Rate per 1000 person-years 2.40 2.36 2.23  
    Crude model 1.00 ref 0.98 (0.60-1.61) 0.93 (0.56-1.53) 0.739 
    Multivariate model 1 1.00 ref 1.06 (0.63-1.78) 0.91 (0.54-1.53) 0.580 
    Multivariate model 2 1.00 ref 1.02 (0.60-1.73) 0.91 (0.54-1.56) 0.630 
Cheese, median [P25-P75]; g/day5 15 [6-27] 23 [15-32] 36 [26-46]  
    Cases/ person-year (n) 31/13437 27/13090 34/12981  
    Rate per 1000 person-years 2.31 2.06 2.62  
    Crude model 1.00 ref 0.89 (0.53-1.49) 1.13 (0.70-1.84) 0.612 
    Multivariate model 1 1.00 ref 0.92 (0.54-1.59) 1.18 (0.71-1.96) 0.479 
    Multivariate model 2 1.00 ref 0.93 (0.54-1.60) 1.19 (0.70-2.02) 0.471 
Total milk, median [P25-P75]; g/day6 0 6 [3-10] 60 [21-180]  
    Cases/ person-year (n) 29/13327 29/12989 34/13192  
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    Rate per 1000 person-years 2.18 2.23 2.58  
    Crude model 1.00 ref 0.82 (0.51-1.31) 0.55 (0.32-0.93) 0.040 
    Multivariate model 1 1.00 ref 0.90 (0.56-1.44) 0.63 (0.36-1.09) 0.126 
    Multivariate model 2 1.00 ref 0.85 (0.52-1.37) 0.60 (0.33-1.08) 0.121 
Low-fat milk, median [P25-P75]; g/day7 15 [0-91] 201 [188-211] 406 [329-497]  
    Cases/ person-year (n) 46/13187 27/13289 19/13032  
    Rate per 1000 person-years 3.49 2.03 1.46  
    Crude model 1.00 ref 0.58 (0.36-0.94) 0.42 (0.25-0.71) 0.001 
    Multivariate model 1 1.00 ref 0.66 (0.41-1.06) 0.50 (0.29-0.87) 0.016 
    Multivariate model 2 1.00 ref 0.64 (0.40-1.04) 0.49 (0.28-0.86) 0.014 
Whole-fat milk, median [P25-P75]; g/day8 0 6 [3-10] 60 [21-180]  
    Cases/ person-year (n) 29/13327 29/12989 34/13192  
    Rate per 1000 person-years 2.18 2.23 2.58  
    Crude model 1.00 ref 1.02 (0.61-1.71) 1.18 (0.72-1.94) 0.497 
    Multivariate model 1 1.00 ref 1.17 (0.69-2.00) 1.18 (0.70-1.99) 0.664 
    Multivariate model 2 1.00 ref 1.14 (0.68-1.93) 1.16 (0.69-1.95) 0.695 
Concentrated full-fat dairy products [P25-P75]; g/day9 11 [6-16] 26 [23-30] 45 [38-55]  
    Cases/ person-year (n) 32/13453 28/13064 32/12992  
    Rate per 1000 person-years 2.38 2.14 2.46  
    Crude model 1.00 ref 0.90 (0.54-1.49) 1.03 (0.63-1.69) 0.783 
    Multivariate model 1 1.00 ref 0.94 (0.55-1.61) 1.07 (0.64-1.78) 0.724 
    Multivariate model 2 1.00 ref 0.94 (0.55-1.61) 1.07 (0.62-1.84) 0.736 
Sugar enriched dairy products [P25-P75]; g/day10 0 [0-1] 5 [3-6] 14 [10-25]  
    Cases/ person-year (n) 28/13369 36/13092 28/13048  
    Rate per 1000 person-years 2.09 2.75 2.15  
    Crude model 1.00 ref 1.31 (0.80-2.15) 1.03 (0.61-1.73) 0.988 
    Multivariate model 1 1.00 ref 1.58 (0.95-2.63) 1.08 (0.61-1.91) 0.960 
    Multivariate model 2 1.00 ref 1.54 (0.92-2.58) 1.06 (0.59-1.91) 0.999 
Fermented dairy products [P25-P75]; g/day11 36 [20-51] 97 [81-115] 166 [147-220]  
    Cases/ person-year (n) 
 
37/13510 29/13099 26/12899  
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    Rate per 1000 person-years 2.74 2.21 2.02  
    Crude model 1.00 ref 0.81 (0.50-1.31) 0.74 (0.45-1.21) 0.218 
    Multivariate model 1 1.00 ref 0.93 (0.56-1.54) 0.88 (0.52-1.48) 0.600 
    Multivariate model 2 1.00 ref 0.93 (0.56-1.56) 0.89 (0.51-1.56) 0.649 
Abbreviations: P, percentile; T, tertile. 
Cox regression model 1 adjusted for intervention group, sex, age (years), leisure time physical activity (METs in min-day), BMI (kg/m2), current smoker (yes/no), former smoker (yes/no), never smoker (yes, no), family 
history of cancer (yes/no), education level (primary or secondary/high school university or graduate), history of diabetes (yes/no) and use of aspirin (yes/no) at baseline. 
Cox regression model 2 additionally adjusted for tertiles of cumulative average consumption during the follow-up of vegetables, fruits, legumes, cereals, fish, meat, olive oil and nuts (all in g/day) and alcohol (g/day and 
quadratic term). 
All models were stratified by recruitment center. 
1Tertile cut-offs are based on energy-adjusted cumulative average total specific dairy product consumption during the follow-up. 
2 Includes all types of yogurt: low-fat and whole-fat yogurt. 
3 Includes low-fat yogurt. 
4 Includes whole-fat yogurt. 
5 Includes all types of cheese: petit Suisse, ricotta, cottage, spreadable and semi-cured/cured cheeses. 
6 Includes all types of milk: semi-skimmed/skimmed milk and whole-fat milk. 
7 Includes semi-skimmed and skimmed-milk. 
8 Includes whole-fat milk. 
9 Includes butter, whipped cream and all types of cheese. 
10 Includes condensed milk, milkshakes, ice cream and custard. 
11 Includes all fermented dairy products: all types of yogurt and cheeses. 
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Chapter 2 
 
Association between the 2018 World Cancer Research Fund/American Institute for 
Cancer Research (WCRF/AICR) and the low-risk lifestyle scores with colorectal cancer 
risk in elderly individuals at high cardiovascular risk. 
 
Barrubés L, Babio N, Hernández-Alonso P, Toledo E, Ramírez Sabio JB, Estruch R, Ros E, Fitó M, 
Alonso-Gómez AM, Fiol M, Lapetra J, Serra-Majem L, Pintó X, Ruiz-Canela M, Corella D, Castañer 
O, Macías-González M, Salas-Salvadó J; PREvención con DIeta MEDiterránea Study Investigators. 
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Abstract: Limited longitudinal studies have been conducted to evaluate colorectal cancer (CRC)
incidence based on the updated 2018 World Cancer Research Fund/American Institute for Cancer
Research (WCRF/AICR) recommendations or other global lifestyle indices, and none in aged
populations at high cardiovascular risk. We aimed to assess the association between CRC incidence
and adherence to two emerging lifestyles indices (2018 WCRF/AICR score and another low-risk
lifestyle (LRL) score comprising smoking status, alcohol consumption, physical activity, diet, and body
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mass index) in the Spanish PREvencion con DIeta MEDiterranea (PREDIMED) cohort. We studied
7216 elderly men and women at high cardiovascular risk. The 2018 WCRF/AICR and LRL scores were
calculated. Multivariable Cox proportional regression models were fitted to estimate the HRs (hazard
ratios) and 95% confidence intervals (CIs) for incident CRC events. During a median interquartile
range (IQR) follow-up of 6.0 (4.4–7.3) years, 97 CRC events were considered. A significant linear
association was observed between each 1-point increment in the WCRF/AICR score (score range from
0 to 7) and CRC risk (HR (95% CI) = 0.79 (0.63–0.99)). Similarly, each 1-point increment in the LRL
score (score range from 0 to 5) was associated with a 22% reduction in CRC risk (0.78 (0.64–0.96)).
Adhering to emergent lifestyle scores might substantially reduce CRC incidence in elderly individuals.
Further longitudinal studies, which take different lifestyle indexes into account, are warranted in
the future.
Keywords: WCRF/AICR score; low-risk lifestyle index; colorectal cancer; PREDIMED; lifestyle patterns
1. Introduction
Worldwide, colorectal cancer (CRC) is an important public health problem since it is the second
most commonly occurring cancer in women and the third in men. CRC is also the second most
common cause of cancer death in both sexes globally. In 2018, there were over 1.8 million new CRC
cases, and the global burden is expected to increase further due to the growth of the aging population
and the adoption of westernized behaviors and lifestyles [1].
There is convincing evidence that some dietary components (i.e., processed meat and alcohol
intake) and body fatness are modifiable risk factors, contributing to the development of CRC, whereas
physical activity decreases the risk [2].
Since foods are not consumed in isolation and have additive or synergistic health-related effects,
the current literature focuses on examining diet as a multidimensional exposure [3]. Several a priori
defined food groups and general index-based dietary patterns have been associated with lower CRC
risk, supporting the hypothesis that high overall diet quality is associated with decreased CRC risk [4,5].
Moreover, since both diet quality and other environmental factors have been shown to play
an important role in the development of chronic diseases, healthy lifestyle indices have emerged.
Previous work on CRC nutritional epidemiology has mainly focused on the World Cancer Research
Fund/American Institute for Cancer Research (WCRF/AICR) score [6]. Nonetheless, very little is known
about other lifestyle indices and their association with the risk of this type of cancer [7].
Some prospective cohort studies [6,8–13] and case-control studies [14–16] have evaluated the
associations between CRC risk and adherence to cancer-specific nutritional recommendations with
inconsistent results. However, limited longitudinal studies [13,16] have been conducted to assess
associations based on the updated 2018 WCRF/AICR recommendations.
Another recent score by Li and coworkers [7], in the context of the Nurses’ Health Study and the
Health Professionals Follow-up Study, composed of five modifiable lifestyle factors (smoking status,
alcohol consumption, physical activity, diet, and body mass index (BMI)), has consistently shown
significant inverse associations with all-cause mortality, including cancer and cardiovascular disease
(CVD) mortality and also with CVD incidence. Recently, this index has been also related to an increased
healthy life expectancy (i.e., free of chronic diseases) [17]. However, information regarding this score
with cancer incidence is lacking [7,18].
Lifestyle scores-generated a priori, according to current scientific knowledge, allows us to examine
the potential combined effect of the individual score components on the incidence of different diseases.
To the best of our knowledge, no previous study has evaluated the association between the aforementioned
lifestyle score (low-risk lifestyle (LRL) score from now on) and the risk of developing CRC.
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In an attempt to know whether using scores based on overall lifestyle patterns may be useful to
prevent CRC in aging individuals, we aimed to evaluate the associations between adherence to the
2018 WCRF/AICR and LRL scores with CRC incidence in elderly Spanish individuals at high CVD risk.
Our secondary objective was to evaluate the associated CRC risk for every individual component of
each score.
2. Materials and Methods
2.1. Study Design
We conducted a prospective, longitudinal, observational cohort study within the frame of the
PREDIMED (PREvencion con DIeta MEDiterranea) study. Briefly, the PREDIMED study is a multicenter,
parallel-group controlled trial designed to assess the effect of a traditional Mediterranean Diet (MedDiet)
on the primary prevention of CVD [19]. The PREDIMED Project was approved by the “Comité Ético
de lnvestigación Clínica Hospital Clínic” from Barcelona (Project identification register: 2002–1244;
date of approval: 16 July 2002).
The design and results of the PREDIMED trial with respect to the primary endpoint have been reported
elsewhere [20]. Before starting the study, all participants provided informed consent. The Institutional
Review Boards of each recruitment center approved the protocol. Even though for the main outcome
of CVD, the trial was completed after a median follow-up of 4.8 years, we analyzed data based on the
extended follow-up until December 2012.
2.2. Participants
A total of 7447 individuals from primary care centers were recruited to the PREDIMED trial
between 2003 and 2009. Eligible participants were community-dwelling men (aged 55–80 years) and
women (aged 60–80 years) free from CVD at baseline but who were at high risk because they had either
type 2 diabetes (T2D) or at least three of the following cardiovascular risk factors: current smoking,
hypertension, hypercholesterolemia, low high-density lipoprotein cholesterol, overweight/obesity,
or family history of premature coronary heart disease.
Exclusion criteria were the presence of any severe chronic illness, malignant tumors diagnosis in
the last five years prior to the recruitment, alcohol or drug abuse, a BMI ≥ 40 kg/m2, and allergy or
intolerance to olive oil or nuts. Participants were allocated to one of the three intervention groups:
Mediterranean Diet (MedDiet) supplemented with nuts, MedDiet supplemented with extra virgin
olive oil, or advice to reduce all sources of fat (control group). Energy restriction and physical activity
were not encouraged in any group during the intervention. For this analysis, those participants who
had implausible baseline daily energy intake values (<500 or >3500 kcal/day for women or <800 or
>4000 kcal/day for men) and those who did not complete the baseline food frequency questionnaire
(FFQ) were excluded.
2.3. Ascertainment of Incident and Fatal CRC
New CRC events were defined as the first invasive CRC according to the International Classification
of Diseases for Oncology topographical codes C18.0–C20.9. The results of the histological examination
were considered confirmatory in most events (n = 67). Events were identified from the following
sources: a review of all the medical records by a panel of physicians and researchers blinded to the
intervention, at both primary healthcare and hospital level, and the national death index. The Endpoint
Adjudication Committee, whose members were also blinded to the intervention, determined the
cause of death, confirmed major events, and updated the endpoints of the PREDIMED study on a
yearly basis.
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2.4. Dietary Assessment
A validated semi-quantitative FFQ [21], which included 137 food items, was used to assess the
dietary habits of participants in face-to-face interviews conducted by trained dietitians. The frequency
of consumption of food items was asked on an incremental scale with 9 levels (never or almost never;
1–3 servings/month; 1, 2–4, and 5–6 servings/weeks; and 1, 2–3, 4–6, and >6 servings/day). We used
Spanish food composition tables to estimate energy and nutrient intake [22,23].
2.5. Other Lifestyle Variables Assessment
Trained personnel took anthropometric measurements (weight, height, and waist circumference).
To measure weight and height, calibrated scales and a wall-mounted stadiometer were used, respectively,
with participants wearing light clothing and no shoes. Waist circumference was measured midway
between the lowest rib and the iliac crest using an anthropometric tape. All anthropometric variables
were measured annually. BMI was calculated by dividing the weight (kg) by the square of the height
(m2). Blood pressure was measured with a validated oscillometer (Omron HEM705CP, Hoofddorp,
The Netherlands) in triplicate with a 5 min interval between each measurement.
The validated Spanish version of the Minnesota leisure-time physical activity (LTPA) questionnaire [24,25]
was used to assess the amount and intensity of LTPA. The questionnaire consisted of 67 activities
divided into 9 sections. The participants were asked to complete the form, reporting the number of days
and minutes/day they had performed the activities during the previous week and year. Physical activity
was quantified in the metabolic equivalent of tasks per minute per day (METs min/day). This unit was
calculated by multiplying the METs assigned to each activity and their mean duration in minutes per
day. LTPA was classified as light (intensity <4 METs), moderate (intensity 4–5.5 METs), and vigorous
(intensity ≥6 METs). This questionnaire was completed during a baseline visit and annually thereafter.
Moderate and vigorous intensity levels were combined into one category for purposes of analysis.
A general questionnaire about lifestyle variables, such as smoking status or education level, medical
history, and medication use, was completed and recorded at baseline and yearly thereafter.
2.6. 2018 WCRF/AICR Score Operationalization
We constructed a 7-point score based on the 2018 WCRF/AICR recommendations for cancer
prevention [2]. The score components were (1) healthy weight, (2) physical activity, (3) plant foods, (4) fast
food and processed foods, (5) red and processed meat, (6) sugar-sweetened beverages, and (7) alcohol.
Detailed information on the score construction is shown in Table S1. The cut-off points for each component
were based on 2018 WCRF/AICR recommendations when available or previously published literature
otherwise. For each of the recommendations, we assigned 1 point when the recommendation was met,
0.5 points when it was partially met, and 0 points when it was not met. For those components with
sub-recommendations, the considered component score was the average of the sub-recommendation
scores. The mean score for each component was between 0.36 (red and processed meat consumption)
and 0.70 (sugar-sweetened drink intake) points. The final index was the sum of all the components and
ranged from 0 to 7. Higher scores indicated better adherence to cancer prevention recommendations.
2.7. Low Risk Lifestyle Score Operationalization
The LRL score is a 5-component index that was developed to assess the impact of healthy lifestyle
factors on any-cause, cardiovascular, and cancer mortality in the US population [7]. We constructed
this score in terms of adherence to the following LRL-related factors: (1) never smoking, (2) healthy
weight, (3) regular physical activity, (4) healthy diet, and (5) moderate alcohol consumption. Detailed
information on the score operationalization is presented in Table S2. For each risk factor, 1 point
was given if the participant met the criterion for low risk or 0 points otherwise. The mean score for
each component was between 0.07 (healthy body weight) and 0.62 (never smoking) points. The final
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score was the sum of all components (score range from 0 to 5), with higher scores indicating a
healthier lifestyle.
2.8. Statistical Analyses
For each participant, we calculated the follow-up time as the interval between the date of randomization
and the date of CRC diagnosis, death from any cause, or the date of the last contact visit, whichever
came first. The baseline characteristics of the participants were expressed as medians and (IQR) for
continuous variables, and percentage (%) and number (n) for categorical variables. Chi-square and
t-Student tests were used to assess differences in the baseline characteristics between CRC incident
events and non-events. Continuous variables were normally distributed.
Multivariable time-dependent Cox proportional regression models were used to evaluate the
associations between 2018 WCRF/AICR and LRL scores at baseline and the risk of developing CRC.
Results were the hazard ratios (HRs) and their 95% confidence intervals (CIs) for the comparison between
the highest vs. the lowest quantile for each overall score (quartile (Q) 4 vs. Q1 for 2018 WCRF/AICR
score, and tertile (T) 3 vs. T1 for LRL score). Quantiles for each index were calculated considering
the distribution of the variable in the analyzed population. The highest vs. the lowest categories for
each individual component and their association with CRC risk were also compared. We used robust
estimates of the variance to correct for potential intra-cluster correlation.
To calculate the associated CRC risk with both lifestyle scores, three different Cox regression
models were used. The crude model was a univariate model. Model 1 was adjusted for age (years, as a
continuous variable) and sex. Model 2 comprised model 1 additionally adjusted for the intervention
group, family history of cancer (yes/no), education level (primary or secondary/high school university
or graduate), history of diabetes (yes/no), baseline energy intake (Kcal/day, as a continuous variable),
and treatment with aspirin (yes/no) at baseline. Model 2 for the 2018 WCRF/AICR score was further
adjusted for smoking (current (yes/no), former (yes/no), or never (yes/no) smoker). The CRC risk
associated with categories of the individual components of the 2018 WCRF/AICR score at baseline was
additionally and mutually adjusted (model 3) for the other individual components at baseline: healthy
weight (0, 0.25, 0.5, >0.75 point), physical activity (0, 0.5, 1 point), consumption of plant foods (0–0.5,
>0.5–0.75, >0.75 point), fast food and processed foods (0, 0.5, 1 point), red and processed meat (0, 0.5, 1
point), sugar-sweetened beverages (0, 0.5, 1 point), and alcohol intake (0, 0.5, 1 point). Model 3 for the
LRL components at baseline was model 2 plus the other individual LRL components at baseline: BMI
≥18.5 and <25 kg/m2 (yes/no), never smoker (yes/no), low-risk alcohol consumption (yes/no), alternate
healthy eating index (AHEI)-2010 score ≥P60 (yes/no), and moderate to vigorous physical activity
(MVPA) ≥150 minutes/wk (yes/no). All models were stratified by recruitment center. The association
with CRC for each 1-point increment in the WCRF/AICR and the LRL scores were also calculated by
adding the score variable as continuous in the Cox regression models.
Statistical interactions between quantiles of both WCRF/AICR and LRL scores and potential
confounders, such as age (years, as continuous), sex, and diabetes status, were evaluated by including
interaction terms in the full-adjusted models. There were no statistical interactions between the
WCRF/AICR and LRL scores, age, sex, and diabetes status. Linear trend tests were conducted by
assigning the median value of each quantile of scores and individual score components and then using
it as a continuous variable. In secondary analyses, we explored the contribution of certain relevant
variables to all primary analyses of the scores. Thus, we conducted subgroup analyses by age (<67 or
≥67 y old), sex (men or women), and T2D status (prevalent or non-prevalent).
To test the robustness of our findings, we used a mixed-effects Cox regression model to take
into account repeated measures of the covariates and the participants’ deviances into the model. We
used a robust estimate of the variance to account for intra-cluster correlation within the same families
or clinics (as previously reported in [20]) and the repeated measures of the covariates as the fixed
effects. However, the variable for the different scores was set at baseline for comparison purposes
with our main analysis. All p-values were two-sided, and a p-value < 0.05 was considered statistically
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significant. Analyses were performed using the STATA (14.0, StataCorp LP, Lakeway Drive, TX. USA)
and R (v. 3.5.1) software (GNU General Public License, Boston, MA, USA).
3. Results
During a median (IQR) follow-up of 6.0 (4.4–7.3) years, we documented 101 CRC events. Of the
7447 participants, we excluded those with energy intake values outside the pre-specified limits (n = 153)
and those lacking baseline FFQ (n = 78). Finally, 7216 individuals and 97 new CRC events were included
in our analysis.
3.1. Baseline Characteristics of the Participants
The general baseline characteristics of the PREDIMED population are shown in Table 1. The median
age of the participants was 67 years, 57% of whom were women, and 49% of whom had prevalent
T2D. The median (IQR) age at cancer diagnosis was 72.4 (66.8–76.4) years. The median (IQR) 2018
WCRF/AICR score in the whole population was 3.8 (3.3–4.4) points, with no statistically significant
differences between events/non-events (p-value = 0.110). The overall median (IQR) for the LRL score
was 2 (1–2) points, with CRC events showing statistically significant lower scores than non-events
(p-value = 0.021). Among the participants who developed CRC, there were significantly more men
than women compared with non-events (58.8% vs. 41.2%, respectively; p-value = 0.001). In addition,
those who did not develop CRC were more likely to be never-smokers in comparison to new CRC
cases (61.7% vs. 47.4%, respectively; p-value = 0.011).
Table 1. Baseline characteristics of the study population in the PREvención con DIeta MEDiterránea
(PREDIMED) study a.
Total Study Population
n = 7216
Colorectal Cancer Events
n = 97
Non-Events
n = 7119 p-Value
b
2018 WCRF/AICR score 3.8 (3.3–4.4) 3.8 (3.2–4.2) 3.8 (3.3–4.4) 0.110
Low-risk lifestyle score 2 (1–2) 1 (1–2) 2 (1–2) 0.021 *
Age, years 67 (62–72) 67 (62–72) 67 (62–72) 0.269
Women, % (n) 57.4 (4145) 41.2 (40) 57.7 (4105) 0.001 *
Education level, % (n)
Primary, secondary, high school 92.9 (6700) 92.8 (90) 92.9 (6610)
0.980University/graduate 7.2 (516) 7.2 (7) 7.2 (509)
Age at diagnosis of cancer, years 72.4 (66.8–76.4) 72.4 (66.8–76.4) – –
Family history of cancer, % (n) 49.2 (3548) 41.2 (40) 49.3 (3508) 0.116
Cancer location
Colon, % (n) 77 (79.4) 77 (79.4) – –
Rectum, % (n) 20 (20.6) 20 (20.6) – –
Diabetes, % (n) 48.9 (3527) 51.6 (50) 48.8 (3477) 0.597
Hypertension, % (n) 82.7 (5970) 80.4 (78) 82.8 (5892) 0.543
Waist circumference, cm
Women 99 (91–105) 98.2 (92–107) 99 (91–105) 0.614
Men 103 (97–109) 103 (96–11) 103 (97–109) 0.441
BMI, kg/m2 29.7 (27.2–32.5) 29.9 (27.6–32.3) 29.7 (27.2–32.5) 0.813
MVPA, min./wk. 42.2 (0–296.5) 52.5 (0–311) 42.1 (0–296.5) 0.982
Smoking status, % (n)
Never smokers 61.5 (4438) 47.4 (46) 61.7 (4392)
0.011 *Former smokers 24.6 (1774) 30.9 (30) 24.5 (1744)
Current smokers 13.9 (1004) 21.7 (21) 13.8 (983)
Current medication, % (n)
Aspirin 22.4 (1613) 24.7 (24) 22.3 (1589) 0.758
HRT (only in women) 2.8 (115) 5 (2) 2.8 (113) 0.234
Intervention groups, % (n)
MedDiet + EVOO 34.3 (2474) 39.2 (38) 34.2 (2436)
0.390MedDiet + nuts 32.7 (2360) 34.0 (33) 32.7 (2327)
Control low–fat diet 33.0 (2382) 26.8 (26) 33.1 (2356)
Energy intake (kcal/day) 2184.4 (1842.9–2579.7) 2183.4 (1942–2669.3) 2184.5 (1841.6–2578.2) 0.263
AHEI–2010 score 64.4 (58.8–70.2) 62.6 (57.4–69.1) 64.4 (58.9–70.2) 0.210
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Table 1. Cont.
Total Study Population
n = 7216
Colorectal Cancer Events
n = 97
Non-Events
n = 7119 p-Value
b
Food consumption, g/day
Vegetables 313.7 (235–408.7) 289.2 (221.2–367) 314 (235–409.3) 0.164
Fruits 333.1 (227.2–475) 324.5 (222.4–459.2) 333.3 (227.6–475) 0.454
Legumes 17.1 (12.6–25.1) 17.1 (16–25.1) 17.1 (12.6–25.1) 0.778
Red and processed meat 68.1 (42.6–100) 68.3 (45.7–111.7) 68.1 (42.4–100) 0.073
Fast food and processed foods 72.4 (45.7–109.2) 77.2 (51–108.6) 72.4 (45.7–109.2) 0.746
Sugar-sweetened beverages 13.3 (0–85.7) 13.3 (0–99.1) 13.3 (0–85.7) 0.388
Alcohol 1.5 (0–10.4) 4.3 (0–12.2) 1.5 (0–10.4) 0.093
a Data are expressed as medians (IQR, interquartile range) for continuous variables and percentage and number (n)
for categorical variables. b p-values for comparison between colorectal cancer cases and non-cases were calculated
by chi-square or t-Student tests for categorical and continuous variables, respectively. All statistical tests were
two-sided. * p-value <0.05. Abbreviations: AHEI, alternate healthy eating index; BMI, body mass index; EVOO,
extra virgin olive oil; HRT, hormone replacement therapy; MedDiet, Mediterranean diet; min/wk., min/week;
MVPA, moderate-to-vigorous physical activity; WCRF/AICR, World Cancer Research Fund/American Institute for
Cancer Research.
3.2. World Cancer Research Fund/American Institute for Cancer Research and Low Risk Lifestyle Scores and
Risk of Colorectal Cancer
Table 2 shows the associations (HRs and 95% CIs) for CRC incidence with the overall 2018
WCRF/AICR and LRL scores at baseline. Statistically significant linear associations were observed
between a 1-point increment in the WCRF/AICR score and CRC risk in all statistical models (HR model 2
(95% CI) = 0.79 (0.63–0.99); p for trend = 0.045). Similarly, each 1-point increment in the LRL score was
associated with a 22% lower CRC risk (HR model 2 (95% CI) = 0.78 (0.64–0.96); p for trend = 0.017).
Table 2. HRs and 95% CIs between the 2018 WCRF/AICR and the low-risk lifestyle scores and colorectal
cancer risk at baseline in the PREDIMED study (n = 7216).
2018 WCRF/AICR Score Low-Risk Lifestyle Score
Continuous Analysis
(1-Point Increment),
HR (95% CI)
p for Trend
Continuous Analysis
(1-Point Increment),
HR (95% CI)
p for Trend
Events/non-events (n) 97/7216 - 97/7216 -
Crude model 0.79 (0.63–0.98) * 0.033 * 0.77 (0.62–0.95) * 0.016 *
Model 1 0.78 (0.62–0.98) * 0.034 * 0.78 (0.64–0.96) * 0.019 *
Model 2 0.79 (0.63–0.99) * 0.045 * 0.78 (0.64–0.96) * 0.017 *
Model 1 adjusted for age (years - continuous) and sex. Model 2 was model 1 plus intervention group (MedDiet +
EVOO, MedDiet + nuts, low-fat control), family history of cancer (yes/no), education level (primary or secondary/high
school, university or graduate), history of diabetes (yes/no), baseline energy intake (Kcal/day, continuous),
and treatment with aspirin (yes/no) at baseline. Model 2 for the 2018 WCRF/AICR score was further adjusted for a
current smoker (yes/no), former smoker (yes/no), never smoker (yes/no). All models were stratified by recruitment
center. * p-value < 0.05. Abbreviations: CI, confidence interval; EVOO, extra virgin olive oil; HR, hazard ratio;
MedDiet, Mediterranean Diet; WCRF/AICR, World Cancer Research Fund/American Institute for Cancer Research.
Along the same lines, when we analyzed the associations between CRC incidence and categories
of adherence to each overall score (Figure 1), high adherence to WCRF/AICR recommendations was
inversely associated with CRC risk (HR Q4 vs. Q1 (95% CI) = 0.52 (0.27–0.99); p for trend = 0.130)
compared to the reference category. For adherence to the LRL score, the reduction in CRC risk remained
statistically significant (HR T3 vs. T1 (95% CI) = 0.48 (0.26–0.86); p for trend = 0.007) when analyzed as
categorical. A sensitivity analysis using mixed-effects Cox regression models mirrored our results for
the WCRF/AICR (HR Q4 vs. Q1 (95% CI) = 0.57 (0.32–0.82)) and LRL scores (HR T3 vs. T1 (95% CI) =
0.44 (0.20–0.68)). Baseline characteristics of the participants and the number of CRC cases according to
quantiles of each score are shown in the Supplementary Materials (Tables S3 and S4).
For each 1-point increment in the number of components of the LRL score, there was a statistically
significant 23% lower risk of CRC (HR model 2 (95% CI) = 0.77 (0.62–0.95); p for trend = 0.016) (Table S5).
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Figure 1. Colorectal cancer risk associated with 2018 WCRF/AICR and low-risk lifestyle scores and
the individual components of each index in the PREvención con DIeta MEDiterránea (PREDIMED)
cohort (n = 7216). Multivariable Cox proportional regression models were used. Results were the HRs
(95% CIs) for the comparison between the highest vs. the lowest quantile for each overall score (2018
WCRF/AICR score: Quartile (Q) 4 vs. Q1; low-risk lifestyle score: Tertile (T) 3 vs. T1) and the comparison
for the highest vs. the lowest category for each individual component of the score (see Tables 3 and 4).
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components of each score, and the diamond represents the HR for the LRL score; Double slash appears
when CI > 2.
3.3. Individual Components of the Scor s and Risk of CRC
Table 3 shows the mutually adjusted HRs and 95% CIs for CRC risk associated with categories
of individual components of the WCRF/AICR score at baseline. In model 3, those individuals with
the maximum score (1 point) for the sugar-sweetened beverages component exhibited a significantly
lower risk of developing CRC (HR (95% CI) = 0.42 (0.19–0.93); p for trend = 0.192) than those with the
lowest score (0 points). Non-statistically significant associations with CRC risk were observed for the
other score components (healthy body weight, physical activity and consumption of plant foods, fast
food and processed foods, red and processed meat, and alcohol intake).
Table 4 shows the HRs and 95% CIs for CRC risk associated with different categories of individual
LRL components at baseline. In the crude model, participants who had never smoked presented a
statistically significant linear decreased risk of developing CRC (HR (95% CI) = 0.55 (0.36–0.83); p for
trend = 0.004) in comparison to current and former smokers. Nonetheless, when the model was further
adjusted for confounding variables, the association was attenuated and became non-significant (HR
(95% CI) = 0.67 (0.40–1.12); p for trend = 0.128). Non-significant inverse associations between the other
LRL recommendations (BMI, alcohol intake, physical activity, and diet) and CRC risk were observed.
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Table 3. Mutually adjusted HRs and 95% CIs for colorectal cancer risk associated with categories of
individual components of the 2018 WCRF/AICR score at baseline in the PREDIMED study (n = 7216).
Component Score, HR (95% CI)
Healthy weight 0 0.25 0.5 >0.75 p for trend
Events/non-events (n) 22/1381 22/1723 33/2233 20/1782 -
Crude model 1.00 0.77 (0.41–1.45) 0.90 (0.50–1.60) 0.62 (0.33–1.17) 0.220
Model 1 1.00 0.71 (0.37–1.33) 0.85 (0.48–1.54) 0.54 (0.28–1.06) 0.135
Model 2 1.00 0.71 (0.38–1.33) 0.87 (0.48–1.55) 0.54 (0.28–1.05) 0.134
Model 3 1.00 0.71 (0.38–1.35) 0.88 (0.49–1.56) 0.55 (0.29–1.08) 0.151
Physical activity 0 0.5 1 - p for trend
Events/non-events (n) 53/3893 11/590 33/2636 -
Crude model 1.00 1.25 (0.63–2.48) 0.82 (0.51–1.32) - 0.441
Model 1 1.00 1.25 (0.63–2.48) 0.75 (0.46–1.22) - 0.254
Model 2 1.00 1.24 (0.62–2.48) 0.76 (0.47–1.22) - 0.271
Model 3 1.00 1.24 (0.63–2.46) 0.76 (0.47–1.22) - 0.268
Plant foods 0-0.5 >0.5–0.75 >0.75 - p for trend
Events/non-events (n) 14/1345 56/3952 27/1822 -
Crude model 1.00 1.38 (0.77–2.47) 1.66 (0.82–3.34) - 0.158
Model 1 1.00 1.34 (0.75–2.40) 1.57 (0.78–3.16) - 0.210
Model 2 1.00 1.34 (0.75–2.41) 1.60 (0.77–3.32) - 0.206
Model 3 1.00 1.38 (0.76–2.49) 1.73 (0.82–3.66) - 0.151
Fast food and processed foods 0 0.5 1 - p for trend
Events/non-events (n) 18/1201 39/2766 40/3152 - -
Crude model 1.00 0.82 (0.46–1.45) 0.72 (0.41–1.26) - 0.258
Model 1 1.00 0.84 (0.47–1.49) 0.72 (0.41–1.28) - 0.260
Model 2 1.00 0.85 (0.48–1.49) 0.73 (0.41–1.29) - 0.278
Model 3 1.00 0.81 (0.47–1.42) 0.70 (0.40–1.25) - 0.247
Red and processed meat 0 0.5 1 - p for trend
Events/non-events (n) 36/2263 58/4577 3/279 - -
Crude model 1.00 0.89 (0.58–1.36) 0.77 (0.23–2.55) - 0.531
Model 1 1.00 0.95 (0.60–1.48) 0.87 (0.26–2.94) - 0.771
Model 2 1.00 0.97 (0.62–1.54) 0.90 (0.26–3.07) - 0.868
Model 3 1.00 0.94 (0.60–1.48) 0.88 (0.25–3.06) - 0.771
Sugar-sweetened beverages 0 0.5 1 - p for trend
Events/non-events (n) 8/326 48/3675 41/3118 - -
Crude model 1.00 0.45 (0.21–0.96) * 0.45 (0.21–0.94) * - 0.298
Model 1 1.00 0.46 (0.22–0.98) * 0.43 (0.20–0.90) * - 0.174
Model 2 1.00 0.47 (0.21–1.02) 0.43 (0.20–0.94) * - 0.185
Model 3 1.00 0.45 (0.21–1.00) 0.42 (0.19–0.93) * - 0.192
Alcohol intake 0 0.5 1 - p for trend
Events/non-events (n) 7/389 60/4111 30/2619 - -
Crude model 1.00 0.86 (0.40–1.86) 0.68 (0.31–1.52) - 0.221
Model 1 1.00 0.86 (0.40–1.85) 0.85 (0.38–1.89) - 0.771
Model 2 1.00 0.96 (0.43–2.12) 0.98 (0.42–2.27) - 0.979
Model 3 1.00 0.82 (0.36–1.87) 0.82 (0.35–1.94) - 0.781
Model 1 adjusted for age (years - continuous) and sex. Model 2 was further adjusted for the intervention group
(MedDiet + EVOO, MedDiet + nuts, low-fat control), current smoker (yes/no), former smoker (yes/no), never
smoker (yes/no), family history of cancer (yes/no), education level (primary or secondary/high school, university or
graduate), history of diabetes (yes/no), baseline energy intake (Kcal/day, continuous), and treatment with aspirin
(yes/no) at baseline. Model 3 was model 2 plus the other individual components at baseline: healthy weight
(0, 0.25, 0.5, >0.75 point), physical activity (0, 0.5, 1 point), plant foods (0–0.5, >0.5–0.75, >0.75 point), fast food and
processed foods (0, 0.5, 1 point), red and processed meat (0, 0.5, 1 point), sugar-sweetened beverages (0, 0.5, 1 point),
and alcohol intake (0, 0.5, 1 point). Categories for each score component were established based on the number of
subcomponents and the score distribution in the population studied. All models were stratified by recruitment
center. * p-value < 0.05. Abbreviations: CI, confidence interval; EVOO, extra virgin olive oil; HR, hazard ratio;
MedDiet: Mediterranean diet; WCRF/AICR, World Cancer Research Fund/American Institute for Cancer Research.
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Table 4. Mutually adjusted HRs and 95% CIs for colorectal cancer risk associated with different
categories of individual low-risk lifestyle components at baseline in the PREDIMED study (n = 7216).
Component Score, HR (95% CI)
BMI 0 1 p for trend
Events/non-events (n) 93/6607 4/512
Crude model 1.00 0.54 (0.20–1.46) 0.222
Model 1 1.00 0.52 (0.19–1.41) 0.200
Model 2 1.00 0.51 (0.19–1.39) 0.190
Model 3 1.00 0.52 (0.19–1.42) 0.202
Smoking status 0 1 p for trend
Events/non-events (n) 51/2727 46/4392
Crude model 1.00 0.55 (0.36–0.83) * 0.004 *
Model 1 1.00 0.66 (0.40–1.11) 0.119
Model 2 1.00 0.66 (0.39–1.10) 0.113
Model 3 1.00 0.67 (0.40–1.12) 0.128
Alcohol consumption 0 1 p for trend
Events/non-events (n) 65/4992 32/2127
Crude model 1.00 1.12 (0.73–1.71) 0.594
Model 1 1.00 0.90 (0.58–1.39) 0.626
Model 2 1.00 0.88 (0.56–1.39) 0.594
Model 3 1.00 0.94 (0.59–1.49) 0.794
Physical activity 0 1 p for trend
Events/non-events (n) 64/4483 33/2636
Crude model 1.00 0.79 (0.51–1.24) 0.303
Model 1 1.00 0.72 (0.45–1.13) 0.155
Model 2 1.00 0.71 (0.45–1.12) 0.146
Model 3 1.00 0.74 (0.47–1.16) 0.187
AHEI-2010 score 0 1 p for trend
Events/non-events (n) 64/4266 33/2853 0.268
Crude model 1.00 0.81 (0.52–1.25) 0.269
Model 1 1.00 0.78 (0.51–1.21) 0.268
Model 2 1.00 0.78 (0.50–1.21) 0.268
Model 3 1.00 0.81 (0.52–1.27) 0.362
Model 1 adjusted for age (years - continuous) and sex. Model 2 was further adjusted for the intervention group
(MedDiet + EVOO, MedDiet + nuts, low-fat control), family history of cancer (yes/no), education level (primary
or secondary/high school, university or graduate), history of diabetes (yes/no), baseline energy intake (Kcal/day,
continuous), and treatment with aspirin (yes/no) at baseline. Model 3 was model 2 plus the other individual low-risk
lifestyle components at baseline: BMI ≥18.5 and ≤24.9 kg/m2 (yes/no), never smoker (yes/no), low-risk alcohol
consumption (yes/no), AHEI-2010 score ≥P60 (yes/no), MVPA ≥150 min./wk (yes/no). All models were stratified by
recruitment center. * p-value <0.05. Abbreviations: AHEI, alternate healthy eating index; BMI, body mass index; CI,
confidence interval; EVOO, extra virgin olive oil; HR, hazard ratio; MedDiet: Mediterranean diet; P, percentile.
We also observed statistically significant differences across age, sex, and prevalent T2D status
(Table S6). The inverse association between CRC risk and the WCRF/AICR score (HR model 2 (95% CI)
= 0.71 (0.50–0.99; p for trend = 0.050) and the LRL score (HR model 2 (95% CI) = 0.76 (0.58–0.99; p for
trend = 0.048) was stronger in those participants above the median age (≥67 years) than in those below.
Associations for the LRL score were stronger in women (HR model 2 (95% CI) = 0.69 (0.50–0.95; p for
trend = 0.023) than in men (HR model 2 (95% CI) = 0.84 (0.65–1.08; p for trend = 0.174). However, for the
2018 WCRF/AICR score, there were no significant differences by sex. Those participants presenting
T2D at baseline exhibited a stronger association between the WCRF/AICR score and CRC risk (HR
model 2 (95% CI) = 0.71 (0.53–0.96; p for trend = 0.024) in comparison to non-prevalent T2D individuals
(HR model 2 (95% CI) = 0.87 (0.61–1.24; p for trend = 0.443). On the contrary, the association between the
LRL score and CRC risk was significantly higher in non-prevalent T2D participants (HR model 2 (95%
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CI) = 0.71 (0.52-0.95; p for trend = 0.021) than in individuals with T2D at baseline (HR model 2 (95% CI)
= 0.81 (0.62–1.06; P for trend = 0.443).
4. Discussion
This prospective cohort study showed that adherence to the most recent 2018 WCRF/AICR
recommendations, as well as accomplishing a cluster of LRL factors, was inversely associated with
CRC incidence in elderly Mediterranean individuals at high cardiovascular risk. As far as we are
aware, this was the first study to assess the relationship between the recent LRL score [7] and the risk of
CRC. On the other hand, this work provided additional support to confirm that new 2018 WCRF/AICR
recommendations also apply for aging individuals at high CVD risk.
In agreement with the results obtained, El Kinany and coworkers [16] found that greater adherence
to the 2018 WCRF/AICR score decreased overall CRC risk by 42% after comparing 1516 cases with
1516 controls in Morocco. Similarly, a 24-year-follow-up cohort study [13], with 68,977 women from
the Nurses’ Health Study and 45,442 men from the Health Professionals Follow-up Study, found a
statistically significant inverse association between adherence to the updated WCRF/AICR score and
the incidence of CRC risk in men. Furthermore, associations in women were weaker. On the other
hand, we did not find any statistically significant differences between sexes in our subgroup analyses
for the WCRF/AICR score. However, differences in the sample size, number of CRC cases, and score
operationalization between both studies might account for this discrepancy.
Our results confirmed the findings of a meta-analysis of seven prospective cohort studies [26],
including 361,616 European and US adults (aged > 60, 43% women) and 6507 CRC cases, within the
Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES)
Project. It showed with a low level of heterogeneity that adherence to WCRF/AICR recommendations
for cancer prevention was also applicable in the elderly. Nonetheless, our findings added new evidence
to suggest that not only might elderly individuals benefit from following these recommendations but
also individuals who are at high CVD risk.
Although some longitudinal studies [6,9,14,15,27] on the former 2007 WCRF/AICR recommendations [28]
have also observed statistically significant inverse associations with CRC risk, non-significant results
have been reported in other studies [10–12,29]. This inconsistency could be due to differences in the
study design, different cut-points used, and the number of components for scoring between studies.
It should be noted that the 2018 WCRF/AICR report [2] again recommends the intake of at least
30 g/day of fiber and reducing the consumption of processed food high in fat and sugars, but no longer
discourages the consumption of energy-dense foods without taking into consideration their nutritional
composition [30].
Even though the LRL score was developed in an attempt to assess the impact of an overall healthy
lifestyle pattern on all-cause mortality (including cancer and CVD mortality), our results suggested that
this score might also be a useful tool for CRC prevention. This is of great potential importance since
non-communicable diseases, such as CVD and cancer, are the leading causes of mortality worldwide [31].
In our study, even though the reduction in CRC risk due to greater adherence to the 2018 WCRF/AICR
score and the LRL index was similar (48% and 52%, respectively), some differences between the two
indexes should be examined. In the WCRF/AICR score, there was no penalty for tobacco use, which could
have modified the inverse association observed. On the other hand, the penalty for alcohol intake was
stricter in the WCRF/AICR score than in the LRL score. The WCRF/AICR advises not to consume alcohol
and focuses on dietary national guidelines in the case of intake, whereas the LRL score accepts a moderate
intake as adhering fully to the alcohol recommendation. These different cut-off points for alcohol intake
might also have had different roles in the associations found. Furthermore, the WCRF/AICR score gives
more weight to nutritional factors, while the LRL score considers the overall diet as a single component
using the AHEI-2010 score and, therefore, does not ignore the synergy between nutritional components.
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Regarding subgroup analyses, considering that no significant interactions were found with CRC
risk, and because confidence intervals strongly overlapped between subgroups, we could not assure a
significant interaction between the scores and CRC risk based on age, sex, and diabetes status.
In terms of the WCRF/AICR score, greater adherence to the sugar-sweetened beverages recommendation
was strongly and inversely associated with a statistically significant decreased risk of developing
CRC of 58%. Because neither the other individual recommendations of the WCRF/AICR score nor the
individual components of the LRL score were significantly associated with CRC risk, it seemed that
a synergistic effect between components might be suggested. However, most of the non-significant
associations between the components of both scores and CRC risk were in the expected direction.
Our results suggested that synergy between the various factors of each score might be one of the
main mechanisms. On the other hand, sugar-sweetened beverages consumption had been shown to
be independently associated with CRC risk in our analyses. It should be noted that according to the
WCRF/AICR, sugar-sweetened beverages intake is mostly linked to weight gain, which increases CRC
risk, while no specific components in the drinks are mentioned that may increase the risk of this cancer.
However, other potential mechanisms suggested in the literature should be further explored.
High glycemic index and glycemic load from sugar-sweetened beverages might stimulate postprandial
glucose and/or insulin response, which is associated with diabetes-related cancer risk [32]. The evidence
suggests that insulin stimulates tumor growth by decreasing the production of insulin-like growth factor-
binding protein 1 (IGFBP-1) [33], increasing the tissue bioavailability of Insuline-like growth factor (IGF)-I,
or inhibiting apoptosis [34]. Furthermore, some in vitro studies have shown that insulin might also
stimulate the mitogenesis of cultured normal colorectal epithelial cells and tumor angiogenesis [35,36].
In addition, it has been reported that consumers of sugar drinks may be exposed to 4-methylimidazole
(4-MEI), a potential carcinogen formed during the manufacture of the caramel color, added to many
widely consumed beverages as a colorant. More studies are needed to investigate how this chemical
contributes to the risk of CRC [37].
The findings of the present study have to be interpreted in light of some limitations. Firstly, score
components were added, so they contributed equally to the total score. The fact that not all the components
of the WCRF/AICR score are associated with the risk of developing CRC might have weakened the
associations observed. Since CRC was a secondary outcome in the PREDIMED trial, we did not have
enough CRC cases to evaluate CRC subtypes separately (colon and rectum) or by tumor site (left
and right colon) with sufficient statistical power. This lack of statistical power might also explain
the lack of association found between individual components consistently associated with decreased
CRC. Because of insufficient data, three items from the WCRF/AICR score (breastfeeding, cancer
prevention supplement use, and following the recommendations after a cancer diagnosis) were omitted.
Nonetheless, it is important to mention that the breastfeeding component is not mandatory since
it is only applicable to a specific subpopulation. In addition, multivitamin supplement use in our
cohort was extremely low. Therefore, this component would have had very little impact on our results.
Besides, we also decided to omit supplement vitamin use and the cancer survivors component because
of operational redundancy [30]. Additionally, a generalization of our results might be limited because
of our specific study population at high cardiovascular risk. Further, although the intervention arm
was considered as a potential confounder in our main statistical models, we could not rule out residual
confounding due to changes in diet between groups. Finally, the causality of the observed associations
could not be established due to the observational nature of our study.
However, our study had several strengths. First, it had a large-scale prospective design, a long
follow-up period, and a large sample. Second, a Clinical Event Adjudication Committee confirmed all
major events annually. Third, we used a validated FFQ and, although residual confounding control could
not be ruled out, we controlled for several potential confounders in our statistical analyses. Fourth, we
used data-driven approaches (quantiles and median cut-offs) to operationalize recommendations that did
not provide quantitative cut-offs, and a three-level WCRF/AICR score, which gives a more continuous
variable and considers partial adherence. Finally, we confirmed the robustness of our results by testing
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our primary results with two different approaches—multivariable time-dependent Cox proportional
regression models and mixed-effects Cox regression models—and stratified analyses.
To conclude, following the 2018 WCRF/AICR recommendations and healthier behavior patterns,
the calculated LRL score could substantially help to reduce the risk of developing CRC in an elderly
Mediterranean population at high CVD risk. Although the WCRF/AICR score was specifically designed
in the context of cancer prevention, we suggest that using other scores based on healthy lifestyle
patterns, such as the LRL index, might also be a useful tool to prevent CRC, especially in elderly
individuals. The results of this study need to be replicated in other populations with different dietary
and lifestyle patterns. For this purpose, large-prospective cohorts with more events are needed to
extend the evidence on lifestyle patterns and CRC risk.
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Table S1. Third expert report 2018 WCRF/AICR score operationalization in the PREDIMED cohort 
  Recommendation Goals Operationalization Scoring 
1 Be a healthy weight 
Ensure that body weight during childhood and adolescence 
projects towards the lower end of the healthy adult BMI 
range 
Insufficient data available - 
Keep your weight as low as you can within the healthy 
range throughout life  
≥18.5 and ≤24.9 Kg/m2 1 
>24.9 and <30 Kg/m2 0.5 
<18.5 or ≥30 Kg/m2 0 
Avoid weight gains (measured as body weight or waist 
circumference) throughout adulthooda  
1st tertile of weight change in all the cohort 1 
2nd tertile of weight change in all the cohort 0.5 
3rd tertile of weight change in all the cohort 0 
2  Be physically active 
Be at least moderately physically active, and follow or 
exceed national guidelines (about 60 to 75% of heart rate 
maximum)  
≥150 min MVPA/wk. 1 
≥75 and <150 min MVPA/wk. 0.5 
<75 min MVPA/wk. 0 
Limit sedentary habits Insufficient data available - 
3  
Eat a diet rich in 
wholegrains, vegetables, 
fruit and beans 
Consume a diet that provides at least 30 g/day of fiber from 
foods  
≥30 g/day 1 
≥15 and <30 g/day 0.5 
<15 g/day 0 
Include in most meals foods containing wholegrains, non-
starchy vegetables, fruit and pulses (legumes) such as beans 
and lentilsb  
<1 serv. legumes/wk. 0 
≥1 and <3 serv. legumes/wk. 0.5 
≥3 serv. legumes/wk. 1 
Eat a diet high in all types of plant foods including at least 
five portions or servings (at least 400 g in total) of a variety 
of non-starchy vegetables and fruit every day  
≥400 g/day 1 
≥200 and <400 g/day 0.5 
<200 g/day 0 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY AND LIFESTYLE DETERMINANTS ASSOCIATED WITH THE RISK OF COLORECTAL CANCER 
Laura Barrubés Piñol 
  Recommendation Goals Operationalization Scoring 
If you eat starchy roots and tubers as staple foods, eat non-
starchy vegetables, fruit and pulses (legumes) regularly too 
if possible 
Insufficient data available - 
4 
Limit consumption of 'fast 
foods' and other processed 
foods high in fat, starches or 
sugars 
Limit consumption of processed foods high in fat, starches 
or sugars -including 'fast foods'; many pre-prepared dishes, 
snacks, bakery foods and desserts; and confectionery 
(candy)c 
<1.5 serv./day 1 
≥1.5 and <3 serv./day 0.5 
≥3 serv./day 0 
5 
Limit consumption of red 
and processed meat 
If you eat red meat, limit consumption to no more than 
about three portions per week. Three portions are equivalent 
to about 350 to 500 g cooked weight of red meat. Consume 
very little, if any, processed meatd  
RM <450 g/wk. and PM <3 g/day 1 
RM <450 g/wk. and PM ≥3 and <50 g/day 0.5 
RM ≥450 g/wk. and PM ≥50 g/day 0 
6  
Limit consumption of sugar 
sweetened drinks 
 
Do not consume sugar-sweetened drinksd  
0 g/day 1 
>0 g/day and <250 g/day 0.5 
≥250 g/day 0 
7  Limit alcohol consumption 
 
For cancer prevention, it is best not to drink alcohole  
0 g ethanol/day 1 
>0 to 20 g ethanol/day (women) 0.5 
>0 to 40 g ethanol/day (men) 0.5 
>20 g ethanol/day (women) 0 
>40 g ethanol/day (men) 0 
8 
Do not use supplements for 
cancer prevention 
High-dose dietary supplements are not recommended for 
cancer prevention - aim to meet nutritional needs through 
diet alone 
Insufficient data available - 
9 
For mothers: breastfeed 
your baby, if you can  
This recommendation aligns with the advice of the WHO, 
which recommends infants are exclusively breastfed for 6 
months, and then up to 2 y of age or beyond alongside 
appropriate complementary foods 
Insufficient data available - 
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  Recommendation Goals Operationalization Scoring 
10  
After cancer diagnosis: 
follow our 
Recommendations, if you 
can 
All cancer survivors should receive nutritional care and 
guidance on physical activity from trained professionals 
Insufficient data available - 
Unless otherwise advised, and if you can, all cancer 
survivors are advised to follow the Cancer Prevention 
Recommendations as far as possible after the acute stage of 
treatment 
Insufficient data available - 
a Distribution of weight gain in the study population over the follow-up. The mean weight change ± SD (n) for the 1st tertile was -5.1 ± 3.7 Kg (2,409 individuals), 
-0.2 ± 0.7 Kg (2,376 individuals) for the 2nd tertile, and +4.2 ± 3.3 Kg (2,303 individuals) for the 3rd tertile.  
b The 3rd expert report did not provide cutoffs. Because we have insufficient data available on whole grains consumption, we did not include this food group in 
the score. Moreover, since fruit and vegetable consumption are considered in another score subcomponent, this item is only composed of legumes consumption 
(1 serv. = 70 g). 
c We did not include food groups overlapping with other score components such as processed meats and sugar-sweetened beverages. We included those foods 
categorized in the 3rd (processed foods) and 4th (ultra-processed foods) groups of the NOVA (a name, not an acronym) classification [1]. 
d The 3rd Expert Report does not provide cut-offs neither for processed meat consumption nor sugar-sweetened beverages intake. Thus, we decided to follow 
the cutoffs from the previous literature for the comparability of data [2].  
e The WCRF/AICR recommendations advise not to consume alcoholic drinks. For those individuals consuming alcohol, the recommendations suggest not to 
exceed the national guidelines. Therefore, we considered the Dietary Guidelines for the Spanish population (SENC, 2016) [3]. 
Abbreviations: WCRF/AICR, World Cancer Research Fund/American Institute for Cancer Research; BMI, Body Mass Index; MVPA, moderate-to-vigorous 
physical activity; wk., week; serv., servings; RM, red meat; PM, processed meat; WHO, World Health Organization; SD, standard deviation; SENC, ‘Sociedad 
Española de Nutrición Comunitaria’. 
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Table S2. Low-risk lifestyle score operationalization in the PREDIMED cohort 
 Individual lifestyle risk factors Operationalization Scoring 
1 Smoking status Never smoking 
 
1 
 
2 Alcohol consumption  
5 to 15 g/day (women) and 5 to 30 g/day (men)  
 
1 
 
3 Physical activity 
 
≥30 min./day MVPA  
 
1 
 
4 AHEI-2010 
 
Upper 40% AHEI-2010  
 
1 
 
5 BMI 
 
BMI (18.5 to 24.9 kg/m2)  
 
1 
 
Abbreviations: min., minutes; MVPA, moderate-to-vigorous physical activity; AHEI, Alternate Healthy Eating Index; BMI, Body Mass Index. 
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Table S3. Baseline characteristics of the study population in the PREDIMED study according to quartiles of WCRF/AICR score a. 
 Quartiles of 2018 WCRF/AICR score  
 Q1  Q2  Q3  
 
Q4 
 
P-valueb 
Events/non-events (n) 30/1,868 20/1,793 32/1,911 15/1,644  
2018 WCRF/AICR score 2.9 [2.6-3.2] 3.6 [3.4-3.7] 4.2 [4-4.3] 4.9 [4.7-5.2] <0.001* 
Low-risk lifestyle score 1.5 [1-2] 2 [1-2.5] 2 [1.5-2.5] 2.5 [2-3] <0.001* 
Age, years 66 [62-71] 66 [62-71] 67 [63-72] 67 [63-72] 0.787 
Women, % (n) 55.5 (1,036) 57.3 (1,027) 58.6 (1,119) 58.6 (963) 0.183 
Education level, % (n)      
Primary, secondary, high school 91.8 (1,715) 92.1 (1,652) 94.3 (1,802) 93.1 (1,531) 
0.014* 
University/graduate 8.2 (153) 7.9 (141) 5.7 (109) 6.9 (113) 
Age at diagnosis of cancer, years 73 [68.4-78] 69 [64.7-76.1] 72.4 [67.7-76.5] 71.7 [63.2-74.8] 0.957 
Family history of cancer, % (n) 49.8 (915) 49 (872) 49.6 (938) 50.5 (823) 0.051 
Diabetes, % (n) 43.3 (809) 46.5 (833) 50.8 (971) 55.6 (914) <0.001* 
Hypertension, % (n) 84.6 (1,581) 83.5 (1,497) 82.6 (1,579) 79.9 (1,313) 0.002* 
Waist circumference, cm      
Women 100 [94-108] 100 [92-106] 97 [90-104] 96 [89-103] 0.018* 
Men 106 [99-112] 104 [98-110] 101 [96-107] 96 [89-103] 0.179 
BMI, kg/m2 30.8 [28.3-33.4] 30.4 [27.7-32.9] 28.9 [26.8-31.6] 28.7 [26.4-31.3] <0.001* 
MVPA, min./wk. 0 [0-37.8] 18.7 [0-182] 98.4 [0-378] 280 [113.7-507.8] <0.001* 
Smoking status, % (n)      
Never smokers 57.2 (1,069) 59.7 (1,070) 64.3 (1,229) 65.1 (1,070) 
<0.001* Former smokers 25.5 (477) 24.3 (436) 24.1 (460) 24.4 (401) 
Current smokers 17.2 (322) 16 (287) 11.6 (222) 10.5 (173) 
Current medication, % (n)      
Aspirin 22.9 (427) 22.7 (407) 21.3 (406) 22.7 (373) 0.664 
HRT (only in women) 3.7 (38) 2.8 (29) 2.9 (32) 1.7 (16) 0.165 
Intervention groups, % (n)      
MedDiet+EVOO 33.6 (628) 33.7 (604) 32.9 (629) 37.3 (613) 
0.107 MedDiet+nuts 32.6 (609) 33 (592) 34.3 (656) 30.6 (503) 
Control low-fat diet 33.8 (631) 33.3 (597) 32.8 (626) 32.1 (528) 
Energy intake (kcal/day) 2,423 [2,043.1-2,834.8] 2,244 [1,868-2,622] 2,116 [1,800-2,453] 1,995.8 [1,705.4-2,321.5] <0.001* 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY AND LIFESTYLE DETERMINANTS ASSOCIATED WITH THE RISK OF COLORECTAL CANCER 
Laura Barrubés Piñol 
AHEI-2010 score 60.3 [54.6-65.7] 63.8 [58.6-69.5] 65.3 [60.6-70.7] 68 [62.8-73.1] <0.001* 
Food consumption, g/day      
Vegetables 294.3 [216.5-383.7] 316.2 [238.3-409.3] 313.7 [237.2-404.3] 336.2 [251.8-433.7] <0.001* 
Fruits 321.4 [213.2-458.1] 332.1 [221.9-482.4] 331.4 [230.7-466.9] 359.7 [243.3-499] <0.001* 
Legumes 16.6 [12-25.1] 17.1 [12.6-25.1] 17.1 [12.6-25.1] 17.1 [12.6-25.7] <0.001* 
Red and processed meat 89.1 [55.7-117.7] 69.1 [43.4-101.4] 62.5 [41.3-93] 54 [32.5-78.4] <0.001* 
Fast food and processed foods 102.6 [72.5-146.4] 77.5 [50-113.9] 65.3 [40.1-94.4] 51.8 [31.4-72.7] <0.001* 
Sugar sweetened beverages 41 [13.3-171.4] 26.7 [0-85.7] 0 [0-85.7] 0 [0-13.3] <0.001* 
Alcohol 4.5 [0.7-13.8] 1.93 [0-11] 1.4 [0-10.4] 0 [0-5.1] <0.001* 
a Data are expressed as medians [IQR, interquartile range] for continuous variables and percentage and number (n) for categorical variables. b P-values for comparison 
between colorectal cancer cases and non-cases were calculated by chi-square or t-Student tests for categorical and continuous variables, respectively. All statistical tests 
were two-sided. *P-value <0.05. Abbreviations: AHEI, Alternate Healthy Eating Index; BMI, body mass index; EVOO, extra virgin olive oil; HRT, hormone replacement 
therapy; MedDiet, Mediterranean Diet; min./wk., minutes/week; MVPA, moderate-to-vigorous physical activity; WCRF/AICR, World Cancer Research Fund/American 
Institute for Cancer Research. 
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Table S4. Baseline characteristics of the study population in the PREDIMED study according to tertiles of low-risk lifestyle score a. 
 Tertiles of low-risk lifestyle score  
 T1  T2  T3  P-value
b 
Events/non-events (n) 55/3,024 27/2,512 15/1,583  
Low-risk lifestyle score 1 [1-1.5] 2 [2-2.5] 3.5 [3-3.5] <0.001* 
2018 WCRF/AICR score 3.5 [3-4] 3.9 [3.4-4.4] 4.4 [3.8-4.9] 0.790 
Age, years 67 [62-72] 67 [62-72] 67 [63-72] 0.154 
Women, % (n) 54.8 (1,688) 62 (1,574) 55.3 (883) <0.001* 
Education level, % (n)     
Primary, secondary, high school 92.5 (2,848) 93.7 (2,380) 92.1 (1,472) 
0.087 
University/graduate 7.5 (231) 6.3 (159) 7.9 (126) 
Age at diagnosis of cancer, years 72.6 [68-76.3] 68.4 [65.1-75.9] 73.5 [64.5-78] 0.154 
Family history of cancer, % (n) 50.2 (1,527) 48.2 (1,209) 51.1 (812) <0.001* 
Diabetes, % (n) 49.4 (1,520) 48.3 (1,225) 48.9 (782) 0.704 
Hypertension, % (n) 83.1 (2,558) 83.5 (2,121) 80.8 (1,291) 0.060 
Waist circumference, cm     
Women 100 [93-107] 98 [91-106] 95 [87-102] 0.023* 
Men 104 [99-111] 102 [97-108] 100 [95-107] 0.158 
BMI, kg/m2 30.3 [27.9-33] 29.7 [27.3-32.5] 28.4 [25.8-31.3] <0.001* 
MVPA, min./wk. 0 [0-74.8] 70.1 [0-342.8] 303.4 [149.5-556] <0.001* 
Smoking status, % (n)     
Never smokers 47.9 (1,476) 68.5 (1,738) 76.6 (1,224) 
<0.001* Former smokers 31.7 (975) 21.1 (535) 16.5 (264) 
Current smokers 20.4 (628) 10.5 (266) 6.9 (110) 
Current medication, % (n)     
Aspirin 22.5 (694) 22.1 (562) 22.3 (357) 0.709 
HRT (only in women) 3.4 (57) 2.4 (38) 2.3 (20) 0.329 
Intervention groups, % (n)     
MedDiet+EVOO 33.7 (1,037) 35.3 (895) 33.9 (542) 
<0.001* MedDiet+nuts 30.7 (945) 31.8 (808) 38 (607) 
Control low-fat diet 35.6 (1,097) 32.9 (836) 38.1 (449) 
Energy intake (kcal/day) 2,227 [1,854.5-2,653.3] 2,135 [1,811.8-2,514.7] 2,186 [1,875.7-2,530.4] <0.001* 
AHEI-2010 score 60.4 [55.6-63.9] 66.5 [60.7-71.4] 70.8 [67.5-75.1] <0.001* 
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Food consumption, g/day     
Vegetables 293.7 [218-380] 318.7 [244.8-419.7] 347.1 [259.8-445] <0.001* 
Fruits 300 [198.3-425] 349.2 [242.6-493.3] 379.5 [268.3-527.9] <0.057 
Legumes 16.6 [12-25.1] 20.6 [16-25.1] 20.6 [16-25.1] <0.001* 
Red and processed meat 75.7 [47.1-106.2] 63.8 [39.9-97.6] 60.5 [38.2-91.6] <0.001* 
Fast food and processed foods 76.4 [48.2-114.8] 71.2 [44.3-106] 68 [44.2-101.8] <0.001* 
Sugar sweetened beverages 26.7 [0-114.3] 13.3 [0-85.7] 0 [0-41.9] <0.001* 
Alcohol 0.7 [0-4.5] 1.5 [0-10.4] 10.2 [1.4-12.5] <0.001* 
a Data are expressed as medians [IQR, interquartile range] for continuous variables and percentage and number (n) for categorical variables. b P-values for comparison 
between colorectal cancer cases and non-cases were calculated by chi-square or t-Student tests for categorical and continuous variables, respectively. All statistical tests 
were two-sided. *P-value <0.05. Abbreviations: AHEI, Alternate Healthy Eating Index; BMI, body mass index; EVOO, extra virgin olive oil; HRT, hormone replacement 
therapy; MedDiet, Mediterranean Diet; min./wk., minutes/week; MVPA, moderate-to-vigorous physical activity; WCRF/AICR, World Cancer Research Fund/American 
Institute for Cancer Research. 
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Table S5. Mutually adjusted HRs and 95% CIs for colorectal cancer risk associated with different categories of a combination of low-risk lifestyle factors at 
baseline in the PREDIMED study (n=7,216) 
 Number of low-risk factors, HR (95% CI) 
P for trend  0 (reference) 1 2 >3 
Continuous analysis 
(1-point increment) 
Events/non-events (n) 9/601 46/2,423 27/2,512 15/1,583   
Crude model 1.00 1.31 (0.62-2.79) 0.72 (0.32-1.65) 0.61 (0.24-1.52) 0.75 (0.60-0.94)* 0.013* 
Model 1 1.00 1.58 (0.75-3.34) 0.87 (0.39-1.96) 0.70 (0.28-1.73) 0.77 (0.62-0.96)* 0.018* 
Model 2 1.00 1.59 (0.76-3.34) 0.86 (0.38-1.94) 0.69 (0.28-1.70) 0.77 (0.62-0.95)* 0.016* 
Model 1 adjusted for age (years, continuous) and sex. 
Model 2 was further adjusted for intervention group (MedDiet + EVOO, MedDiet + nuts, low-fat control), family history of cancer (yes/no), education level 
(primary or secondary/high school university or graduate), history of diabetes (yes/no), baseline energy intake (Kcal/day, continuous) and treatment with aspirin 
(yes/no) at baseline.  
*p-value <0.05 
Abbreviations: HR, Hazard Ratio; CI, confidence interval; MedDiet, Mediterranean Diet; EVOO, extra virgin olive oil. 
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Table S6. HRs and 95% CIs between the 2018 WCRF/AICR and the low-risk lifestyle scores and colorectal cancer risk at baseline in the PREDIMED study by 
subgroups (age, sex and T2D status) 
 2018 WCRF/AICR score Low-risk lifestyle score 
 Continuous analysis 
 (1-point increment), HR (95% CI) 
P for trend 
Continuous analysis  
(1-point increment), HR (95% CI) 
P for trend 
Age< 67 years     
Events/non-events (n) 41/3,499 - 41/3,499 - 
Crude model 0.89 (0.68-1.17) 0.403 0.78 (0.59-1.05) 0.099 
Model 1 0.90 (0.68-1.19) 0.458 0.79 (0.60-1.05) 0.110 
Model 2 0.88 (0.67-1.17) 0.382 0.79 (0.60-1.05) 0.109 
Age≥ 67 years     
Events/non-events (n) 56/3,717 - 56/3,717 - 
Crude model 0.70 (0.50-0.97)* 0.032* 0.73 (0.54-0.99)* 0.041* 
Model 1 0.70 (0.50-0.97)* 0.032* 0.76 (0.58-1.00) 0.051 
Model 2 0.71 (0.50-0.99)* 0.050* 0.76 (0.58-0.99)* 0.048* 
Men     
Events/non-events (n) 57/3,071 - 57/3,071 - 
Crude model 0.86 (0.64-1.16) 0.323 0.85 (0.66-1.10) 0.213 
Model 1 0.80 (0.58-1.11) 0.185 0.83 (0.65-1.07) 0.154 
Model 2 0.85 (0.62-1.17) 0.315 0.84 (0.65-1.08) 0.174 
Women     
Events/non-events (n) 40/4,145 - 40/4,145 - 
Crude model 0.75 (0.55-1.01) 0.059 0.69 (0.50-0.96)* 0.028* 
Model 1 0.75 (0.55-1.02) 0.064 0.70 (0.50-0.97)* 0.030* 
Model 2 0.72 (0.51-1.02) 0.064 0.69 (0.50-0.95)* 0.023* 
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Prevalent T2D     
Events/non-events (n) 50/3,527 - 50/3,527 - 
Crude model 0.69 (0.51-0.93)* 0.014* 0.81 (0.60-1.07) 0.142 
Model 1 0.68 (0.50-0.92)* 0.012* 0.81 (0.62-1.07) 0.138 
Model 2 0.71 (0.53-0.96)* 0.024* 0.81 (0.62-1.06) 0.123 
Non-prevalent T2D     
Events/non-events (n) 47/3,689 - 47/3,689 - 
Crude model 0.89 (0.64-1.23) 0.475 0.69 (0.50-0.95)* 0.021* 
Model 1 0.90 (0.64-1.27) 0.550 0.72 (0.53-0.97)* 0.028* 
Model 2 0.87 (0.61-1.24) 0.443 0.71 (0.52-0.95)* 0.021* 
Model 1 adjusted for age (years, continuous) and sex. 
Model 2 was model 1 plus intervention group (MedDiet + EVOO, MedDiet + nuts, low-fat control), family history of cancer (yes/no), education level (primary 
or secondary/high school university or graduate), history of diabetes (yes/no), baseline energy intake (Kcal/day, continuous) and treatment with aspirin (yes/no) 
at baseline. Model 2 for 2018 WCRF/AICR score was further adjusted for current smoker (yes/no), former smoker (yes/no), never smoker (yes/no). 
All models were stratified by node. *p-value <0.05 
Abbreviations: HR, Hazard Ratio; CI, confidence interval; WCRF/AICR, World Cancer Research Fund/American Institute for Cancer Research; T2D, type 2 
diabetes; MedDiet, Mediterranean Diet; EVOO, extra virgin olive oil.  
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SUPPLEMENT
Association Between Dairy Product Consumption
and Colorectal Cancer Risk in Adults: A Systematic
Review and Meta-Analysis of Epidemiologic
Studies
Laura Barrubés,1,2 Nancy Babio,1,2 Nerea Becerra-Tomás,1,2 Núria Rosique-Esteban,1,2 and Jordi Salas-Salvadó1,2
1Universitat Rovira i Virgili, Department of Biochemistry and Biotechnology, Human Nutrition Unit, Sant Joan de Reus Hospital, IISPV, Reus, Spain; and 2CIBER
de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
ABSTRACT
Dairy product consumption may decrease colorectal cancer (CRC) risk, but very few studies have evaluated the association between different types
of dairy products and CRC location. The aim of this systematic review and meta-analysis was to examine the associations between dairy product
consumption and CRC incidence. Summary RRs and ORs with 95% CIs were estimated. A total of 15 cohort studies and 14 case-control studies
comprising a total of >22,000 cases were included in the quantitative synthesis. The cohort studies showed a consistent significant decrease in CRC
risk associated with higher consumption of total dairy products (RR: 0.80; 95% CI: 0.70, 0.91) and total milk (RR: 0.82; 95% CI: 0.76, 0.88) compared with
the CRC risk associated with lower consumption. These studies also showed a significant protective association between low-fat milk consumption
and CRC (RR: 0.76; 95% CI: 0.66, 0.88), but only for colon cancer (RR: 0.73; 95% CI: 0.61, 0.87). Cheese consumption was inversely associated with the
risk of CRC (RR: 0.85; 95% CI: 0.76, 0.96) and proximal colon cancer (RR: 0.74; 95% CI: 0.60, 0.91). No significant associations with CRC were found for
the consumption of low-fat dairy products, whole milk, fermented dairy products, or cultured milk. Most of these associations were not supported
by the case-control studies. In conclusion, high consumption of total dairy products and total milk was associated with a lower risk of developing
CRC at any anatomic location, including the proximal and distal colon and the rectum. Low-fat milk consumption was associated with a lower risk
of CRC, but this association was restricted to colon cancer. Cheese consumption was associated with the prevention of CRC, specifically proximal
colon cancer. Further studies on larger samples and with longer follow-up periods, along with appropriately designed and executed clinical trials,
are warranted to determine whether dairy product consumption affects CRC development. Adv Nutr 2019;10:S190–S211.
Keywords: dairy, milk, yogurt, cheese, colorectal cancer, systematic review, meta-analysis, prospective studies, case-control studies, adults
Introduction
In 2016, there were 1.7 million incident cases of colon and
rectal cancer, with 830,000 deaths worldwide (1). Over the
next 15 years, the global burden of colorectal cancer (CRC)
is expected to increase by 60% and cause 1.1 million deaths
(2).
It has been suggested that factors such as body
weight/adiposity, physical activity, and diet are leading
risk factors for CRC (3). Several studies have shown that a
healthy dietary pattern, such as that in the Mediterranean
diet, characterized by high intakes of vegetables, fruits,
whole grains, nuts, and olive oil; moderate intakes of fish,
poultry, and low-fat dairy foods; and low intakes of red meat,
processed meat, and sugar-sweetened drinks, may decrease
the risk of CRC (4, 5).
Although there is considerable evidence to suggest that
the consumption of processed meat and alcohol are risk
factors for CRC, evidence for an association between the
consumption of dairy products and the risk of CRC is not as
strong. The latest report from the Continuous Update Project
(CUP), led by the World Cancer Research Fund/American
Institute for Cancer Research (WCRF/AICR), concluded
that there is strong evidence that the consumption of dairy
products may help to protect against CRC (3). However, the
risk of CRC associated with the consumption of different
types of dairy products (i.e., yogurt, cultured milk, or hard
cheese), as well as the consumption of dairy product subtypes
and their fat composition (i.e., low-fat or high-fat dairy
products, low-fat or full-fat yogurt, and skim/semiskim or
whole milk), remains unclear (6–19).
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Although most current dietary guidelines advocate the
consumption of fat-free or low-fat dairy products in the
context of a healthy diet to prevent chronic diseases (20–23),
evidence has shown no association between the consumption
of full-fat dairy products and either the risk of CRC (6, 12, 19)
or a reduction in the risk (14). Therefore, further research on
the association between the consumption of milk foods and
the risk of CRC should be of considerable interest in terms of
public health.
The aim of this systematic review and meta-analysis
was to extend the available evidence and combine all the
results from prospective cohorts and case-control studies in
adults so that the association between the consumption of
specific types of dairy products and CRC incidence could be
examined. We also investigated whether these associations
depended on the CRC subsite (colon or rectal) and colon
cancer location (proximal or distal colon).
Methods
Design
This systematic review and meta-analysis study was con-
ducted in accordance with the Cochrane Handbook for
Systematic Reviews of Interventions (24). The results are pre-
sented following the “Meta-Analysis of Observational Studies
in Epidemiology” (25) and the “Preferred Reporting Items
for Systematic Reviews and Meta-Analyses: The PRISMA
Statement” guidelines (see the PRISMA checklist in the
Supplementary Data) (26). The protocol for the systematic
review and meta-analysis is available in PROSPERO (www.
crd.york.ac.uk; identifier: CRD42017057490).
Study selection
We systematically searched for published case-control and
prospective cohort studies evaluating the associations be-
tween the consumption of total dairy products (and their
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subtypes) and the incidence of CRC (total CRC, colon or
rectal cancer, and proximal or distal colon cancer). One
review author (LB) searched for relevant keywords and
medical subject heading terms related to the consumption of
dairy products (i.e., “dairy” or “dairy products”) and subtypes
of dairy products (i.e., “milk” or “yogurt” or “yoghurt” or
“cheese” or “cultured milk products”) in combination with
keywords related to CRC events (i.e., “colorectal cancer”
or “colorectal neoplasms”). No restrictions on the study
design or language of the publication were considered.
The MEDLINE (PubMed), Cochrane Library, CINAHL, and
ScienceDirect databases were searched up to 4 June, 2018
(see all search strategies in Supplemental Table 1). We also
carried out a manual search of the bibliographies of the
articles we assessed and contacted the authors of unavailable
sources.
All studies that met the following criteria were considered
for inclusion in the meta-analysis: 1) those conducted in
humans (>18 y old); 2) those written in English, Spanish,
or French; 3) those in which the outcome of interest
was CRC, colon, or rectal cancer; 4) those that provided
estimates of the OR or RR (such as the HR or risk ratio)
with the corresponding 95% CIs, or gave sufficient data
for these values to be calculated; 5) those in which the
estimates were adjusted for age; 6) those that evaluated
the consumption of dairy products through the use of
validated food questionnaires; and 7) those that assessed the
consumption of any subtype or total dairy product (cow,
goat, or sheep milk; skim, low-fat, or full-fat milk; total, low-
fat, or full-fat yogurt; cheese; and full-fat dairy, sweetened
dairy, or other dairy products) as the exposure variable.
For the dose-response analysis we required the following
criteria to be met: 1) a quantitative measure of intake had to
be provided; 2) when there were several publications from
the same study, we selected the publication with the largest
number of cases; and 3) if all the information required was
not provided in the paper, we used the publication that
provided enough information for a dose-response analysis
to be conducted. The following types of publications were
excluded: 1) nonoriginal papers (reviews, commentaries,
editorials, or letters); 2) ecologic assessments and correlation
studies; 3) cross-sectional studies; 4) meta-analysis studies;
5) non-peer-reviewed articles; 6) off-topic studies; 7) studies
on CRC mortality; 8) studies lacking specific CRC data; 9)
animal and mechanistic studies; 10) studies conducted in
children, adolescents, or pregnant women; 11) supplements
to the main manuscript; 12) duplicate publications; and 13)
low-quality studies.
Data extraction
First, we removed duplicate works from the databases men-
tioned above and from the manual search. Second, the titles
and abstracts were screened for eligibility independently and
in duplicate by 2 researchers (NB and LB) at the Human
Nutrition Unit to exclude obviously irrelevant studies. After
the primary screening, the full texts of potentially relevant
Dairy product consumption and colorectal cancer risk S191
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reports were retrieved, and the inclusion and exclusion
criteria and the quality of the study were assessed by 2
researchers (NR-E and LB) (see the PRISMA flow diagram,
Figure 1) with the use of a data extraction form developed
for this study. If the 2 review authors could not reach
agreement, a third author (JS-S) was consulted to make a
decision.
The data extracted for each individual study included the
following: first author of the article, name of the journal in
which the article was published, year of the study, title of the
article, study dates, sample size, population characteristics
(age, sex, and health status), country of recruitment, covari-
ates included in the fully adjusted models, dietary assess-
ment method, outcome and outcome assessment method,
language of the publication, endpoint variables, exposure
variables (type of dairy product consumed and intake range),
statistical methods and statistical software used, endpoint
data, funding sources, and frequency of data collection. For
case-control studies, the length of the study period and the
number of cases and controls were collected, and for cohort
studies, the follow-up period and number of events were
collected.
Study quality assessment
To evaluate the validity of the individual studies, 2 reviewers
(NR-E and LB) worked independently to determine the qual-
ity of the included studies based on the use of the Newcastle-
Ottawa Scale (NOS) for cohort or case-control studies (27).
The evaluation was based on the following criteria: 1) the
study selection (maximum 4 points); 2) the adequacy of the
outcome in cohort studies and the adequacy of the exposure
in case-control studies (maximum 3 points); and 3) the
comparability of the studies (maximum 2 points). Depending
on the score assigned, the studies were categorized as either
high quality or low quality. The maximum score was 9, and a
high score (≥6) indicated high methodologic quality. A con-
sensus was reached between the reviewers if there were any
discrepancies.
Statistical analysis
To calculate the summary risk estimates and 95% CIs
for the highest compared with the lowest categories of
consumption of dairy products and dairy product subtypes,
we conducted both random (≥5 study comparisons) and
fixed (<5 study comparisons) effects analyses. We natural
log–transformed and pooled the RRs/HRs (cohort studies)
and ORs (case-control studies) through the use of the
generic inverse variance method. When the highest level
of consumption was considered as the reference category,
we recalculated the estimate (RR and 95% CI) of the
highest category (28). A 2-tailed P < 0.05 was considered
statistically significant. The heterogeneity among studies
was assessed with the use of Cochran’s Q statistic and
quantified with the I2 statistic (P < 0.10 was considered
significant, and I2 ≥ 50% was interpreted as substantial
heterogeneity).
When the results of the studies were stratified by sub-
groups, such as sex, they were treated as separate studies.
We carried out prespecified stratified analyses for the study
design (prospective cohort and case-control studies) and
outcome (CRC, colon cancer, proximal or distal colon cancer,
and rectal cancer).
Analyses were performed with Review Manager
(RevMan) version 5.3 (The Nordic Cochrane Center)
and STATA version 14.0 (StataCorp LP) software.
We performed linear and nonlinear dose-response anal-
yses with data from the cohort studies. We carried out
generalized least-squares trend estimation modeling and
spline curve modeling (MKspline STATA command). This
method requires at least 3 quantitative exposure levels or
quantiles. To impute missing data, such as the number of
participants and cases, in each quantile, we used the method
of Bekkering et al. (29). For studies that did not include the
total number of participants in each quantile but reported the
total number of participants, we divided the total sample size
by the number of quantiles. When the number of cases in
each category was not given, we used the RR to impute the
number of cases.
For studies that reported the range of consumption of
dairy products but not the mean or median intake, we
calculated the midpoint. For those reporting open-ended
lower or upper boundaries, we assumed a range equal to the
adjacent range. If the consumption of dairy products was
given in grams/day, we converted the intake into servings/day
based on the use of standard units: 200 g for total dairy
products, 200 g for milk (1 glass), 125 g for yogurt (1
commercial serving), and 30 g for cheese. When the intakes
were reported in densities (grams · 1000 kcal–1 · day–1),
we recalculated the reported intakes by considering the
mean energy intake specified in the publication (30). If the
study reported the consumption of cheese in slices/day, we
regarded each slice as 25 g (17). If the estimated risks for skim
and semiskim milk were reported separately, we considered
only the measure for skim milk (18) because this is the
most widely consumed type of milk. When hard cheese and
other types of cheese, such as cottage or cream cheese, were
reported individually, we used the estimates for hard cheese
(17, 31) so that our results were comparable to the current
evidence. When both baseline and repeated measurement
analyses were reported, we used the repeated measurements
because they more accurately represent changes in dietary
consumption (32). When the fully adjusted model was not
adjusted for age, we used the age-adjusted estimates (32).
To determine whether our results were robust, we per-
formed a sensitivity analysis by recalculating the summary
estimates after excluding 1 study at a time (Supplemental
Tables 2 and 3).
Results
Study selection
Figure 1 shows the flow diagram summarizing the identifi-
cation and selection of the relevant publications. Of the 780
S192 Barrubés et al.
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FIGURE 1 Flow of information through the different phases of the identification and selection of relevant studies examining the
associations between the consumption of dairy products and the risk of CRC in adults. CRC, colorectal cancer.
reports remaining after duplicates were removed, 29 studies
were included in the meta-analysis: 15 prospective cohort
studies (6, 8, 11, 14, 17–19, 30, 32–38) and 14 case-control
studies (28, 31, 39–50).
Study characteristics
Tables 1 and 2 show the main characteristics of the studies
selected. In total, the cohort studies included 1,371,848
participants (66% women, 31% men, and 3% undefined) with
11,733 cases recorded during follow-up periods that ranged
from 4 to 14.8 y (Table 1). The case-control studies included
10,921 cases and 13,398 controls (Table 2).
Of the cohort studies, 6 were conducted in the United
States, 2 in Norway, 3 in Sweden, 1 in China, 1 in Italy,
1 in Spain, and 1 in each of 10 different European countries.
The case-control studies were conducted in 9 countries
(China, Italy, the Netherlands, France, the United States,
Japan, Canada, Australia, and Korea).
All cohort and case-control studies were conducted in
adults. Most of the studies obtained funding only from
agencies, but 1 study was agency-industry funded, 1 reported
industry funding, 3 did not report the funding source, and
1 did not report receiving a specific grant.
High consumption compared with low consumption
analyses
Prospective cohort studies.
Total dairy products. Eight cohort study comparisons (11,
17–19, 30, 36) were used to assess the association between the
highest and the lowest consumption of total dairy products
and CRC risk; 910,047 individuals and 8424 cases were
included. The summary RR for CRC was 0.80 (95% CI: 0.70,
0.91; I2 = 45%; P-heterogeneity = 0.08) (Figure 2 and Supple-
mental Figure 1). Significant inverse associations were also
observed for colon cancer (summary RR: 0.76; 95% CI: 0.66,
0.87; I2 = 14%; P-heterogeneity = 0.33; n = 7) (Figure 3 and
Supplemental Figure 2), proximal colon cancer (summary
RR: 0.75; 95% CI: 0.63, 0.89; I2 = 63%; P-heterogeneity =
0.04; n = 4) (Figure 4), distal colon cancer (summary RR:
0.73; 95% CI: 0.62, 0.88; I2 = 10%; P-heterogeneity = 0.34;
n = 4) (Figure 4), and rectal cancer (summary RR: 0.83;
95% CI: 0.71, 0.96; I2 = 32%; P-heterogeneity = 0.22; n = 4)
(Figure 5).
High-fat dairy products. Two cohort studies (14, 19),
comprising 67,924 participants and 895 cases, were used to
analyze the effects of the highest compared with the lowest
consumption of high-fat dairy products on CRC risk. The
pooled RR was 0.68 (95% CI: 0.53, 0.87), with substantial
Dairy product consumption and colorectal cancer risk S193
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FIGURE 2 Summary estimates (RRs for cohort studies and ORs for case-control studies, with the corresponding 95% CIs; log scale)
examining the associations between the consumption of dairy products and the risk of CRC. The meta-analysis included prospective
cohort and case-control studies analyzing the consumption of total dairy products, high-fat dairy products, low-fat dairy products, total
milk, whole milk, low-fat milk, fermented dairy products, total yogurt, cultured milk, or cheese. CRC, colorectal cancer; MetS, metabolic
syndrome.
heterogeneity (I2 = 71%; P-heterogeneity = 0.06) (Figure 2).
The summary RR for colon cancer was 0.82 (95% CI: 0.62,
1.08; I2 = 0%; P-heterogeneity = 0.77; n = 3) (Figure 3).
Low-fat dairy products. Two cohort studies, comprising
68,859 participants and 669 cases (11, 19), were used in the
meta-analysis of the effects of the highest compared with the
lowest consumption of low-fat dairy products on CRC risk.
The overall RRs for CRC (summary RR: 0.91; 95% CI: 0.79,
1.06; I2 = 52%; P-heterogeneity = 0.15) (Figure 2) and colon
cancer (summary RR: 0.91; 95% CI: 0.72, 1.15; I2 = 0%; P-
heterogeneity = 0.68; n = 3) (Figure 3) were not statistically
significant.
Total milk. The analysis of the association of the highest
compared with the lowest consumption of total milk on
CRC risk included 9 cohort study comparisons (1,003,303
individuals and 9118 cases) (17–19, 30, 32, 36, 37). We
found evidence of a significant inverse association with
the summary RR of CRC (summary RR: 0.82; 95% CI:
0.76, 0.88; I2 = 2%; P-heterogeneity = 0.42) (Figure 2 and
Supplemental Figure 3). A significant inverse association
with no significant heterogeneity was also observed for colon
cancer (summary RR: 0.79; 95% CI: 0.72, 0.87; I2 = 0%; P-
heterogeneity = 0.96; n = 8) (Figure 3 and Supplemental
Figure 4), proximal colon cancer (summary RR: 0.81; 95%
CI: 0.68, 0.96; I2 = 0%; P-heterogeneity = 0.70; n = 3) (Figure
4), distal colon cancer (summary RR: 0.75; 95% CI: 0.63, 0.90;
I2 = 25%; P-heterogeneity = 0.26; n = 3) (Figure 4), and rectal
cancer (summary RR: 0.84; 95% CI: 0.73, 0.97; I2 = 0%; P-
heterogeneity = 0.84; n = 5) (Figure 5).
FIGURE 3 Summary estimates (RRs for cohort studies and ORs for case-control studies, with the corresponding 95% CIs; log scale)
examining the associations between the consumption of dairy products and the risk of colon cancer. The meta-analysis included
prospective cohort and case-control studies analyzing the consumption of total dairy products, high-fat dairy products, low-fat dairy
products, total milk, whole milk, low-fat milk, fermented dairy products, total yogurt, cultured milk, or cheese. MetS, metabolic syndrome.
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Whole milk. Three cohort studies (14, 18, 19) were
used to compare the effects of the highest and the lowest
consumption of whole milk on CRC risk (545,046 individuals
and 5198 cases). The pooled risk estimate showed an RR
of 0.97 (95% CI: 0.86, 1.09), with moderate heterogeneity
among the studies (I2 = 40%; P-heterogeneity = 0.19) (Figure
2). We did not observe a significant inverse association with
colon cancer risk in the analysis of the highest compared
with the lowest consumption (summary RR: 0.87; 95% CI:
0.72, 1.05; I2 = 0%; P-heterogeneity = 0.35; n = 2) (Figure
3), proximal colon cancer (summary RR: 1.20; 95% CI: 0.96,
1.49; I2 = 83%; P-heterogeneity = 0.02; n = 2) (Figure 4),
distal colon cancer (summary RR: 0.78; 95% CI: 0.60, 1.01;
I2 = 0%; P-heterogeneity = 0.64; n = 2) (Figure 4), or rectal
cancer (summary RR: 0.94; 95% CI: 0.76, 1.16; I2 = 0%; P-
heterogeneity = 0.66; n = 2) (Figure 5).
Low-fat milk. The combined RR for CRC for the highest
compared with the lowest consumption of low-fat milk (18,
19) was 0.76 (95% CI: 0.66, 0.88; I2 = 42%; P-heterogeneity
= 0.19) (Figure 2). The analysis considered 2 cohorts with
a total of 484,338 participants and 3507 cases. The overall
RR for colon cancer was 0.73 (95% CI: 0.61, 0.87; I2 = 0%;
P-heterogeneity = 0.77; n = 2) (Figure 3).
Fermented dairy products. Two cohort studies (11, 19)
(68,859 individuals and 669 cases) were included in the meta-
analysis of the association between the highest and lowest
consumption of fermented dairy products and CRC risk.
The summary RR was 0.90 (95% CI: 0.73, 1.11; I2 = 0%; P-
heterogeneity = 1.00) (Figure 2). The association for colon
cancer was not statistically significant (summary RR: 0.84;
95% CI: 0.66, 1.07; I2 = 43%; P-heterogeneity = 0.18; n = 2)
(Figure 3).
Total yogurt. Four cohort studies, with a total of 529,579
and 4899 cases (18, 19, 38), were used to compare the overall
risk of CRC between the groups with the highest and lowest
consumption of total yogurt. The summary RR was 0.87 (95%
CI: 0.79, 0.96; I2 = 57%; P-heterogeneity = 0.07) (Figure 2).
Cultured milk. Two cohort studies (14, 17), with a total
of 106,014 participants and 1247 cases, were used to analyze
the association between the highest and lowest consumption
of cultured milk and CRC risk. The summary RR was 0.92
(95% CI: 0.79, 1.07; I2 = 69%; P-heterogeneity = 0.07) (Figure
2). Similarly, for proximal and distal colon cancer (Figure 4)
and rectal cancer (Figure 5), the inverse associations were not
significant (the P-values were 0.52 for proximal colon cancer,
0.92 for distal colon cancer, and 0.55 for rectal cancer).
Cheese. Four prospective cohort studies (14, 17–19)
(590,352 participants and 5857 cases) were used to analyze
the association between the highest and lowest consumption
of cheese and CRC risk. The pooled RR was 0.85 (95%
CI: 0.76, 0.96), with no significant heterogeneity between
the studies (I2 = 27%; P-heterogeneity = 0.25) (Figure
2). However, the inverse relationship was not statistically
significant for colon cancer (summary RR: 0.88; 95% CI:
0.77, 1.01; I2 = 44%; P-heterogeneity = 0.15; n = 4) (Figure
3). The RR for proximal colon cancer showed a significant
inverse association (summary RR: 0.74; 95% CI: 0.60, 0.91;
I2 = 0%; P-heterogeneity = 0.99; n = 3) (Figure 4). The inverse
relationships for distal colon cancer (summary RR: 0.86; 95%
CI: 0.69, 1.09; I2 = 54%; P-heterogeneity = 0.11; n = 3) (Figure
4) and rectal cancer (summary RR: 0.93; 95% CI: 0.76, 1.13;
I2 = 0%; P-heterogeneity = 0.85; n = 3) (Figure 5) were not
statistically significant.
Case-control studies.
Total dairy products. Five case-control study comparisons
were used to assess the associations between the highest and
lowest consumption of total dairy products and the risk of
CRC (40, 46, 48, 50). The summary OR was 0.87 (95% CI:
0.64, 1.20), with moderate heterogeneity among the studies
(I2 = 52%; P-heterogeneity = 0.08) (Figure 2). The pooled OR
was 0.84 (95% CI: 0.71, 1.00) for colon cancer (Figure 3) and
0.63 (95% CI: 0.50, 0.80) for rectal cancer (Figure 5), with
no significant heterogeneity (P-heterogeneity = 0.11 and 0.15,
and n = 8 and 4, respectively) among the studies.
High-fat dairy products. We used 6 case-control study
comparisons to analyze the association between colon cancer
and the highest and lowest intakes of high-fat dairy products
(28, 42, 44). The summary OR for colon cancer was 1.11 (95%
CI: 0.90, 1.37), with moderate heterogeneity (I2 = 53%; P-
heterogeneity = 0.06) (Figure 3). For rectal cancer, the OR
was 0.92 (95% CI: 0.71, 1.20; I2 = 0%; P-heterogeneity = 0.45;
n = 2) (Figure 5).
Low-fat dairy products. We used 6 case-control study
comparisons to analyze the association between colon cancer
and the highest and lowest intakes of low-fat dairy products
(28, 42, 44). The summary OR for colon cancer was 0.85 (95%
CI: 0.71, 1.02; I2 = 24%; P-heterogeneity = 0.26) (Figure 3).
For rectal cancer, the summary OR was 0.78 (95% CI: 0.58,
1.04; I2 = 0%; P-heterogeneity = 0.53; n = 2) (Figure 5).
Total milk. Eight case-control study comparisons (31, 39,
40, 43, 46, 48, 49) were used to analyze the association
between the highest and lowest intakes of total milk and CRC
risk. We observed a significant inverse association (OR: 0.85;
95% CI: 0.73, 0.99) for CRC, with no important heterogeneity
(I2 = 0%; P-heterogeneity = 0.50) (Figure 2). The summary
OR for rectal cancer was not statistically significant (OR: 0.88;
95% CI: 0.69, 1.13; I2 = 40%; P-heterogeneity = 0.17; n = 4)
(Figure 5).
Total yogurt. In the analysis of the highest compared with
the lowest intake of total yogurt, the pooled risk estimate
for CRC was not significant (OR: 0.92; 95% CI: 0.77, 1.09;
I2 = 0%; P-heterogeneity = 0.60). This analysis included
3 case-control study comparisons (31, 48) (Figure 2). For
the analysis of colon cancer risk, the summary OR was
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FIGURE 4 Summary estimates (RRs with 95% CIs; log scale) examining the associations between the consumption of dairy products and
the risk of colon cancer by subsite (proximal or distal colon). The meta-analysis included prospective cohort studies analyzing the
consumption of total dairy products, high-fat dairy products, low-fat dairy products, total milk, whole milk, low-fat milk, fermented dairy
products, total yogurt, cultured milk, or cheese. MetS, metabolic syndrome.
1.06 (95% CI: 0.90, 1.25; I2 = 25%; P-heterogeneity = 0.26;
n = 5) (Figure 3). The association for rectal cancer was
statistically significant (OR: 0.75; 95% CI: 0.59, 0.95; I2 = 52%;
P-heterogeneity = 0.15, n = 2) (Figure 5).
Cheese. The combined OR for CRC in the analysis of the
highest compared with the lowest consumption of cheese
included 5 case-control study comparisons (31, 40, 43, 48).
The pooled OR was 0.95 (95% CI: 0.79, 1.14; I2 = 0%; P-
heterogeneity = 0.62) (Figure 2). Similarly, we found no
evidence of a significant association between colon cancer
risk (OR: 0.87; 95% CI: 0.74, 1.02; I2 = 0%; P-heterogeneity
= 0.40; n = 3) (Figure 3) or rectal cancer (OR: 0.77; 95% CI:
0.55, 1.09; I2 = 0%; P-heterogeneity = 0.46; n = 2) and the
highest and lowest consumption of cheese (Figure 5).
Subgroup Studies, n RR/OR [95% CI] I 2 (%) P -value P -value
Cohort studies RR [95% CI]
Total dairy products 4 0.83 [0.71, 0.96] 32 0.22 0.01
High-fat dairy products 0 - - - -
Low-fat dairy products 0 - - - -
Total milk 5 0.84 [0.73, 0.97] 0 0.84 0.01
Whole milk 2 0.94 [0.76, 1.16] 0 0.66 0.56
Low-fat milk 0 - - - -
Fermented dairy products 0 - - - -
Total yogurt 0 - - - -
Cultured milk 2 0.93 [0.72, 1.20] 0 0.90 0.55
Cheese 3 0.93 [0.76, 1.13] 0 0.85 0.44
Case-control studies OR [95% CI]
Total dairy products 4 0.63 [0.50, 0.80] 43 0.15 <0.01
High-fat dairy products 2 0.92 [0.71, 1.20] 0 0.45 0.53
Low-fat dairy products 2 0.78 [0.58, 1.04] 0 0.53 0.09
Total milk 4 0.88 [0.69, 1.13] 40 0.17 0.31
Whole milk 0 - - - -
Low-fat milk 0 - - - -
Fermented dairy products 0 - - - -
Total yogurt 2 0.75 [0.59, 0.95] 52 0.15 0.02
Cultured milk 0 - - - -
Cheese 2 0.77 [0.55, 1.09] 0 0.46 0.14
Protective association Adverse association
Heterogeneity
Pooled RR/OR [95% CI]
0.5 1 1.5
FIGURE 5 Summary estimates (RRs for cohort studies and ORs for case-control studies, with the corresponding 95% CIs; log scale)
examining the associations between the consumption of dairy products and the risk of rectal cancer. The meta-analyses included
prospective cohort and case-control studies analyzing the consumption of total dairy products, high-fat dairy products, low-fat dairy
products, total milk, whole milk, low-fat milk, fermented dairy products, total yogurt, cultured milk, or cheese.
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Dose-response analyses
Total dairy products.
The linear RR for CRC per 1 serving increment of total
dairy products was 0.92 (95% CI: 0.88, 0.96; P < 0.001)
(Supplemental Figure 5). This inverse association was
significant for colon cancer (RR: 0.91; 95% CI: 0.88, 0.95;
P < 0.001) (Supplemental Figure 6) but not for proximal
colon cancer (P = 0.094) (Supplemental Figure 7). The
inverse associations for distal colon cancer (RR: 0.88; 95%
CI: 0.84, 0.93; P < 0.001) (Supplemental Figure 8) and
rectal cancer (RR: 0.94; 95% CI: 0.88, 0.99; P = 0.023)
(Supplemental Figure 9) were also significant.
Total milk.
The linear RR of CRC per 1 serving increment of total milk
was 0.90 (95% CI: 0.86, 0.93; P < 0.001) (Supplemental
Figure 10). There was also a significant linear association
for colon cancer (RR: 0.88; 95% CI: 0.84, 0.93; P < 0.001)
(Supplemental Figure 11) and rectal cancer (RR: 0.91; 95%
CI: 0.84, 0.97; P = 0.005) (Supplemental Figure 12).
Total yogurt.
The combined linear RR for CRC for an increment of one
serving of yogurt was 0.72 (95% CI: 0.47, 1.10; P = 0.128)
(Supplemental Figure 13).
Cheese.
We detected a significant linear RR for CRC per 1 serving
increment of cheese (RR: 0.93; 95% CI: 0.88, 0.98; P = 0.006).
The linear RR for colon cancer per 1 serving increment was
also significant (RR: 0.91; 95% CI: 0.84, 0.99; P = 0.030)
(Supplemental Figures 14 and 15).
Sensitivity analyses
To detect whether the exclusion of a particular study
modified the associations observed, we excluded 1 study
at a time from the analyses of highest compared with
lowest consumption for both the cohort and the case-control
studies (Supplemental Tables 2 and 3, respectively). For the
cohort studies, after the study by Murphy et al. (18) was
removed, the inverse associations between the consumption
of total dairy products and the risk of proximal colon,
distal colon, and rectal cancer were no longer significant.
Likewise, the removal of the same study (18) also decreased
the summary RR for proximal colon and rectal cancer for
total milk consumption and the pooled RR for CRC for
cheese consumption.
In the analysis of total dairy products, the study by Larsson
et al. (17) explained most of the observed heterogeneity
(I2 = 8%; P-heterogeneity = 0.36). After the study by Terry
et al. (11) was excluded, the heterogeneity was reduced
(I2 = 44%; P-heterogeneity = 0.17). The study by Pala et
al. (38) explained most of the heterogeneity among the
studies when the association between the consumption of
total yogurt and CRC risk (I2 = 0%; P-heterogeneity = 0.43)
was assessed.
For the case-control studies, the heterogeneity in the
association between the consumption of total dairy products
and CRC risk was no longer significant after the study by
Chun et al. (50) was removed (I2 = 0%; P-heterogeneity =
0.84). The case-control study conducted by Murtaugh et al.
(28) accounted for most of the heterogeneity in the analysis
of high-fat dairy products and colon cancer risk (I2 = 0%; P-
heterogeneity = 0.52).
Discussion
In this meta-analysis of 29 prospective cohort and case-
control studies including >22,000 CRC cases, prospective
cohort studies showed an association between a higher
consumption of total dairy products and total milk and a
consistently and significantly decreased risk of CRC across
all CRC subsites. High low-fat milk and cheese consumption
was also associated with a decreased risk of CRC. However,
this inverse association for low-fat milk was restricted to
colon cancer, whereas after stratification by CRC subsite,
cheese had a significant association only with proximal colon
cancer. Although the high consumption of high-fat dairy
products and total yogurt showed a significant inverse as-
sociation with CRC risk, there was substantial heterogeneity
among the few studies that had been conducted. Therefore,
these observations should be interpreted cautiously. No
significant associations were found between CRC risk and
the consumption of low-fat dairy products, whole milk,
fermented dairy products, or cultured milk. Most of the
associations found were not supported by the case-control
studies. This discrepancy may be largely explained by the
differences in study design between cohort and case-control
studies, differences in categorizing the frequency of dairy
product consumption and the amounts of dairy products
consumed, and differences in the covariates considered as
potential confounders in the statistical models.
Our results are in line with those of a pooled analysis of
10 cohort studies (51) and previous meta-analyses of case-
control and cohort studies (52, 53). Likewise, systematic
reviews and meta-analyses of prospective studies (54–57)
showed a reduced risk of CRC associated with the consump-
tion of total dairy products, milk, or a combination. Our
findings are also in accordance with the conclusion of the
latest WCRF/AICR report (3).
In our meta-analysis, the consumption of total dairy
products and milk was associated with a significant decrease
in the risk of both colon and rectal cancers, although these
inverse associations were slightly higher for colon cancer. In
contrast, most systematic reviews and meta-analyses have
shown that the inverse associations between CRC risk and
the consumption of milk and total dairy products (54–57)
are mainly restricted to colon cancer. To our knowledge, no
previous systematic reviews or meta-analyses have assessed
the link between CRC risk and the consumption of low-fat
and whole milk. Furthermore, the associations between the
consumption of dairy products with different fat contents
and CRC risk were not documented in the latest report by
the CUP panel (3). On the one hand, we found that the
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consumption of low-fat milk is associated with a 24% and
27% reduction in the risk of colorectal and colon cancer,
respectively, with no significant heterogeneity among the
studies. On the other hand, we did not observe a significant
association between whole-milk consumption and CRC risk.
These results are, therefore, of great importance, because
despite the lack of scientific evidence, most dietary rec-
ommendations encourage the consumption of low-fat dairy
products.
We found that cheese consumption may decrease the risk
of CRC, particularly proximal colon cancer. These results
are consistent with the conclusions of the latest CUP report
(3). We also augmented the current evidence for these
associations by our finding of a linear relationship between
cheese consumption and CRC. Ralston et al. (55) found no
evidence of a significant inverse relationship between solid
cheese consumption and CRC. These discrepancies could be
explained by the inclusion of 2 large cohort studies assessing
cheese consumption, and because CRC risk was included in
our study but not in Ralston’s systematic review and meta-
analysis (18, 19).
The protective association we found between yogurt con-
sumption and CRC risk is inconsistent with other evidence
(54, 55). As previously mentioned, this result should be
taken with caution since there was substantial heterogeneity
among the studies analyzed. Similarly, the inverse association
between high-fat dairy products and CRC risk showed
substantial heterogeneity, and the summary risk estimate
included only 2 studies (14, 19).
The mechanisms involved in the possible decrease in CRC
risk are unclear. The most-studied chemopreventive agent in
dairy products is calcium, because dairy products are one of
the main contributors of calcium in the diet. According to the
hypothesis of Newmark et al. (58), fatty acids and bile acids
in the colon may play an important role in the initial steps
of colorectal carcinogenesis. Calcium might protect against
CRC by the colonic sequestration of secondary bile acids such
as deoxycholic acid and phospholipids. These components
have been shown to promote colorectal tumors in animal
models, probably by regulating protein kinase C (59, 60).
On the other hand, calcium could lead to differentiation
in normal cells and apoptosis in transformed cells (61, 62).
Conjugated linoleic acid, which is naturally present in dairy
products, might also have a protective effect against CRC
by inhibiting cell proliferation, modifying the fluidity of
cell membranes, decreasing the production of inflammatory
mediators, and stimulating the immune response (63–66).
Other components, such as butyric acid (62, 67), lactoferrin
(68), and vitamin D (52, 69), in fortified dairy foods might
also have protective effects.
Our systematic review and meta-analysis has several
strengths: 1) we identified prospective cohort and case-
control studies through a systematic search; 2) we used a
quantitative NOS scale to exclude low-quality studies; and
3) all of the studies in our analysis used a validated food-
frequency questionnaire to assess dairy product consump-
tion.
Despite the high quality of the studies we analyzed, we
also acknowledge some limitations, such as potential residual
confounding because of the observational nature of the
studies included or the possibility that not all the studies were
adjusted for important dietary variables. Moreover, some
of the dietary assessments were self-reported, which may
affect the reliability of the reported intakes. However, the
use of validated food-frequency questionnaires could reduce
this bias. Although some heterogeneity among studies was
observed, this heterogeneity was explained by the removal
of individual studies. For studies reporting both skim and
semiskim milk and different types of cheese separately, we
considered only the values for skim milk and hard cheese,
so the risk estimates might be somewhat overestimated.
Since we were not able to search all available databases,
we cannot ignore the possibility that some references may
have been missed. Finally, given the observational nature of
the present meta-analysis, our results cannot support causal
relationships between dairy product consumption and CRC
risk.
Conclusions
Our systematic review and meta-analysis of observational
studies shows a consistent inverse association between
higher consumption of dairy products and total milk and
the risk of CRC at all sites. Low-fat milk consumption
was associated with a decreased risk of CRC, although
this inverse association was restricted to the colon. This
systematic review and meta-analysis is the first to evaluate
the association between subtypes of milk and CRC risk. An
inverse association between cheese consumption and the risk
of CRC, particularly proximal colon cancer, was also found.
No harmful effects associated with the consumption of any
type of dairy product, including whole-fat dairy products,
were observed. Therefore, it seems reasonable to claim that
the consumption of dairy foods, especially low-fat milk and
cheese, might be related to a lower risk of CRC. Further
prospective studies with large samples and long follow-up
periods, as well as clinical trials that take into account
the long latency period of CRC, known difficulties with
dietary compliance, and other complexities such as the high
economic cost, are needed to clarify the associations between
CRC, including the differences in CRC risk across subsites,
and the fat and sugar contents of dairy products.
Acknowledgments
LB, NB, NB-T, NR-E and JS-S had full access to all of the
data in the study and take responsibility for the integrity of
the data and the accuracy of the data analysis and drafted
the manuscript; NB ans JS-S: study concept and design; LB:
statistical analyses; LB, NB, NB-T, NR-E and JS-S: critically
revised the manuscript for important intellectual content and
read and approved the final manuscript.
References
1. Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei
R, Allen C, Alsharif U, Alvis-Guzman N, Amini E, Anderson BO, et al.
Dairy product consumption and colorectal cancer risk S209
D
ow
nloaded from
 https://academ
ic.oup.com
/advances/article-abstract/10/suppl_2/S190/5489434 by N
ottingham
 Trent U
niversity user on 17 July 2019
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY AND LIFESTYLE DETERMINANTS ASSOCIATED WITH THE RISK OF COLORECTAL CANCER 
Laura Barrubés Piñol 
Global, regional, and national cancer incidence, mortality, years of life
lost, years lived with disability, and disability-adjusted life-years for 29
cancer groups, 1990 to 2016. JAMA Oncol 2018;4(11):1553–68.
2. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F.
Global patterns and trends in colorectal cancer incidence and mortality.
Gut 2017;66:683–91.
3. World Cancer Research Fund/American Institute for Cancer Research.
Diet, nutrition, physical activity and cancer: a global perspective.
Continuous Update Project Expert Report 2018.
4. Schwingshackl L, Hoffmann G. Adherence to Mediterranean diet and
risk of cancer: an updated systematic review and meta-analysis of
observational studies. Cancer Med 2015;4:1933–47.
5. Feng Y-L, Shu L, Zheng P-F, Zhang X-Y, Si C-J, Yu X-L, Gao W,
Zhang L. Dietary patterns and colorectal cancer risk. Eur J Cancer Prev
2017;26:201–11.
6. Bostick RM, Potter JD, Sellers TA, McKenzie DR, Kushi LH, Folsom
AR. Relation of calcium, vitamin D, and dairy food intake to incidence
of colon cancer among older women. The Iowa Women’s Health Study.
Am J Epidemiol 1993;137:1302–17.
7. Kampman E, Goldbohm RA, Brandt PA Van Den, Van P. Fermented
dairy products, calcium, and colorectal cancer in the Netherlands
Cohort Study. Cancer Res 1994;54(12):3186–90.
8. Kearney J, Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz
GA, Wing A, Kampman E, Willett WC. Calcium, vitamin D, and dairy
foods and the occurrence of colon cancer in men. Am J Epidemiol
1996;143:907–17.
9. Pietinen P, Malila N, Virtanen M, Hartman TJ, Tangrea JA, Albanes D,
Virtamo J. Diet and risk of colorectal cancer in a cohort of Finnish men.
Cancer Causes Control 1999;10:387–96.
10. Järvinen R, Knekt P, Hakulinen T, Aromaa A. Prospective study on milk
products, calcium and cancers of the colon and rectum. Eur J Clin Nutr
2001;55:1000–7.
11. Terry P, Baron JA, Bergkvist L, Holmberg L, Wolk A. Dietary calcium
and vitamin D intake and risk of colorectal cancer: a prospective cohort
study in women. Nutr Cancer 2002;43:39–46.
12. Lin J, Zhang SM, Cook NR, Lee I-M, Buring JE. Dietary fat and
fatty acids and risk of colorectal cancer in women. Am J Epidemiol
2004;160:1011–22.
13. Sanjoaquin MA, Appleby PN, Thorogood M, Mann JI, Key TJ.
Nutrition, lifestyle and colorectal cancer incidence: a prospective
investigation of 10 998 vegetarians and non-vegetarians in the United
Kingdom. Br J Cancer 2004;90:118–21.
14. Larsson SC, Bergkvist L, Wolk A. High-fat dairy food and conjugated
linoleic acid intakes in relation to colorectal cancer incidence in the
Swedish Mammography Cohort. Am J Clin Nutr 2005;82:894–900.
15. Lin J, Zhang SM, Cook NR, Manson JE, Lee I-M, Buring JE. Intakes of
calcium and vitamin D and risk of colorectal cancer in women. Am J
Epidemiol 2005;161:755–64.
16. Kesse E, Boutron-Ruault MC, Norat T, Riboli E, Clavel-Chapelon F.
Dietary calcium, phosphorus, vitamin D, dairy products and the risk of
colorectal adenoma and cancer among French women of the E3N-EPIC
prospective study. Int J Cancer 2005;117:137–44.
17. Larsson SC, Bergkvist L, Rutegård J, Giovannucci E, Wolk A. Calcium
and dairy food intakes are inversely associated with colorectal cancer
risk in the Cohort of Swedish Men. Am J Clin Nutr 2006;83:667–73.
18. Murphy N, Norat T, Ferrari P, Jenab M, Bueno-de-Mesquita B,
Skeie G, Olsen A, Tjønneland A, Dahm CC, Overvad K, et al.
Consumption of dairy products and colorectal cancer in the European
Prospective Investigation into Cancer and Nutrition (EPIC). PLoS One
2013;8:e72715.
19. Barrubés L, Babio N, Mena-Sánchez G, Toledo E, Ramírez-Sabio JB,
Estruch R, Ros E, Fitó M, Arós F, Fiol M, et al. Dairy product
consumption and risk of colorectal cancer in an older Mediterranean
population at high cardiovascular risk. Int J Cancer 2018;143(6):1356–
66.
20. Eckel RH, Jakicic JM, Ard JD, Hubbard VS, de Jesus JM, Lee IM,
Lichtenstein AH, Loria CM, Millen BE, Houston Miller NAmerican
College of Cardiology American/Heart Association Task Force
on Practice Guidelines, et al. American College of Cardiology
American/Heart Association Task Force on Practice Guidelines. 2013
AHA/ACC guideline on lifestyle management to reduce cardiovascular
risk: a report of the American College of Cardiology American/Heart
Association Task Force on Practice Guidelines. Circulation 2014;129(25
Suppl 2):S76–99.
21. National Health and Medical Research Council. Australian Dietary
Guidelines. Canberra: National Health and Medical Research Council;
2013.
22. US Department of Health and Human Services and US Department of
Agriculture. 2015–2020 Dietary Guidelines for Americans. [Internet].
8th ed. 2015. Available from: http://health.gov/dietaryguidelines/2015/
guidelines/.
23. Aranceta Bartrina J, Arija Val V, Maíz Aldalur E, Martínez de la
Victoria Muñoz E, Ortega Anta RM, Pérez-Rodrigo C, Quiles Izquierdo
J, Rodríguez Martín A, Román Viñas B, Salvador i Castell G,, et al.
Guías alimentarias para la población española (SENC, 2016); la nueva
pirámide de la alimentación saludable. Nutr Hosp 2016;33:1–48.
24. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic
Reviews of Interventions. Version 5.1.0. [Internet]. Oxford: Cochrane
Collaboration; 2011. Available from: www.handbook.cochrane.org.
25. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie
D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of
observational studies in epidemiology: a proposal for reporting. JAMA
2000;283(15):2008–12.
26. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred
reporting items for systematic reviews and meta-analyses: the PRISMA
Statement. PLoS Med 2009;6:e1000097.
27. Wells G, Shea B, O’Connel D. The Newcastle-Ottawa Scale (NOS)
for assessing the quality of nonrandomised studies in meta-analyses.
Ottawa Hospital Research Institute; 2014.
28. Murtaugh MA, Sweeney C, Ma K-N, Potter JD, Caan BJ, Wolff
RK, Slattery ML. Vitamin D receptor gene polymorphisms, dietary
promotion of insulin resistance, and colon and rectal cancer. Nutr
Cancer 2006;55:35–43.
29. Bekkering GE, Harris RJ, Thomas S, Mayer A-MB, Beynon R, Ness AR,
Harbord RM, Bain C, Smith GD, Sterne JAC. How much of the data
published in observational studies of the association between diet and
prostate or bladder cancer is usable for meta-analysis? Am J Epidemiol
2008;167:1017–26.
30. Park S-Y, Murphy SP, Wilkens LR, Nomura AMY, Henderson BE,
Kolonel LN. Calcium and vitamin D intake and risk of colorectal cancer:
the Multiethnic Cohort Study. Am J Epidemiol 2007;165:784–93.
31. Boutron MC, Faivre J, Marteau P, Couillault C, Senesse P, Quipourt
V. Calcium, phosphorus, vitamin D, dairy products and colorectal
carcinogenesis: a French case-control study. Br J Cancer 1996;74:145–
51.
32. Bakken T, Braaten T, Olsen A, Hjartåker A, Lund E, Skeie G. Milk and
risk of colorectal, colon and rectal cancer in the Norwegian Women and
Cancer (NOWAC) Cohort Study. Br J Nutr 2018;119:1274–85.
33. Gaard M, Tretli S, Løken EB. Dietary factors and risk of colon cancer:
a prospective study of 50,535 young Norwegian men and women. Eur J
Cancer Prev 1996;5:445–54.
34. Singh PN, Fraser GE. Dietary risk factors for colon cancer in a low-risk
population. Am J Epidemiol 1998;148:761–74.
35. Sellers TA, Bazyk AE, Bostick RM, Kushi LH, Olson JE, Anderson
KE, Lazovich D, Folsom AR. Diet and risk of colon cancer in a
large prospective study of older women: an analysis stratified on
family history (Iowa, United States). Cancer Causes Control 1998;9:
357–67.
36. McCullough ML, Robertson AS, Rodriguez C, Jacobs EJ, Chao A,
Carolyn J, Calle EE, Willett WC, Thun MJ. Calcium, vitamin D, dairy
products, and risk of colorectal cancer in the Cancer Prevention Study
II Nutrition Cohort (United States). Cancer Causes Control 2003;14:
1–12.
37. Lee S-A, Shu XO, Yang G, Li H, Gao Y-T, Zheng W. Animal origin foods
and colorectal cancer risk: a report from the Shanghai Women’s Health
Study. Nutr Cancer 2009;61:194–205.
S210 Barrubés et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/advances/article-abstract/10/suppl_2/S190/5489434 by N
ottingham
 Trent U
niversity user on 17 July 2019
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY AND LIFESTYLE DETERMINANTS ASSOCIATED WITH THE RISK OF COLORECTAL CANCER 
Laura Barrubés Piñol 
38. Pala V, Sieri S, Berrino F, Vineis P, Sacerdote C, Palli D, Masala G,
Panico S, Mattiello A, Tumino R, et al. Yogurt consumption and risk of
colorectal cancer in the Italian European prospective investigation into
cancer and nutrition cohort. Int J Cancer 2011;129:2712–9.
39. Lee HP, Gourley L, Duffy SW, Estève J, Lee J, Day NE. Colorectal cancer
and diet in an Asian population—a case-control study among Singapore
Chinese. Int J Cancer 1989;43:1007–16.
40. Centonze S, Boeing H, Leoci C, Guerra V, Misciagna G. Dietary habits
and colorectal cancer in a low-risk area. Results from a population-
based case-control study in southern Italy. Nutr Cancer 1994;21:233–
46.
41. Kampman E, van ’t Veer P, Hiddink GJ, van Aken-Schneijder P,
Kok FJ, Hermus RJ. Fermented dairy products, dietary calcium and
colon cancer: a case-control study in the Netherlands. Int J Cancer
1994;59:170–6.
42. Shannon J, White E, Shattuck AL, Potter JD. Relationship of food groups
and water intake to colon cancer risk. Cancer Epidemiol Biomarkers
Prev 1996;5:495–502.
43. Boutron-Ruault MC, Senesse P, Faivre J, Chatelain N, Belghiti C,
Méance S. Foods as risk factors for colorectal cancer: a case-control
study in Burgundy (France). Eur J Cancer Prev 1999;8:229–35.
44. Kampman E, Slattery ML, Caan B, Potter JD. Calcium, vitamin D,
sunshine exposure, dairy products and colon cancer risk (United States).
Cancer Causes Control 2000;11:459–66.
45. Satia-Abouta J, Galanko JA, Martin CF, Ammerman A, Sandler
RS. Food groups and colon cancer risk in African-Americans and
Caucasians. Int J Cancer 2004;109:728–36.
46. Mizoue T, Kimura Y, Toyomura K, Nagano J, Kono S, Mibu R, Tanaka
M, Kakeji Y, Maehara Y, Okamura T, et al. Calcium, dairy foods,
vitamin D, and colorectal cancer risk: the Fukuoka Colorectal Cancer
Study. Cancer Epidemiol Biomarkers Prev 2008;17:2800–7.
47. Williams CD, Satia JA, Adair LS, Stevens J, Galanko J, Keku TO, Sandler
RS. Dietary patterns, food groups, and rectal cancer risk in whites and
African-Americans. Cancer Epidemiol Biomarkers Prev 2009;18:1552–
61.
48. Sun Z, Wang PP, Roebothan B, Cotterchio M, Green R, Buehler S, Zhao
J, Squires J, Zhao J, Zhu Y, et al. Calcium and vitamin D and risk of
colorectal cancer: results from a large population-based case-control
study in Newfoundland and Labrador and Ontario. Can J Public Heal
2011;102:382–9.
49. Green CJ, de Dauwe P, Boyle T, Tabatabaei SM, Fritschi L, Heyworth
JS. Tea, coffee, and milk consumption and colorectal cancer risk. J
Epidemiol 2014;24:146–53.
50. Chun YJ, Sohn S-K, Song HK, Lee SM, Youn YH, Lee S, Park H.
Associations of colorectal cancer incidence with nutrient and food
group intakes in Korean adults: a case-control study. Clin Nutr Res
2015;4:110.
51. Cho E, Smith-Warner SA, Spiegelman D, Beeson WL, van den Brandt
PA, Colditz GA, Folsom AR, Fraser GE, Freudenheim JL, Giovannucci
E, et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis
of 10 cohort studies. J Natl Cancer Inst 2004;96:1015–22.
52. Norat T, Riboli E. Dairy products and colorectal cancer. A review of
possible mechanisms and epidemiological evidence. Eur J Clin Nutr
2003;57:1–17.
53. Huncharek M, Muscat J, Kupelnick B. Colorectal cancer risk and dietary
intake of calcium, vitamin D, and dairy products: a meta-analysis
of 26,335 cases from 60 observational studies. Nutr Cancer 2009;61:
47–69.
54. Aune D, Lau R, Chan DSM, Vieira R, Greenwood DC, Kampman
E, Norat T. Dairy products and colorectal cancer risk: a systematic
review and meta-analysis of cohort studies. Ann Oncol 2012;23:
37–45.
55. Ralston RA, Truby H, Palermo CE, Walker KZ. Colorectal cancer and
nonfermented milk, solid cheese, and fermented milk consumption: a
systematic review and meta-analysis of prospective studies. Crit Rev
Food Sci Nutr 2014;54:1167–79.
56. Vieira AR, Abar L, Chan D, Vingeliene S, Polemiti E, Stevens C,
Greenwood D, Norat T. Foods and beverages and colorectal cancer risk:
a systematic review and meta-analysis of cohort studies, an update of the
evidence of the WCRF-AICR Continuous Update Project. Ann Oncol
Off J Eur Soc Med Oncol 2017;28(8):1788–802
57. Schwingshackl L, Schwedhelm C, Hoffmann G, Knüppel S, Laure
Preterre A, Iqbal K, Bechthold A, De Henauw S, Michels N,
Devleesschauwer B, et al. Food groups and risk of colorectal cancer. Int
J Cancer 2018;142:1748–58.
58. Newmark HL, Wargovich MJ, Bruce WR. Colon cancer and dietary fat,
phosphate, and calcium: a hypothesis. J Natl Cancer Inst 1984;72:1323–
5.
59. Govers MJ, Termont DS, Lapré JA, Kleibeuker JH, Vonk RJ, Van der
Meer R. Calcium in milk products precipitates intestinal fatty acids and
secondary bile acids and thus inhibits colonic cytotoxicity in humans.
Cancer Res 1996;56:3270–5.
60. Holt PR, Moss SF, Whelan R, Guss J, Gilman J, Lipkin M.
Fecal and rectal mucosal diacylglycerol concentrations and epithelial
proliferative kinetics. Cancer Epidemiol Biomarkers Prev 1996;5:
937–40.
61. Lamprecht SA, Lipkin M. Cellular mechanisms of calcium and vitamin
D in the inhibition of colorectal carcinogenesis. Ann N Y Acad Sci
2001;952:73–87.
62. Pufulete M. Intake of dairy products and risk of colorectal neoplasia.
Nutr Res Rev 2008;21:56–67.
63. Parodi PW. Cows’ milk fat components as potential anticarcinogenic
agents. J Nutr 1997;127:1055–60.
64. Kritchevsky D. Antimutagenic and some other effects of conjugated
linoleic acid. Br J Nutr 2000;83:459–65.
65. Bassaganya-Riera J, Hontecillas R, Beitz DC. Colonic anti-inflammatory
mechanisms of conjugated linoleic acid. Clin Nutr 2002;21:
451–9.
66. Bassaganya-Riera J, Hontecillas R, Horne WT, Sandridge M, Herfarth
HH, Bloomfeld R, Isaacs KL. Conjugated linoleic acid modulates
immune responses in patients with mild to moderately active Crohn’s
disease. Clin Nutr 2012;31:721–7.
67. Williams L, Williams EA, Coxhead JM, Mathers JC. Anti-cancer effects
of butyrate: use of micro-array technology to investigate mechanisms.
Proc Nutr Soc 2017;62:107–15.
68. Tsuda H, Kozu T, Iinuma G, Ohashi Y, Saito Y, Saito D, Akasu T,
Alexander DB, Futakuchi M, Fukamachi K, et al. Cancer prevention
by bovine lactoferrin: from animal studies to human trial. BioMetals
2010;23:399–409.
69. Garland CF, Gorham ED. Dose-response of serum 25-hydroxyvitamin
D in association with risk of colorectal cancer: a meta-analysis. J Steroid
Biochem Mol Biol 2017;168:1–8.
Dairy product consumption and colorectal cancer risk S211
D
ow
nloaded from
 https://academ
ic.oup.com
/advances/article-abstract/10/suppl_2/S190/5489434 by N
ottingham
 Trent U
niversity user on 17 July 2019
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY AND LIFESTYLE DETERMINANTS ASSOCIATED WITH THE RISK OF COLORECTAL CANCER 
Laura Barrubés Piñol 
Supplementary data 
1 
 
Supplemental table 1. Search strategy (databases and search terms)  
MEDLINE (through PUBMED)  
(("dairy"[All Fields] OR "dairy products"[MeSH Terms] OR ("dairy"[All Fields] AND "products"[All Fields])) OR ("milk"[All Fields] OR 
"milk"[MeSH Terms]) OR ("yogurt"[MeSH Terms] OR "yogurt"[All Fields] OR "yoghurt"[All Fields]) OR ("cheese"[MeSH Terms] OR 
"cheese"[All Fields]) OR ("cultured milk products"[MeSH Terms] OR ("cultured"[All Fields] AND "milk"[All Fields] AND "products"[All Fields]) 
OR "cultured milk products"[All Fields] OR ("cultured"[All Fields] AND "milk"[All Fields]) OR "cultured milk"[All Fields]))  
AND (("colorectal neoplasms"[MeSH Terms] OR ("colorectal"[All Fields] AND "neoplasms"[All Fields]) OR "colorectal neoplasms"[All Fields] 
OR ("colorectal"[All Fields] AND "cancer"[All Fields]) OR "colorectal cancer"[All Fields]) OR (("neoplasms"[MeSH Terms] OR "neoplasms"[All 
Fields] OR "cancer"[All Fields]) AND "sigma"[All Fields]) OR (("neoplasms"[MeSH Terms] OR "neoplasms"[All Fields] OR "cancer"[All Fields]) 
AND "rectal"[All Fields])) 
COCHRANE 
#1 MeSH descriptor: [Colorectal Neoplasms] explode all trees 
#2 colorectal  
#3 neoplasms  
#4 colorectal neoplasms  
#5 cancer  
#6 colorectal cancer  
#7 #2 and #3  
#8 #2 and #5  
#9 #1 or #4 or #6 or #7 or #8  
#10 MeSH descriptor: [Neoplasms] explode all trees 
#11 #3 or #5 or #10  
#12 sigma  
#13 #11 and #12  
#14 rectal  
#15 #11 and #14  
#16 dairy  
#17 MeSH descriptor: [Dairy Products] explode all trees 
#18 products  
#19 #16 and #18  
#20 #16 or #17 or #19  
#21 milk  
#22 MeSH descriptor: [Milk] explode all trees 
#23 #21 or #22  
#24 MeSH descriptor: [Yogurt] explode all trees 
#25 yogurt  
#26 yoghurt  
#27 #24 or #25 or #26  
#28 MeSH descriptor: [Cheese] explode all trees 
#29 cheese  
#30 #28 or #29  
#31 MeSH descriptor: [Cultured Milk Products] explode all trees 
#32 cultured  
#33 cultured milk products  
#34 cultured milk  
#35 #18 and #21 and #32  
#36 #21 and #32  
#37 #31 or #34 or #35 or #36  
#38 (#20 or #23 or #27 or #30 or #37) and (#9 or #13 or #15)  
 
SCIENCE DIRECT 
TITLE-ABSTR-KEY((("dairy") OR ("milk") OR ("yogurt") OR ("yoghurt") OR ("cheese")) AND (("cancer" OR "neoplasms") AND (colorectal OR 
colon OR sigma OR rectum))) 
CINAHL 
S1 colorectal neoplasms 
S2 colorectal 
S3 neoplasms 
S4 colorectal cancer 
S5 cancer 
S6 s2 AND s3 
S7 s2 AND s5 
S8 s1 OR s6 OR s4 OR s7 
S9 sigma 
S10 s3 OR s5 
 
S11 s10 AND s9 
S12 rectal 
S13 s10 AND s12 
S14 dairy 
S15 dairy products 
S16 products 
S17 s14 AND s16 
S18 s14 OR s15 OR s17 
S19 milk  
S20 yogurt 
S21 yoghurt  
S22 s20 OR s21 
S23 cheese  
S24 cultured milk products 
S25 cultured  
S26 milk 
S27 products  
S28 s25 AND s26 AND s27 
S29 S25 AND s26 
S30 s24 OR s28 OR s29 
S31 s18 OR s19 OR s20 OR s23 OR s30 
S32 s8 OR s11 OR s13 
S33 s31 AND s32 
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Study n participants n cases Weight, 
% 
RR (95% CI) 
Terry et al., 2002 (11) 61,643 572 12.7 0.97 (0.73-1.29) 
McCullough et al., 2003 W (36) 66,883 262 5.7 1.11 (0.68-1.82) 
McCullough et al., 2003 M (36)  60,866 421 9.3 0.96 (0.67-1.38) 
Larsson et al., 2006 (17) 45,306 449 7.1 0.46 (0.30-0.71) 
Park et al., 2007 M (30) 85,903 1,138 16.9 0.80 (0.64-0.99) 
Park et al., 2007 W (30) 105,108 972 17.1 0.81 (0.65-1.00) 
Murphy et al., 2013 (18)  477,122 4,513 26.8 0.77 (0.69-0.85) 
Barrubés et al., 2018 (19) 7,216 97 4.4 0.55 (0.31-0.98) 
     
Total 95% CI 910,047 8,424 100 0.80 (0.70-0.91) 
I2= 45%  (P= 0.08)     
Test for overall effect:  Z= 3.42  (P= 0.0006)  
 
 
 
Supplemental figure 1. RRs and 95% CIs (log scale) for fully adjusted random-effects models evaluating the associations between the 
consumption of total dairy products and the risk of CRC in the meta-analysis of 8 prospective cohort studies (high vs. low intake). The pooled risk 
estimate is represented by the black diamond. CI: confidence interval, CRC: colorectal cancer, M: only in men, RR: relative risk, W: only in 
women. 
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Study n participants n cases Weight, 
% 
RR (95% CI) 
Bostick et al., 1993 (6) 35,216 212 4.8 0.72 (0.38-1.36) 
Sellers et al., 1998 FH (35) 4,239 61 5.0 0.70 (0.37-1.31) 
Sellers et al., 1998 NFH (35) 22,698 180 8.9 0.70 (0.44-1.11) 
Terry et al., 2002 (11) 61,643 371 13.8 1.03 (0.72-1.47) 
McCullough et al., 2003 (36) 60,866 302 9.7 0.84 (0.54-1.30) 
Larsson et al., 2006 (17) 45,306 276 6.2 0.44 (0.25-0.77) 
Murphy et al., 2013 (18) 477,122 2,868 51.6 0.75 (0.66-0.86) 
     
Total 95% CI 707,090 4,270 100 0.76 (0.66-0.87) 
I2= 14%  (P= 0.33)     
Test for overall effect:  Z= 3.79  (P= 0.0002) 
 
 
 
Supplemental figure 2. RRs and 95% CIs (log scale) for fully adjusted random effects models evaluating the associations between the consumption 
of total dairy products and the risk of colon cancer in the meta-analysis of 7 prospective cohort studies (high vs. low intake). The pooled risk 
estimate is represented by the black diamond. CI: confidence interval, FH: positive family history of colon cancer, NFH: no family history of colon 
cancer, RR: relative risk. 
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Study n participants n cases Weight, 
% 
RR (95% CI) 
McCullough et al., 2003 W (36) 66,883 262 4.5 1.18 (0.84-1.65) 
McCullough et al., 2003 M (36) 60,866 421 7.5 0.86 (0.66-1.12) 
Larsson et al., 2006 (17) 45,306 449 7.1 0.67 (0.51-0.88) 
Park et al., 2007 W (30) 105,108 972 10.3 0.85 (0.68-1.06) 
Park et al., 2007 M (30) 85,903 1,138 11.4 0.78 (0.63-0.96) 
Lee et al., 2009 (37) 73,224 394 2.7 0.80 (0.52-1.24) 
Murphy et al., 2013 (18) 477,122 4,513 43.4 0.81 (0.73-0.90) 
Bakken et al., 2018 (32) 81,675 872 11.5 0.85 (0.69-1.05) 
Barrubés et al., 2018 (19) 7,216 97 1.6 0.63 (0.36-1.10) 
     
Total 95% CI 1,003,303 9,118 100 0.82 (0.76-0.88) 
I2= 2%  (P= 0.42)     
Test for overall effect:  Z= 5.49  (P<0.00001) 
 
 
 
Supplemental figure 3. RRs and 95% CIs (log scale) for fully adjusted random effects models evaluating the associations between the consumption 
of total milk and the risk of CRC in the meta-analysis of 9 prospective cohort studies (high vs. low intake). The pooled risk estimate is represented 
by the black diamond. CI: confidence interval, CRC: colorectal cancer, M: only in men, RR: relative risk, W: only in women. 
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Study n participants n cases Weight, 
% 
RR (95% CI) 
Kearney et al., 1996 (8) 47,935 203 3.8 0.87 (0.52-1.45) 
Gaard et al., 1996 M (33) 25,638 84 0.9 0.72 (0.25-2.07) 
Gaard et al., 1996 W (33) 24,897 63 0.6 1.24 (0.35-4.40) 
McCullough et al., 2003 (36) 60,866 302 10.7 0.81 (0.60-1.10) 
Larsson et al., 2006 (17) 45,306 276 8.5 0.65 (0.46-0.91) 
Lee et al., 2009 (37) 73,224 236 2.8 0.80 (0.44-1.44) 
Murphy et al., 2013 (18) 477,122 2,868 57.3 0.80 (0.70-0.91) 
Bakken et al., 2018 (32) 81,675 617 15.3 0.80 (0.62-1.03) 
     
Total 95% CI 836,663 4,649 100 0.79 (0.72-0.87) 
I2= 0%  (P= 0.96)     
Test for overall effect:  Z= 4.63  (P<0.00001) 
 
 
 
Supplemental figure 4. RRs and 95% CIs (log scale) for fully adjusted random effects models evaluating the associations between the consumption 
of total milk and the risk of colon cancer in the meta-analysis of 8 prospective cohort studies (high vs. low intake). The pooled risk estimate is 
represented by the black diamond. CI: confidence interval, M: only in men, RR: relative risk, W: only in women. 
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Supplemental figure 5. Linear and nonlinear dose-response analysis of the association between 
an increase of one serving/day of total dairy products and the risk of colorectal cancer. Each study 
was centered on the baseline reference dose for the estimation of risk for dose increases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental figure 6. Linear and nonlinear dose-response analysis of the association between 
an increase of one serving/day of total dairy products and the risk of colon cancer. Each study 
was centered on the baseline reference dose for the estimation of risk for dose increases. 
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Supplemental figure 7. Linear and nonlinear dose-response analysis of the association between 
an increase of one serving/day of total dairy products and the risk of proximal colon cancer. Each 
study was centered on the baseline reference dose for the estimation of risk for dose increases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental figure 8. Linear and nonlinear dose-response analysis of the association between 
an increase of one serving/day of total dairy products and the risk of distal colon cancer. Each 
study was centered on the baseline reference dose for the estimation of risk for dose increases. 
 
0.10
0.40
0.70
1.00
1.30
R
e
la
ti
v
e
 R
is
k
0 1 2 3 4 5 6 7 8 9
serving/day
Linear Model
Spline Model
Linear RR per 1 serving increment: 0.93 [95% CI, 0.86 to 1.01]; p= 0.094
Departure from linearity= 0.805
Random effects dose-response model
Linear odel 
Spline l 
 
Servings/day 
 
Linear RR per 1 serving increment: 0.93 [95%CI, 0.86 to 1.01]; P=0.094 
Departure from linearity= 0.805. Random effects dose-response model 
 
R
el
a
ti
v
e 
R
is
k
 
 
0.10
0.40
0.70
1.00
1.30
R
e
la
ti
v
e
 R
is
k
0 1 2 3 4 5 6 7 8 9
serving/day
Linear Model
Spline Model
Linear RR per 1 serving increment: 0.88 [95% CI, 0.84 to 0.93]; p= 0.000
Departure from linearity= 0.473
Random effects dose-response model
R
el
a
ti
v
e 
R
is
k
 
 
Linear RR per 1 serving increment: 0.88 [95%CI, 0.84 to 0.93]; P<0.001 
Departure fro  linearity= 0.473. Random effects dose-response model 
 
 
 
 
Servings/day 
 
 
 
 
Linear Mode  
Spline odel 
 
 
 
 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY AND LIFESTYLE DETERMINANTS ASSOCIATED WITH THE RISK OF COLORECTAL CANCER 
Laura Barrubés Piñol 
Supplementary data 
8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental figure 9. Linear and nonlinear dose-response analysis between increasing one 
serving/day of total dairy products and the risk of rectal cancer. Each study was centered on the 
baseline reference dose for the estimation of risk for dose increases. 
 
 
 
 
 
Supplemental figure 10. Linear and nonlinear dose-response analysis of the association between 
an increase of one serving/day of total milk and the risk of colorectal cancer. Each study was 
centered on the baseline reference dose for the estimation of risk for dose increases. 
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Supplemental figure 11. Linear and nonlinear dose-response analysis of the association between 
an increase of one serving/day of total milk and the risk of colon cancer. Each study was centered 
on the baseline reference dose for the estimation of risk for dose increases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental figure 12. Linear and nonlinear dose-response analysis of the association between 
an increase of one serving/day of total milk and the risk of rectal cancer. Each study was centered 
on the baseline reference dose for the estimation of risk for dose increases. 
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Supplemental figure 13. Linear and nonlinear dose-response analysis of the association between 
an increase of one serving/day of total yogurt consumption and the risk of colorectal cancer. Each 
study was centered on the baseline reference dose for the estimation of risk for dose increases. 
 
 
 
Supplemental figure 14. Linear and nonlinear dose-response analysis of the association between 
an increase of one serving/day of total cheese and the risk of colorectal cancer. Each study was 
centered on the baseline reference dose for the estimation of risk for dose increases. 
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Supplemental figure 15. Linear and nonlinear dose-response analysis of the association between 
an increase of one serving/day of total cheese consumption and the risk of colon cancer. Each 
study was centered on the baseline reference dose for the estimation of risk for dose increases.
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Supplemental table 2. Sensitivity analysis excluding one study at a time (cohort studies) 
TOTAL DAIRY      
Colorectal cancer     (RR [95% CI]= 0.80 [0.70, 0.91], I2 (%)= 45, P-value= 0.08) 
Excluded study or subgroup RR (95% CI) I2 (%) P-value 
Terry et al., 2002 (only women) (11) 0.77 (0.68, 0.89) 43 0.10 
McCullough et al., 2003 (men) (36) 0.78 (0.68, 0.90) 48 0.07 
Mc Cullough et al., 2003 (women) (36)  0.78 (0.69, 0.89) 45 0.09 
Larsson et al., 2006 (only men) (17) 0.81 (0.74, 0.89) 8 0.36 
Park et al., 2007 (men) (30) 0.80 (0.68, 0.93) 53 0.05 
Park et al., 2007 (women) (30) 0.79 (0.68, 0.93) 53 0.05 
Murphy et al., 2013 (18) 0.80 (0.67, 0.96) 51 0.06 
Barrubés et al., 2018 (19) 0.81 (0.71, 0.92) 47 0.08 
Colon     (RR [95% CI]= 0.76 [0.66, 0.87], I2 (%)= 14, P-value= 0.33) 
Excluded study or subgroup RR (95% CI) I2 (%) P-value 
Bostick et al., 1993 (6) 0.76 (0.64, 0.90) 28 0.23 
Sellers et al., 1998 (positive family history) (35) 0.76 (0.64, 0.90) 27 0.23 
Sellers et al., 1998 (no family history) (35) 0.76 (0.64, 0.91) 27 0.23 
Terry et al., 2002 (only women) (11) 0.73 (0.65, 0.82) 0 0.58 
McCullough et al., 2003 (men) (36) 0.75 (0.62, 0.89) 26 0.24 
Larsson et al., 2006 (only men) (17)  0.77 (0.69, 0.87) 0 0.68 
Murphy et al., 2013 (18) 0.75 (0.60, 0.95) 27 0.23 
Proximal colon     (RR [95% CI]= 0.75 [0.63, 0.89], I2 (%)= 63, P-value= 0.04) 
Excluded study or subgroup RR (95% CI) I2 (%) P-value 
Terry et al., 2002 (only women) (11) 0.71 (0.59, 0.85) 44 0.17 
McCullough et al., 2003 (men) (36) 0.77 (0.65, 0.92) 70 0.04 
Larsson et al., 2006 (only men) (17) 0.78 (0.65, 0.93) 62 0.07 
Murphy et al., 2013 (18) 0.77 (0.52, 1.13) 75 0.02 
Distal colon     (RR [95% CI]= 0.73 [0.62, 0.88], I2 (%)= 10, P-value= 0.34) 
Excluded study or subgroup RR (95% CI) I2 (%) P-value 
Terry et al., 2002 (only women) (11) 0.74 (0.61, 0.88) 40 0.19 
McCullough et al., 2003 (men) (36) 0.72 (0.60, 0.86) 0 0.41 
Larsson et al., 2006 (only men) (17) 0.76 (0.63, 0.91) 0 0.50 
Murphy et al., 2013 (18) 0.71 (0.47, 1.07) 39 0.19 
Rectum     (RR [95% CI]= 0.83 [0.71, 0.96], I2 (%)= 32, P-value= 0.22) 
Excluded study or subgroup RR (95% CI) I2 (%) P-value 
Terry et al., 2002 (only women) (11)  0.81 (0.69, 0.95) 43 0.17 
McCullough et al., 2003 (men) (36)  0.81 (0.70, 0.95) 33 0.23 
Larsson et al., 2006 (only men) (17)  0.48 (0.23, 1.00) 8 0.34 
Murphy et al., 2013 (18) 0.92 (0.65, 1.29) 50 0.13 
HIGH-FAT DAIRY 
Colon cancer     (RR [95% CI]= 0.82 [0.62, 1.08], I2 (%)= 0, P-value= 0.77) 
Excluded study or subgroup RR (95% CI) I2 (%) P-value 
Bostick et al., 1993 (6) 0.83 (0.60, 1.15) 0 0.48 
Sellers et al., 1998 (no family history) (35) 0.74 (0.50, 1.11) 0 0.79 
Sellers et al., 1998 (positive family history) (35) 0.86 (0.63, 1.18) 0 0.68 
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LOW-FAT DAIRY      
Colon cancer     (RR [95% CI]= 0.91 [0.72, 1.15], I2 (%)= 0, P-value= 0.68) 
Excluded study or subgroup RR (95% CI) I2 (%) P-value 
Sellers et al., 1998 (no family history) (35) 0.98 (0.73, 1.32) 0 0.74 
Sellers et al., 1998 (positive family history) (35) 0.91 (0.71, 1.18) 0 0.38 
Terry et al., 2002 (only women) (11) 0.83 (0.60, 1.15) 0 0.74 
TOTAL MILK      
Colorectal cancer     (RR [95% CI]= 0.82 [0.76, 0.88], I2 (%)= 2, P-value= 0.42) 
Excluded study or subgroup RR (95% CI) I2 (%) P-value 
McCullough et al., 2003 (men) (36) 0.82 (0.75, 0.89) 12 0.33 
Mc Cullough et al., 2003 (women) (36) 0.80 (0.75, 0.86) 0 0.85 
Larsson et al., 2006 (only men) (17) 0.83 (0.77, 0.89) 0 0.56 
Park et al., 2007 (women)  0.82 (0.75, 0.89) 13 0.33 
Park et al., 2007 (men) (30) 0.82 (0.76, 0.90) 12 0.34 
Lee et al., 2009 (only women) (37) 0.82 (0.75, 0.89) 14 0.32 
Murphy et al., 2013 (18) 0.82 (0.74, 0.91) 13 0.33 
Bakken et al., 2018 (32) 0.81 (0.75, 0.89) 12 0.33 
Barrubés et al., 2018 (19) 0.82 (0.76, 0.88) 4 0.40 
Colon cancer     (RR [95% CI]= 0.79 [0.72, 0.87], I2 (%)= 0, P-value= 0.96) 
Excluded study or subgroup RR (95% CI) I2 (%) P-value 
Kearney et al., 1996 (only men) (8) 0.79 (0.71, 0.87) 0 0.93 
Gaard et al., 1996 (33) 0.79 (0.71, 0.87) 0 0.92 
McCullough et al., 2003 (men) (36) 0.79 (0.71, 0.87) 0 0.92 
Larsson et al., 2006 (only men) (17) 0.80 (0.72, 0.89) 0 1.00 
Lee et al., 2009 (only women) (37) 0.79 (0.71, 0.87) 0 0.91 
Murphy et al., 2013 (18) 0.80 (0.70, 0.91) 0 0.93 
Bakken et al., 2018 (32) 0.79 (0.71, 0.88) 0 0.92 
Proximal cancer     (RR [95% CI]= 0.81 [0.68, 0.96], I2 (%)= 0, P-value= 0.70) 
Excluded study or subgroup RR (95% CI) I2 (%) P-value 
McCullough et al., 2003 (men) (36)  0.81 (0.68, 0.96) 0 0.70 
Larsson et al., 2006 (only men) (17) 0.81 (0.68, 0.98) 0 0.42 
Murphy et al., 2013 (18) 0.71 (0.50, 1.02) 0 0.76 
Distal colon     (RR [95% CI]= 0.75 [0.63, 0.90], I2 (%)= 25, P-value= 0.26)   
Excluded study or subgroup RR (95% CI) I2 (%) P-value 
McCullough et al., 2003 (men) (36) 0.73 (0.60, 0.89) 51 0.15 
Larsson et al., 2006 (only men) (17) 0.80 (0.66, 0.97) 0 0.57 
Murphy et al., 2013 (18) 0.68 (0.47, 0.97) 55 0.14 
Rectum     (RR [95% CI]= 0.84 [0.73, 0.97], I2 (%)= 0, P-value= 0.84)        
Excluded study or subgroup RR (95% CI) I2 (%) P-value 
McCullough et al., 2003 (men) (36) 0.84 (0.72, 0.97) 0 0.71 
Larsson et al., 2006 (only men) (17) 0.86 (0.74, 1.00) 0 0.91 
Lee et al., 2009 (only women) (37)  0.84 (0.73, 0.97) 0 0.70 
Murphy et al., 2013 (18) 0.84 (0.67, 1.07) 0 0.70 
Bakken et al., 2018 (32) 0.82 (0.71, 0.96) 0 0.85 
WHOLE-MILK      
Colorectal cancer     (RR [95% CI]= 0.97 [0.86, 1.09], I2 (%)= 40, P-value= 0.19)   
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Excluded study or subgroup RR (95% CI) I2 (%) P-value 
Larsson et al., 2005 (only women) (14) 0.88 (0.75, 1.04) 0 0.44 
Murphy et al., 2013 (18) 1.08 (0.91, 1.28) 0 0.95 
Barrubés et al., 2018 (19) 0.96 (0.85, 1.09) 69 0.07 
TOTAL YOGURT 
Colorectal cancer     (RR [95% CI]= 0.87 [0.79, 0.96], I2 (%)= 57, P-value= 0.07)   
Excluded study or subgroup RR (95% CI) I2 (%) P-value 
Pala et al., 2011 (women) (38) 0.88 (0.80, 0.97) 64 0.06 
Pala et al., 2011 (men) (38) 0.89 (0.81, 0.98) 0 0.43 
Murphy et al., 2013 (18) 0.68 (0.52, 0.89) 40 0.19 
Barrubés et al., 2018 (19) 0.87 (0.79, 0.95) 71 0.03 
CHEESE 
Colorectal cancer     (RR [95% CI]= 0.85 [0.76, 0.96], I2 (%)= 27, P-value= 0.25)   
Excluded study or subgroup RR (95% CI) I2 (%) P-value 
Larsson et al., 2005 (only women) (14)  0.88 (0.78, 0.99) 2 0.36 
Larsson et al., 2006 (only men) (17) 0.86 (0.76, 0.97) 48 0.14 
Murphy et al., 2013 (18) 0.81 (0.64, 1.02) 47 0.15 
Barrubés et al., 2018 (19) 0.84 (0.74, 0.94) 2 0.36 
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Supplemental table 3. Sensitivity analysis excluding one study at a time (case-control studies) 
TOTAL DAIRY 
Colorectal cancer     (RR [95% CI]= 0.87 [0.64, 1.20], I2 (%)= 52, P-value= 0.08)   
Excluded study or subgroup OR (95% CI) I2 (%) P-value 
Centonze et al., 1994 (40) 0.94 (0.66, 1.34) 60 0.06 
Mizoue et al., 2008 (46) 0.93 (0.61, 1.42) 64 0.04 
Sun et al., 2011 NL (48) 0.89 (0.59, 1.34) 64 0.04 
Sun et al., 2011 ON (48) 0.94 (0.59, 1.51) 62 0.05 
Chun et al., 2015 (50) 0.78 (0.64, 0.94) 0 0.84 
Colon cancer     (RR [95% CI]= 0.84 [0.71, 1.00], I2 (%)= 40, P-value= 0.11)   
Excluded study or subgroup OR (95% CI) I2 (%) P-value 
Shannon et al., 1996 (women) (42) 0.88 (0.77, 1.01) 6 0.38 
Shannon et al., 1996 (men) (42) 0.83 (0.69, 1.01) 48 0.07 
Kampman et al., 2000 (men) (44) 0.84 (0.69, 1.04) 47 0.08 
Kampman et al., 2000 (women) (44)  0.87 (0.72, 1.06) 36 0.15 
Satia Abouta et al., 2004 Caucasian (45) 0.83 (0.68, 1.01) 48 0.07 
Satia Abouta et al., 2004 African (45) 0.84 (0.69, 1.02) 48 0.07 
Murtaugh et al., 2006 Ff/ff (28) 0.79 (0.68, 0.93) 11 0.35 
Murtaugh et al., 2006 FF (28) 0.82 (0.67, 1.00) 46 0.09 
Rectal cancer     (RR [95% CI]= 0.63 [0.50, 0.80], I2 (%)= 43, P-value= 0.15)   
Excluded study or subgroup OR (95% CI) I2 (%) P-value 
Murtaugh et al., 2006 FF (28) 0.59 (0.45, 0.78) 55 0.11 
Murtaugh et al., 2006 Ff/ff (28) 0.62 (0.47, 0.82) 62 0.07 
Williams et al., 2009 Whites (47) 0.75 (0.56, 1.01) 0 0.44 
Williams et al., 2009 African (47) 0.60 (0.47, 0.76) 26 0.26 
HIGH-FAT DAIRY 
Colon cancer     (RR [95% CI]= 1.11 [0.90, 1.37], I2 (%)= 53, P-value= 0.06)   
Excluded study or subgroup OR (95% CI) I2 (%) P-value 
Shannon et al., 1996 (women) (42) 1.12 (0.89, 1.41) 60 0.04 
Shannon et al., 1996 (men) (42) 1.17 (0.95, 1.43) 49 0.10 
Kampman et al., 2000 (women) (44)  1.16 (0.93, 1.46) 49 0.10 
Kampman et al., 2000 (men) (44) 1.09 (0.84, 1.42) 61 0.03 
Murtaugh et al., 2006 Ff/ff (28) 1.04 (0.88, 1.22) 0 0.52 
Murtaugh et al., 2006 FF (28) 1.07 (0.81, 1.41) 62 0.03 
LOW-FAT DAIRY 
Colon cancer     (RR [95% CI]= 0.85 [0.71, 1.02], I2 (%)= 24, P-value= 0.26)   
Excluded study or subgroup OR (95% CI) I2 (%) P-value 
Shannon et al., 1996 (women) (42) 0.88 (0.73, 1.06) 23 0.27 
Shannon et al., 1996 (men) (42) 0.83 (0.67, 1.02) 36 0.18 
Kampman et al., 2000 (women) (44) 0.89 (0.73, 1.09) 19 0.29 
Kampman et al., 2000 (men) (44) 0.86 (0.66, 1.10) 35 0.19 
Murtaugh et al., 2006 FF (28) 0.85 (0.69, 1.04) 38 0.17 
Murtaugh et al., 2006 Ff/ff (28) 0.77 (0.64, 0.92) 0 0.76 
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TOTAL MILK 
Colorectal cancer     (RR [95% CI]= 0.85 [0.73, 0.99], I2 (%)= 0, P-value= 0.50)   
Excluded study or subgroup OR (95% CI) I2 (%) P-value 
Lee et al., 1989 (39) 0.84 (0.71, 0.99) 3 0.40 
Centonze et al., 1994 (40) 0.86 (0.74, 0.99) 0 0.43 
Boutron et al., 1996 (31) 0.83 (0.72, 0.97) 0 0.51 
Boutron-Ruault M-C et al., 1999 (43) 0.84 (0.72, 0.98) 0 0.42 
Mizoue et al., 2008 (46) 0.90 (0.76, 1.05) 0 0.78 
Sun et al., 2011 ON (48) 0.89 (0.74, 1.06) 0 0.46 
Sun et al., 2011 NL (48) 0.84 (0.72, 0.98) 2 0.41 
Green et al., 2014 (49) 0.82 (0.70, 0.96) 0 0.52 
Rectal cancer     (RR [95% CI]= 0.88 [0.69, 1.13], I2 (%)= 40, P-value= 0.17)   
Excluded study or subgroup OR (95% CI) I2 (%) P-value 
Lee et al., 1989 (39) 0.84 (0.64, 1.10) 54 0.11 
Williams et al., 2009 African (47) 0.88 (0.67, 1.14) 60 0.08 
Williams et al., 2009 Whites (47) 1.13 (0.81, 1.59) 0 0.79 
Green et al., 2014 (49) 0.77 (0.58, 1.03) 9 0.34 
TOTAL YOGURT 
Colorectal cancer     (RR [95% CI]= 0.92 [0.77, 1.09], I2 (%)= 0, P-value= 0.32)   
Excluded study or subgroup OR (95% CI) I2 (%) P-value 
Boutron et al., 1996 (31) 0.91 (0.75, 1.09) 0 0.35 
Sun et al., 2011 ON (48) 1.01 (0.78, 1.32) 0 0.95 
Sun et al., 2011 NL (48) 0.87 (0.71, 1.07) 0 0.56 
Colon cancer     (RR [95% CI]= 1.06 [0.90, 1.25], I2 (%)= 25, P-value= 0.26)   
Excluded study or subgroup OR (95% CI) I2 (%) P-value 
Kampman et al., 1994 (41) 1.03 (0.89, 1.20) 14 0.32 
Shannon et al., 1996 (women) (42)  1.09 (0.95, 1.23) 0 0.50 
Shannon et al., 1996 (men) (42) 1.04 (0.86, 1.26) 39 0.18 
Kampman et al., 2000 (men) (44) 1.04 (0.79, 1.38) 40 0.17 
Kampman et al., 2000 (women) (44) 1.09 (0.83, 1.43) 38 0.19 
CHEESE 
Colorectal cancer     (RR [95% CI]= 0.95 [0.79, 1.14], I2 (%)= 0, P-value= 0.62)   
Excluded study or subgroup OR (95% CI) I2 (%) P-value 
Centonze et al., 1994 (40) 0.97 (0.80, 1.18) 0 0.60 
Boutron et al., 1996 (31) 0.93 (0.76, 1.13) 0 0.55 
Boutron-Ruault M-C et al., 1999 (43) 0.95 (0.78, 1.16) 0 0.45 
Sun et al., 2011 NL (48) 0.90 (0.74, 1.11) 0 0.74 
Sun et al., 2011 ON (48) 1.02 (0.76, 1.35) 0 0.52 
Colon cancer     (RR [95% CI]= 0.87 [0.74, 1.02], I2 (%)= 0, P-value= 0.4)   
Excluded study or subgroup OR (95% CI) I2 (%) P-value 
Kampman et al., 1994 (41) 0.84 (0.71, 1.00) 0 0.51 
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Kampman et al., 2000 (men) (44) 0.85 (0.69, 1.04) 42 0.19 
Kampman et al., 2000 (women) (44) 0.95 (0.75, 1.21) 0 0.38 
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VI.  DISCUSSION 
 
Each Chapter of the present doctoral thesis includes a discussion section. However, some aspects 
that could not be deeply addressed in the articles, as well as new evidence after their publication 
are further discussed in this section. Furthermore, limitations and strengths of our articles are 
also provided. 
 
1. GENERAL DISCUSSION 
Within the frame of the PREDIMED study, the present doctoral dissertation provides new 
prospective evidence on the associations between the consumption of different subtypes of dairy 
products, considering their composition in sugar and fat, and the risk of developing CRC. 
Moreover, the present thesis provides updated meta-analytical evidence of the available scientific 
literature on the associations between the consumption of different types of dairy products and 
CRC incidence in adults. Finally, the associations between adhering to cancer-specific and healthy 
lifestyle recommendations and CRC risk in the context of the PREDIMED trial are also addressed.  
The findings of this thesis suggest that high total dairy product consumption was inversely 
associated with CRC incidence in elderly Spanish individuals with CVD risk, and especially, of 
importance was the intake of low-fat milk, which was the main driver behind the inverse 
association. However, the intake of other dairy product subtypes (whole-fat and low-fat dairy 
products; total, low-fat and whole-fat yogurt; cheese; total, low-fat and whole-fat milk; 
concentrated full-fat dairy products, sugar-enriched dairy products and fermented dairy products) 
was not significantly associated with CRC risk.  
In addition, the systematic-review and meta-analysis of observational studies included in the 
present thesis showed that higher consumption of total dairy products and total milk was 
consistently inversely related to CRC risk at all site. Moreover, cheese consumption was inversely 
associated with the risk of CRC and proximal colon cancer, and low-fat milk consumption was 
associated with decreased colon cancer risk in adults. No significant associations were found 
between CRC and the consumption of low-fat dairy products, whole milk, fermented dairy 
products or cultured milk.  
Our results concerning the consumption of dairy products and the associated CRC risk in the 
PREDIMED study, are in agreement with the last Diet, nutrition, physical activity and colorectal 
cancer report 144, in which dairy products (this category includes evidence from total dairy, milk, 
cheese and calcium intakes) are judged to decrease CRC risk with strong evidence. Likewise, the 
UNIVERSITAT ROVIRA I VIRGILI 
DIETARY AND LIFESTYLE DETERMINANTS ASSOCIATED WITH THE RISK OF COLORECTAL CANCER 
Laura Barrubés Piñol 
most current systematic reviews and meta-analyses of prospective studies have reported that 
total dairy product or milk consumption is inversely associated with CRC risk 130,187.  
However, although an inverse association between dairy product consumption, and especially 
milk, and CRC risk is suggested based on prospective cohort studies conducted in healthy 
populations 165,179–186, there is insufficient evidence in older individuals at high cardiovascular risk. 
Simultaneously, case-control studies investigating the associations between dairy product 
consumption and CRC risk have shown inconclusive results 168,169,178,170–177. 
In our prospective observational cohort study, cheese intake was not significantly associated with 
the risk of developing CRC, probably due to the limited number of CRC cases, and because of the 
low consumption of fermented dairy in our cohort. This discrepancy might be also explained by 
differences in the populations studied, the dietary assessment tools used, and types of cheese 
assessed. Besides, bioaccessibility and bioavailability of the nutrients contained in dairy foods 
might be different depending on the nature of the food matrix 236. For instance, the high lactose 
content in milk in comparison to fermented dairy products might decrease the bioavailability of 
calcium 237, which seems to be the main contributor to the potential protective effect of dairy 
products against CRC. Likewise, we hypothesized that fat content in full-fat milk might mitigate 
the potential benefits of the other bioactive components 238. In this regard, it is necessary to 
emphasize that in the recent systematic review and meta-analysis of prospective studies by 
Schwingshackl 130, inverse associations with CRC risk for both low and high-fat dairy product 
intakes were found. 
Altogether, the results of this thesis expand the associations between dairy product consumption 
and CRC incidence to other populations, suggesting that low-fat milk intake might decrease CRC 
in elderly individuals with CVD risk. In addition, the consumption of other subtypes of dairy foods 
including whole-fat dairy products was not associated with CRC risk. As outlined in the 
Introduction section of the present thesis, in the last decades, most dietary worldwide guidelines 
have encouraged the consumption of low-fat dairy products instead of their full-fat counterparts. 
This might be probably the main cause for the low consumption of whole-fat milk (a median 1.7% 
of the total milk intake) in our cohort. Thus, our findings also suggest that there is currently not 
enough scientific data to make strong dietary recommendations that promote avoiding full-fat 
dairy product consumption. 
On the other hand, the results regarding the consumption of dairy products and CRC risk based 
on the PREDIMED study were supported by the findings of the systematic-review and meta-
analysis included in the present doctoral thesis. After conducting a systematic review and meta-
analysis of all available scientific literature on dairy product consumption and the associated risk 
of developing CRC, we found that the highest intake of low-fat milk, compared to the lowest, was 
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related to 26% lower risk of CRC, although only for colon cancer. Furthermore, the consumption 
of total dairy products was significantly associated with 20% decreased CRC risk. It is also 
important to note that, the cohort studies analyzed in our systematic-review and meta-analyses 
showed a lower risk of CRC associated with higher cheese consumption, which is in accordance 
with the last WCRF/AICR conclusions 144.  
From a mechanistic point of view, dairy product may decrease CRC risk by several mechanisms. 
However, the most widely studied anticarcinogenic component in dairy products and probably the 
main contributor to this protective effect is its calcium content. An established mechanism 
proposed for calcium action is its capability to bind unconjugated bile acids and free fatty acids, 
lessening their toxic effects on the colorectum 239. Basic and clinical studies suggest that 
intracellular calcium may also reduce proliferation and promote colonic epithelial differentiation, 
likely by influencing different cell-signaling pathways 240,241. Calcium may also prevent colonic K-
Ras mutations and inhibit heme-induced promotion of colon carcinogenesis 242,243. Epidemiological 
evidences also indicate the importance for CRC risk of some dietary components found in dairy 
products such as vitamin D in enriched dairy products, and calcium 222,244–246. On the other hand, 
other components naturally present in dairy products such as conjugated linoleic acid, butyric 
acid, lactoferrin, folate and lactic acid bacteria in fermented foods have been also suggested to 
exert protective effects against colorectal carcinogenesis by different mechanisms 247–252.  
Finally, adhering to emergent lifestyle scores, such as the 2018 WCRF/AICR and the LRL scores, 
may substantially reduce CRC risk in the PREDIMED study. The second prospective work included 
in the present dissertation, which focuses on the associations between following healthy lifestyle 
recommendations and the associated CRC risk, showed that adhering to the 2018 WCRF/AICR 
recommendations and following healthier behavior patterns, calculated as LRL score, may 
considerably help to reduce by almost 50% the risk of developing CRC in an elderly Mediterranean 
population at high CVD risk. Even though the WCRF/AICR score was specifically designed in a 
context of cancer prevention, our results suggest that using other scores based on healthy lifestyle 
patterns such as the LRL index, which was developed to evaluate the impact of an overall healthy 
lifestyle pattern on all-cause mortality (comprising cancer and CVD mortality), might also be a 
useful tool to prevent CRC, especially in elderly individuals. These results are of great importance 
since, as far as we are aware, this is the first study based on the LRL score focusing on CRC 
incidence. Another great advantage of this prospective observational cohort study from the 
PREDIMED trial is that, it provides scientific evidence in a population under-studied in this field. 
Furthermore, most studies on which the WCRF/AICR recommendations are based on, are focused 
on a general adult population. 
Additionally, our results suggest that synergy between the various factors of each score might be 
one of the main mechanisms for the decreased CRC risk, thereby showing that the sum of all 
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components might be more than the action of each one individually. On the other hand, SSB 
consumption was shown to be independently associated with CRC risk in our analyses, which is 
in accordance with the WCRF/AICR conclusions 144. This recognized international organism states 
that SSB intake is mostly linked to weight gain, which increases CRC risk. However, other 
potential mechanisms suggested in the literature should be further explored. 
According to the results of the present doctoral thesis, owing to the evidence on the benefits that 
the consumption of low-fat milk might have on the risk of CRC in elderly individuals with CVD 
risk, and the lack of evidence on an increased CRC derived from full-fat dairy consumption, it is 
suggested that there are no consistent reasons to advice against whole-fat dairy product intake 
in this population. Hence, although further prospective research on the topic is warranted, the 
recommendation to drink milk might be reasonable. In addition, adopting healthier lifestyle habits 
that not keep diet in mind, but also other lifestyle factors, should be of primary interest for 
preventing the risk of developing CRC in Mediterranean elderly individuals with overweight or 
obesity who have CVD risk.  
 
2. LIMITATIONS AND STRENGTHS 
 
The results from the present doctoral thesis should be interpreted considering some limitations: 
 
▸ With respect to the PREDIMED-studies: 
 
• The causality of the observed associations in the observational cohorts within the context of 
the PREDIMED study cannot be established due to the observational nature of the study 
design. 
• Regarding the observational cohort studies from the PREDIMED trial, it might be difficult to 
generalize the results to other populations because we studied an older Mediterranean 
population at high cardiovascular risk. However, the inverse associations observed in both 
works have been previously recognized, especially for dairy product intake, in young 
individuals from different populations. Thus, our results expand the evidence to the previous 
findings reported on these associations.  
• Because the consumption of dairy product has been associated to a decreased risk of obesity 
and T2D, both conditions highly prevalent in older populations, we cannot discard that the 
inverse associations that we observed might have been mediated by these metabolic 
conditions. 
• Although dietary variables were assessed by using a validated FFQ, potential measurement 
errors are unavoidable. Further, although the intervention arm was considered as a potential 
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confounder in our main statistical models, we cannot discard residual confounding due to the 
dietary interventions. 
• Because this is a prospective, observational study based on a randomized clinical trial, we 
cannot rule out a restriction on the consumption of dairy products due to the dietary 
intervention, especially in the control group, which may have had an impact on the outcomes. 
• Since the score components in the second Chapter of the present thesis were added, they 
contributed equally to the total score. The fact that not all the components of the WCRF/AICR 
score are associated with the risk of CRC might have weakened the associations observed. 
• Because CRC was a secondary outcome in the PREDIMED trial, we did not have enough CRC 
cases to investigate CRC cases separately or by tumor site with enough statistical power. This 
lack of statistical power might also explain the lack of association found between individual 
components consistently associated with decreased CRC risk. 
   
▸ With respect to the meta-analysis: 
 
• Despite the high-quality of the studies we analyzed in our systematic-review and meta-
analysis, owing to the observational nature of the studies included and due to the possibility, 
that not all the studies were adjusted for important dietary variables potential residual 
confounding cannot be ruled out. 
• Some of the dietary assessments were self-reported, which might affect the reliability of the 
reported intakes. However, the use of validated FFQs could have decreased this bias. 
• There was some statistical heterogeneity among the studies included in the systematic review 
and meta-analysis. Nevertheless, this heterogeneity was explained by the removal of 
individual studies.  
• Because we were not able to search for all available databases, we cannot ignore the 
possibility that some references may have been missed in the systematic search. 
• Given the observational nature of the studies included in the systematic review and meta-
analysis, the results cannot support causal relationships between dairy product consumption 
and CRC risk. 
 
The present investigation has also several strengths: 
 
▸ With respect to the PREDIMED-studies: 
 
• The large-scale prospective design with a long follow-up period and a large sample of the 
observational cohorts based on the PREDIMED trial. 
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• CRC cases in the PREDIMED were ascertained and confirmed by an independent Event 
Adjudication Committee annually. 
• Food consumption in the PREDIMED study was assessed by using a validated FFQ. 
• We had the ability to control for several potential confounders in our statistical analyses. 
• In the observational cohort study assessing dairy product intake and CRC risk, to minimize 
errors in diet measurements caused by within-person variation and dietary changes, we took 
advantage of the repeated measurements of intake, and we calculated the cumulative average 
for dietary variables. 
• We confirmed the robustness of our results by testing our primary results with different 
approaches and sensitivity analyses. 
 
▸ With respect to the meta-analysis: 
 
• For the systematic review and meta-analysis we a) identified prospective cohort and case-
control studies through a systematic search, b) used a quantitative NOS scale to exclude low-
quality studies, and 3) all the studies in our analyses used a validated FFQ to assess dairy 
product consumption. 
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VII. Conclusions 
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VII.  CONCLUSIONS 
 
 
The main goals of this thesis were a) to investigate the associations between the consumption of 
different subtypes of dairy products and the risk of developing CRC in the PREDIMED trial, b) to 
assess the associations between cancer-based recommendations and healthier lifestyle patterns 
with CRC in the PREDIMED study, and c) to meta-analyze all the available scientific evidence on 
dairy product consumption and CRC risk in adults. Because prospective evidences studying the 
association between dairy product consumption and CRC incidence in elderly individuals was 
limited, and because of the lack of prospective studies assessing the CRC risk associated with 
healthier lifestyle recommendations in elderly individuals, this thesis has contributed to increase 
the scientific epidemiological knowledge in this field.   
 
In this section, the conclusions of the present dissertation are presented in response to each of 
the hypotheses raised at the beginning of the present thesis. 
▸ Hypothesis 1: Consumption of different subtypes of dairy products, considering their sugar 
and fat content might be differently associated with the risk of CRC in the PREDIMED study. 
 
• Within the frame of the PREDIMED cohort of older Spanish individuals at high CVD risk, 
high total dairy product consumption was inversely associated with CRC incidence, and 
the intake of low-fat milk was supposed to be the main driver behind this inverse 
association. However, no significant associations with other dairy products (whole-fat and 
low-fat dairy products; total, low-fat and whole-fat yogurt; cheese; total, low-fat and 
whole-fat milk; concentrated full-fat dairy products, sugar-enriched dairy products and 
fermented dairy products) were found. 
 
▸ Hypothesis 2: High adhesion to a priori lifestyle scores (the WCRF/AICR and the LRL scores) 
might decrease the risk of developing CRC in the PREDIMED study. 
 
• Adherence to the most recent 2018 WCRF/AICR recommendations, as well as 
accomplishing a cluster of LRL factors, was inversely associated with CRC incidence in 
elderly Spanish individuals at high CVD risk. 
• In terms of the WCRF/AICR score, greater adherence to the SSB recommendation was 
strongly and inversely associated with a statistically significant decreased risk of 
developing CRC. Neither the other individual recommendations of the WCRF/AICR 
score nor the individual components of the LRL score were significantly associated with 
CRC risk in elderly Spanish individuals at high CVD risk. 
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▸ Hypothesis 3: The consumption of dairy products and the risk of developing CRC might be 
associated in different ways depending on the type of dairy product and CRC subsite and 
location. 
 
• Higher consumption of total dairy products and total milk was consistently inversely 
related to CRC risk at all sites, cheese consumption was inversely associated with the 
risk of CRC and proximal colon cancer, and low-fat milk consumption was associated 
with decreased colon cancer risk in adults. No significant associations were found 
between CRC and the consumption of low-fat dairy products, whole milk, fermented 
dairy products or cultured milk. The associations between different subtypes of dairy 
products and CRC risk differed by colon cancer location and subsite. 
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VIII. Global and future 
insights 
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VIII. GLOBAL AND FUTURE INSIGHTS 
 
CRC might be prevented in nearly half of new cases through lifestyle changes. Although the 
increase in the incidence and mortality of CRC in future decades is unavoidable due to the 
development and westernization of nutritional and lifestyle habits, scientific evidence suggests 
that reducing adiposity, increasing PA, adhering to a healthy diet, decreasing alcohol intake and 
reducing smoking, among other factors, could substantially reduce the risk of CRC. 
This doctoral thesis adds new evidence to the current scientific literature regarding the nutritional 
epidemiology of CRC. On the one hand, our results allow us to better understand the associations 
between the consumption of certain foods that are part of a healthy dietary pattern, such as dairy 
products, with CRC incidence. Additionally, our research also permits to gain understanding of 
the synergistic association between different lifestyle risk factors and the risk of developing CRC 
in elderly individuals with cardiovascular risk. 
Based on the results found in this dissertation, and considering the available scientific literature 
on this subject, different aspects are suggested to address in future research, which are necessary 
to clarify the role that different dietary and lifestyle components may play in the development of 
CRC, as well as their combined effect: 
 
▸ Additional prospective studies are needed, both in the general and in specific populations, in 
other geographical regions that confirm our results on the relationship between dairy 
consumption and CRC risk, and allow them to be extrapolated to the general population. 
▸ Further prospective studies with large samples and long follow-up periods, as well as clinical 
trials that take into account the long latency period of CRC, known difficulties with dietary 
compliance, and other complexities are needed to clarify the associations between CRC risk, 
including the differences in CRC risk across subsites, and the fat and sugar contents of dairy 
products. 
▸ Dietary assessment tools used in nutritional epidemiological studies should be improved in 
order to represent the usual intake. For instance, new varieties of dairy products such as 
artificially sweetened dairy products are not considered in most studies. Additionally, most of 
dietary questionnaires do not bear in mind different subtypes of cheese but include them in 
the same category. On the other hand, some studies do not use standardized serving sizes 
which difficult comparability and generalization of the results. The results of our research 
based on the adherence to emergent lifestyle scores need to be replicated in other populations 
with different dietary and lifestyle patterns. For this purpose, large-prospective cohorts with 
more events are needed to extend the evidence on lifestyle patterns and CRC risk
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▸ OMICS, and in particular metabolomics, can give us the opportunity to identify biomarkers of 
dairy food intake and its effects on metabolism in order to better identify the relationship 
between dairy intake and disease as well as to identify potential pathways implicated in these 
relationships.   
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3. Mobility 
 
Length: 3 months (01/04/2019 - 30/06/2019) 
Institution : Équipe de Recherche en Épidémiologie Nutritionnelle (EREN). UMR U1153 Inserm / 
U1125 Inrae / Cnam / Université Paris 13 - Sorbonne Paris Nord. Centre de Recherche en 
Epidémiologie et Statistiques - Université de Paris (CRESS). 
Location: 93017 Bobigny CEDEX. France 
Supervision: Dr. Mathilde Touvier 
Objectives set during the stay and degree of achievement: During the 3-month stay, it was 
assessed the association between dairy product consumption (total dairy, cheese, white cheese, 
yogurt and yogurt-like products) and the risk of developing total cancer, breast cancer, prostate 
cancer and CRC, in the context of the NutriNet Santé cohort (n=101,279). The objective was to 
verify whether the relationships observed in the present thesis regarding dairy products may be 
extrapolated to the general population. 
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The predoctoral stay in the EREN team allowed to: 
• Gain experience in the field of epidemiological research within a relevant international 
group on the thesis subject. 
• Learn how to work with new statistical tools (SAS program®).  
• Improve skills at the personal and teamwork level. 
• Expand knowledge about the food-to-cancer ratio within a large-scale cohort. Specifically, 
about the association between the different dairy subtypes and the risk of different types 
of cancer (specified previously), including CRC, which belongs to the subject of the doctoral 
thesis. 
• Open the doors to possible future collaborations. With the results obtained during the 
doctoral stay, as a result of the collaboration between the EREN group and the Human 
Nutrition Unit a publication will be carried out. 
• Improve language skills in English and French.  
• Obtain a doctoral degree with international mention. 
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